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General introduction
General introduction
Fibromyalgia, a musculoskeletal pain syndrome, poses a great burden to the 
patients who suffer from it.1 In addition to chronic widespread pain and tenderness 
in at least 11 of the 18 so-called tender points, patients endure a substantial 
number of accompanying complaints among which functional disability, fatigue, 
morning stiffness, sleep disturbances and psychological distress. Varying between 
2% and 10%, the prevalence of fibromyalgia in Western countries is fairly high and 
the majority of patients is female.2 3 Fibromyalgia is estimated to have about the 
highest impact of all rheumatic and chronic pain conditions. Individuals diagnosed 
with fibromyalgia, for example, report higher levels of pain and functional 
disability and judge their quality of life as poorer than patients with other 
rheumatic conditions.45 They, moreover, make extensive use of health services, 
adding substantially to the medical and societal care costs.6 The syndrome's 
pathology is not well understood and biomedical findings are limited. Fibromyalgia 
thus poses an important challenge to clinicians, while to date no single treatment 
has proven effective in fully alleviating its symptoms. Combinations of cognitive 
behavioral therapy (CBT) and physical exercise training have so far yielded the 
most promising results, but overall effects were limited.7'11 The unsatisfactory 
outcomes of non-pharmacological treatments are at the basis of the studies 
reported in this thesis, which together aimed at gaining more insight into better 
screening methods and hence potentially more successful tailored treatment 
approaches for patients with this poorly understood but debilitating condition.
Health outcom es in fibrom yalgia
The assessment of health outcome is a prerequisite in the study of treatment 
effects. In line with general definitions, physical as well as psychological 
functioning are relevant dimensions of health.12 Physical functioning is evaluated 
based on several specific symptoms, but in fibromyalgia pain is the sole diagnostic 
criterion, which is also commonly seen as the main subjective complaint. In 
addition, fatigue is another frequently reported symptom. Furthermore, the 
syndrome strongly affects a patient's daily functioning, often leading to limitations 
in daily activities. With regard to psychological functioning, many patients with 
fibromyalgia suffer from heightened levels of anxiety and negative mood.1314 In 
addition to these general physical and psychological health outcomes, impact of 
fibromyalgia on daily life describes the effects of the entire spectrum of problems 
(in)directly related to fibromyalgia, such as interference with daily activities.15 In
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sum, and as depicted in Figure 1, the three delineated outcomes together are 
important indicators of health in fibromyalgia and frequently applied in studies 
examining treatment outcome in this population.
Figure  1 Health outcomes in fibromyalgia
Physical functioning Psychological functioning Im pact of fibrom yalgia  
on daily life
including: including: including:
>  Pain > Negative mood > Impact on daily activities
> Fatigue
> Functional disability
> Anxiety and work capacity
Supplementary to the standardized health outcomes, in clinical research and 
practice, the patient's perspective has gained importance. Due to the growing 
awareness that the patient's point of view on the care process has great relevance, 
concepts such as treatment satisfaction, perceived usefulness of the treatment, 
and the patient's perception of improvement during treatment are assessed more 
frequently and used as indicators of treatment value, quality and outcome.1617 Yet, 
even though we still know little about the magnitude and significance of response 
shifts that could influence their assessment and the clinical relevance of the 
measures themselves, standardized measures of health outcome are generally 
still considered the golden standard in clinical research,1819 whereas outcomes 
from the patient's perspective reflect the patient's judgment, thus making them 
clinically relevant measures. Since the relationship between outcomes determined 
with validated measures and those based on the patient's perspective is as yet 
unclear, both types of outcome measures should be considered relevant when 
studying treatment effects.
Cognitive behavioral factors in fibrom yalgia
Biopsychosocial models in fibromyalgia and chronic pain underscore the importance 
of cognitive behavioral factors that can account for the development, maintenance 
and exacerbation of chronic pain. The frequently studied fear-avoidance model is 
such a biopsychosocial model of chronic pain.2022 The model postulates fear of
14
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pain, worrying about the negative consequences of pain and a heightened 
attention to pain (hypervigilance) as aggravating factors, which leads to avoidance 
behavior or withdrawal from activities. Long-lasting avoidance of activities can 
eventually lead to changes in the musculoskeletal system due to physical 
deconditioning and impaired muscle coordination, also known as the 'disuse 
syndrome'.23 The resultant deficient physical condition may in turn exacerbate the 
pain problem. This habitual pattern of physiological, behavioral and cognitive 
reactions to pain can be generalized to various other situations that will also 
negatively affect long-term outcomes. Patients with pronounced avoidance 
behavior have, for instance, been shown to have a tendency to restrict their daily 
and social activities and withdraw from work, which will negatively affect 
long-term pain outcomes.2425 Social factors, like external reinforcements by the 
patient's social network, can further reinforce and maintain the avoidant behavior. 
In addition, avoidance may also include withdrawal from positive reinforcers such 
as social and leisure activities, resulting in social isolation which may in turn 
exacerbate the psychological distress and reduce quality of life even further.26 A 
vicious cycle has thus been established (Figure 2). There is some evidence from 
experimental and prospective studies for the relevance of several of thefactors of 
fear-avoidance models in chronic pain, including fibromyalgia. For example, 
higher levels of pain and depression and a lower quality of life were prospectively 
predicted by catastrophizing in patients with fibromyalgia.27 Passive pain-coping 
behaviors have also been shown to predict higher levels of functional disability 
and complaints in several chronic pain conditions.28-31 Experimental studies 
demonstrated that fibromyalgia patients tend to display hypervigilance for 
aversive stimuli such as pain or for bodily sensations in general.3233 Fear of pain 
has additionally been associated with an increased susceptibility to pain and 
greater disability and depressed mood in patients with fibromyalgia.3435
At the same time, underlying pain mechanisms that are not captured by the 
fear-avoidance model are gaining increased attention. Preliminary evidence 
suggests a distinctive pattern in patients who tend to persist in their activities in 
spite of the complaints, that can lead to physical overload and more complaints in 
the long run.36-40 Cognitive factors such as persistence-related self-statements 
and ignoring pain or pain-related thoughts are proposed to trigger and reinforce 
persistence behavior. The repetitive ineffective attempts to ignore the pain is 
likely to exacerbate depressive complaints.37 Furthermore, when bodily warning 
signals are ignored, this may increase the risk of overactivity and possibly physical 
overload over time. In the long run, persistence patterns may be detrimental
15
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because the disbalance in activity and inactivity (long periods full of activities 
until exhaustion sets in followed by long periods of inactivity) will likely cause 
more pain and fatigue and consequently increasingly more psychological distress 
(Figure 2). Preliminary evidence suggests that these persistence mechanisms 
could be risk factors for the development and maintenance of physical and 
psychological impairments.2737'40'41
Figure  2 Proposed theoretical model of pain-related avoidance and 
persistence patterns in fibromyalgia
PAIN-AVOIDANCE PATTERN PAIN-PERSISTENCE PATTERN
Pain-avoidance behavior:
High avoidance behavior
Functional disability 
Fatigue 
Psychological distress
Pain
Pain-persistence behavior:
Low avoidance behavior 
Low activity pacing
■
Pain-avoidance cognitions:
Fear of pain 
Hypervigilance 
Worrying about pain
Pain-persistence cognitions:
Persistence statements 
Ignoring pain
In addition to these pain-related cognitions and behaviors, generic cognitive 
behavioral factors have been shown to be relevant for health outcomes in 
fibromyalgia. For example, illness cognitions related to the concept of control, 
such as acceptance and helplessness, have been shown to affect outcome in 
several chronic conditions, including fibromyalgia.42'44 Helplessness theories 
suggest that patients who feel unable to control their condition are more 
susceptible to negative outcomes, like depression, but there is also evidence that 
attempts to control, rather than accept, uncontrollable conditions like chronic 
pain can be detrimental in the long-term.45-47 Social support is another important
16
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genericaspectthatcan actasa protectivefactoragainst negative health outcomes 
in chronic conditions, for example by stimulating social activities, with qualitative 
aspects of social support being more important than quantitative aspects.48,49
O ptim izing the treatm ent of fibrom yalgia
Over the past few decades, a wide range of potentially promising treatments have 
been tested in fibromyalgia populations. Pharmacological therapies primarily 
comprise analgesics, antidepressants, anticonvulsants, hormone therapy or a 
combination of these drugs. A review of the various regimens showed that tricyclic 
anti depressants (e.g., amitriptyline and cyclobenzaprine) were the most promising 
in reducing pain and sleep problems.8'50 Apparently however, many patients 
report symptoms of drug intolerance and consequently discontinue taking their 
medication.51 Whereas medicinal treatment mainly aim at a short-term relief of 
symptoms, non-pharmacological interventions aim to address the long-term 
consequences of the condition, such as functional disability, fatigue, psychological 
distress, and muscular deconditioning. Combinations of CBTand physical exercise 
training have, so far, yielded the most promising results, although the effects 
were overall limited and showed large individual variability.7,52 Currently, all 
fibromyalgia patients are treated with one more or less uniform intervention, 
despite the individual diversity, which may explain the generally disappointing 
effect sizes and high drop-out rates. In line with findings in various other 
conditions associated with chronic physical symptoms, recent developments in 
fibromyalgia research suggest that the effectiveness of interventions may be 
improved by taking the heterogeneity of the patient group into consideration. 
Tailoring approaches may comprise selecting specific homogeneous patient 
groups and customizing the type, content, and timing of the intervention.
Selecting specific patients for treatment
Psychological distress has been shown to be an important riskfactorfor a negative 
long-term outcome in several chronic pain conditions, including fibromyalgia. It 
has, for example, been shown to be a prognostic factor for overall health status, 
including high levels of pain, fatigue and functional disability.53-55 Accordingly, 
psychological distress is regarded a keyfactorin the early identification of patients 
at risk of long-term dysfunction. Furthermore, high levels of distress have been 
shown to be an indicator of maladaptive cognitive behavioral patterns targeted in 
CBT.56,57 Several treatment studies indeed found relatively highly distressed 
fibromyalgia patients to have better treatment outcomes.56,58'59 Therefore,
17
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selecting patients showing heightened distress at subclinical levels of anxiety and 
depression to be included in targeted interventions may help enhance treatment 
effects.
Tailoring treatment to the patient's cognitive behavioral pattern
There is some evidence to suggest that targeted non-pharmacological 
interventions that address the specific needs of a particular subgroup are more 
effective. In his overview, Turk60 supports the notion that results of treatment in 
patients with chronic pain can be enhanced if the intervention is tailored to the 
patient's characteristics. In order to improve treatment effects, interventions need 
to be systematically based on the cognitive behavioral mechanisms proven to 
play a prominent role in the development and perpetuation of chronic pain. CBT 
interventions that systematically address key elements of the fear-avoidance 
model through exposure in vivo, for instance, have yielded promising results in 
patients with chronic low-back pain, particularly for those patients with high 
levels of fear of pain.61 In addition, other treatment approaches tailored to the 
patients' individual risk factors have been found effective in improving physical 
and psychological functioning in several chronic pain conditions.5762Thieme and 
colleagues,63 found that the fibromyalgia patients who had benefited from a 
pain-avoidance treatment aimed at increasing daily activities and diminishing the 
patients' fear of pain, reported higher baseline levels of pain behavior, social 
reinforcement, and catastrophizing than their peers who reported no change, 
while the patients who benefited from a pain-persistence treatment aimed at 
pacing their activities and changing their high self-demands less frequently 
reported pain behavior and social reinforcement at baseline than their counterparts 
reporting no change. The distinction of patients with pain-related avoidance and 
persistence patterns offers new possibilities for a tailored approach. Nevertheless, 
we need more direct evidence to underscore the efficacy of treatment approaches 
that are tailored to these specific cognitive behavioral patterns in improving 
physical and psychological functioning in fibromyalgia.
Offering a timely intervention
The significance of an early detection and timely treatment of patients at high risk 
of developing chronic pain and related problems is increasingly recognized.46 
Timing is important for several reasons. Firstly, fibromyalgia is a condition 
associated with pronounced pain, multiple disabilities in daily life, serious 
psychological distress, and significantly reduced quality of life. Intervening early
18
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in the course of a pain condition may help prevent the vicious cycle of long-term 
physical and psychological suffering. Secondly, patients who have had fibromyalgia 
for an extended period may have ingrained, maladaptive cognitive behavioral 
pain-coping patterns and illness behaviors that are rather resistant to treatment, 
making it more difficult for patients to change their attitude and behavior. Finally, 
early intervention has the potential to reduce or prevent disability in patients with 
chronic pain syndromes, which, in turn, will reduce the resultant societal and 
medical costs. From the above, it follows that early intervention is far more likely 
to be effective than interventions delivered at the later stages of the condition. 
Consequently, non-pharmacological treatments that are initiated shortly after a 
patient has been diagnosed with fibromyalgia can help prevent long-term 
dysfunction and chronicity in this population. Some preliminary evidence has 
been published indicating that such an early intervention is indeed an important 
factor in augmenting treatment outcomes in fibromyalgia. Keel et al64 showed 
that a subgroup of fibromyalgia patients with a shorter duration of complaints 
responded best to the treatment. Similar results are also found in other chronic 
pain conditions. Marhold et al65 showed that a cognitive behavioral return-to-work 
programme was effective in those chronic pain patients that had been on sick 
leave for a relatively short time but not for those that had been out of work longer. 
Also, two studies showed the effectiveness of cognitive behavioral interventions 
for patients recently diagnosed with rheumatoid arthritis (RA).57,66 Other 
retrospective findings of studies in RA also demonstrated that the patients who 
were treated shortly after the diagnosis responded best to non-pharmacological 
treatment.6768 Collectively, these findings indeed suggest that relatively early 
treatment of chronic pain conditions is likely to enhance the efficacy of cognitive 
behavioral interventions and thus also CBT targeting fibromyalgia. The studies 
reported in this thesis were accordingly designed and conducted to add insight to 
the existing theories on fibromyalgia, its underlying mechanisms and treatment.
Aim and outline of the thesis
The main objectives of the studies presented in this thesis were to gain a further 
understanding of two cognitive behavioral patterns observed in fibromyalgia, i.e. 
pain-avoidance and pain-persistence patterns, to explore screening methods for 
these patterns, and to test the effectiveness of interventions that specifically 
address these patterns. Part I concerns the theoretical and empirical background 
of non-pharmacological treatment in fibromyalgia. Chapter2 comprises a review 
summarizing the existing literature on cognitive behavioral therapy and exercise
19
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training or a combination of the two in treatment for fibromyalgia. It further 
discusses future directions to enhance the effectiveness of treatment for 
fibromyalgia. In Part II, evidence on cognitive behavioral patterns and screening 
issues is described to facilitate the selection of specific subgroups of patients for 
treatment. For tailored treatment to be successful, a reliable and valid screening 
procedure is indispensable as well as more in-depth knowledge of the patient's 
underlying cognitive behavioral mechanisms. In Chapter 3, we report a study in 
which we explored the validity of a screening instrument to distinguish between 
pain-avoidance and pain-persistence patterns in patients with fibromyalgia. The 
results of the screening instrument were compared with regard to several 
pain-related cognitive behavioral factors, the level of physical fitness, as well as 
the judgm ent of therapists. A screening instrument of psychological distress was 
also used to help identify patients with heightened levels of distress who are at 
high risk of long-term dysfunction, and who have been proposed to be most likely 
to benefit from multidisciplinary treatment. Of particular interest with this 
screening instrument is the long-term course in relatively well-functioning 
fibromyalgia patients with current low levels of distress who are rarely considered 
for multidisciplinary treatment. To prevent long-term dysfunction in these 
patients it is important to identify those patients that may be a risk of aggravated 
psychological distress in an early stage. In Chapter 4 we, therefore, studied 
potential risk factors for longer-term psychological distress in this subgroup of 
patients with low levels of distress. In Part III of the thesis, the outcomes of tailored 
treatment programmes for fibromyalgia consisting of CBT and exercise training 
are reported and discussed. In Chapter5, we present two case studies to illustrate 
our targeted approach to the treatment of fibromyalgia. One patient characterized 
by pain-avoidance patterns, i.e. prone to avoidance behavior when dealing with 
pain, participated in a group intervention aimed at changing pain-avoidance 
mechanisms, while a second patient showing persistence patterns, i.e. tendency 
to persist in activities in spite of the pain, joined a group programme aimed at 
changing her persistence mechanisms. In clinically research and practice, 
increasing attention is devoted to the patient's perspective. Concepts such as 
patient satisfaction and the patient's perception of improvement are increasingly 
applied as indicators of treatment quality and even outcome. However, the 
relationship between the patient's views on treatment progress and standardized 
pre-post changes in health outcomes is not well understood. Therefore, in Chapter 
6 we looked more closely at the associations between the patient's perceived gain 
following a treatment consisting of CBT and exercise training and standardized
20
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pre-post changes. The effectiveness of our two treatments targeting pain- 
avoidance and pain-persistence patterns was assessed in a randomized controlled 
trial (RCT) of high-risk patients recently diagnosed with fibromyalgia. In Chapter7 
we discuss the results of this RCT on self-reported physical and psychological 
functioning and impact of fibromyalgia assessed before and after treatment and 
at 6-month follow-up. As physical exercise training aimed at increasing the 
patients' physical fitness was one of the components of our treatment approaches, 
in Chapter 8 we evaluated the effectiveness of the two tailored treatments with 
regard to the level of physical fitness assessed with two physical fitness tests. In 
Chapter 9, we discuss the effects of the pain-avoidance and the pain-persistence 
treatment in terms of self-reported changes in several pain-related cognitive 
behavioral factors to provide insight in their working mechanisms, specifically the 
effect of pain-avoidance behaviors and activity pacing as the main proposed 
cognitive behavioral mechanisms of pain-avoidance and pain-persistence 
patterns, respectively. Concluding this thesis, in Chapter 70the main results of the 
reported studies are summarized and in Chapter 11 the theoretical and clinical 
implications of our findings and directionsforfuture research are discussed in the 
light of the existing knowledge as well as of recent developments in the field of 
cognitive behavioral treatments for fibromyalgia.
21
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Abstract
This review provides an overview of the effects of non-pharmacologica I treatments 
for patients with fibromyalgia (FM), including cognitive behavioral therapy, 
exercise training programmes, or a combination of the two. After summarizing 
and discussing preliminary evidence of the rationale of non-pharmacological 
treatment in patients with FM, we reviewed randomized, controlled trials for 
possible predictors of the success of treatment such as patient and treatment 
characteristics. In spite of support for their suitability in FM, the effects of non- 
pharmacological interventions are limited and positive outcomes largely 
disappear in the long-term. However, within the various populations with FM, 
treatment outcomes showed considerable individual variations. In particular, 
specific subgroups of patients characterised by relatively high levels of 
psychological distress seem to benefit most from non-pharmacological 
interventions. Preliminary evidence of retrospective treatment analyses suggests 
that the efficacy may be enhanced by offering tailored treatment approaches at 
an early stage to patients who are at risk of developing chronic physical and 
psychological impairments.
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Introduction
Fibromyalgia (FM) is a chronic musculoskeletal pain syndrome characterized by 
widespread pain and tenderness in at least 11 of the 18 socalled tender points. 
Patients frequently report sensations of fatigue, sleep disturbances, morning 
stiffness, symptoms associated with irritable bowel syndrome and affective 
distress.1 The prevalence of FM in Western countries varies between 2% and 10% 
and the majority of the patients is female.2 3 Most patients report a high degree of 
impairment in their daily functioning. In comparison with other chronic pain 
conditions, patients with FM report higher levels of pain and functional disability 
and judge their quality of life as poorer.4'6 Moreover, they make extensive use of 
health services, thus leading to high costs for medical and societal care.7 
The syndrome's pathology is not well understood, and to date no treatment has 
proven effective in fully alleviating its symptoms.
Over the past few decades, a wide range of potential treatments has been 
applied and evaluated. Pharmacological therapies primarily comprise analgesics, 
antidepressants, anticonvulsants, hormone therapy or a combination of these 
drugs. A recent review of the various treatments showed that tricyclic antidepres­
sants, for example, amitriptyline and cyclobenzaprine, are the most promising in 
reducing pain and sleep problems in patients with FM.8 However, it has been 
argued that many patients report symptoms of drug intolerance and consequently 
discontinue taking them.9 Furthermore, the treatment effects disappear as soon 
as the treatment regimen is ended. Medication mainly focuses on short-term relief 
of symptoms, whereas non-pharmacological interventions aim to address the 
long-term consequences of the condition, such as disability, psychological 
distress, muscular deconditioning and weakness. Interventions mainly consist of 
elements of cognitive behavioral therapy (CBT), exercise training, or a combination 
of the two. Overall, reviews have shown non-pharmacological approaches to be 
more effective than pharmacological treatments.1011 Several meta-analyses have 
specifically examined the effects of non-pharmacological interventions for 
patients with FM. It is concluded that the combination of CBT and exercise training 
is the most effective treatment.8101213 Non-pharmacological interventions such as 
CBT and exercise programmes are generally based on biopsychosocial models of 
FM and chronic pain.
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Rationale of CBT and exercise program m es
Biopsychosocial models describe the transition of acute to chronic pain, 
independent of a biomedical cause, as in FM. In acute pain, three response systems 
are involved: behavioral reactions (e.g., avoidance behavior), cognitive reactions 
(e.g., increased attention to bodily sensations and catastrophising) and 
physiological reactions (e.g., an elevated autonomous arousal and muscle tension). 
All are appropriate adaptive short-term reactions to acute pain, but they become 
less functional and even detrimental when applied long-term and in response to 
chronic pain.14'16 Avoidance behavior has been described as an important aspect 
contributing to the aggravation of pain. This behavior is affected by classic and 
operant learning processes, and is an prominent factor of the fear-avoidance 
model.1718 The key concept of the model is fear of pain following the sensation of 
acute pain, for example, pain experienced during or after a road accident. People 
may react to this pain-related fear with avoidance or withdrawal of activities in 
order to prevent or escape pain. Cognitions such as the expectation that an 
activity will lead to pain or an increase in pain may also trigger avoidance 
behavior.1920 Avoidance behavior is easily reinforced by the belief that one has 
successfully prevented increments in pain. As long as activities are avoided, it is 
impossible to refute the belief that activity will lead to pain. Catastrophising is 
another important cognitive factor that plays a role in chronic pain.1821 People 
who have exaggerated negative interpretations of pain show elevated levels of 
painrelated fear. Moreover, there is evidence that fear of pain intensifies attention 
to bodily sensations, triggering hypervigilance to pain.22 Long-lasting avoidance 
of activities can lead to changes in the musculoskeletal system caused by physical 
deconditioning and impairments in muscle coordination, also called the disuse 
syndrome.23 The resultant deficient physical condition may in turn exacerbate the 
pain problem. Physiological reactions to pain such as heightened muscular 
tension and increased autonomic arousal may also lead to higher levels of pain 
and functional disability in the long-term.14 Furthermore, this autonomic arousal 
could be misinterpreted as evidence of physical harm and subsequently lead to 
more avoidance behavior.24 This habitual pattern of physiological, behavioral and 
cognitive reactions to pain might be generalized to various other situations and 
areas independent of objective pathology and intensity of pain. Patients with 
high levels of avoidance behavior have been shown to have a tendency to restrict 
their daily and social activities and withdraw from work, which will negatively 
affect long-term pain outcomes.15 16 25 Social factors, such as externa I reinforcements 
from the patient's social network, can further reinforce and maintain avoidance
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behavior. In addition, avoidance may also include withdrawal from positive 
reinforcers such as leisure activities which in turn can exacerbate psychological 
distress and reduce their quality of life.20 A vicious cycle has thus been 
established.
There has been incidental evidence from experimental and prospective 
studies for the various factors of biopsychosocial models in FM. For example, 
higher levels of pain and depression and a lower quality of life in FM could be 
prospectively predicted by catastrophising.26 Experimental studies have shown 
that patients with FM tend to display hypervigilance for aversive stimuli such as 
pain or for bodily sensations in general.2728 Furthermore, a large number of cross- 
sectional studies underline the relevance of cognitive behavioral factors in FM. 
Crombez and colleagues29 found that patients with FM reported higher vigilance 
to pain and more intense catastrophic thinking than other patients with chronic 
pain. Catastrophising has been found to be associated with higher levels of 
disability30 and pain.31 Finally, fear of pain is associated with an increased 
susceptibility to pain3233 and greater disability and depressed mood33 in patients 
with FM. Studies on mediators of change in CBT treatment of patients with FM and 
chronic pain also provide evidence for possible mediating effects of specific 
cognitive behavioral factors. For example, several studies have shown that 
reductions in catastrophising and helplessness are related to and partly mediate 
CBT treatment outcomes of, for example, disability and depression in chronic 
pain.34'36 Although these findings are by no means conclusive and clearly warrant 
additional longitudinal and experimental research, these results deliver a 
preliminary theoretical basis that non-pharmacological treatments consisting of 
CBT and exercise programmes can be beneficial for patients with FM.
Attempts have been made to direct non-pharmacological treatments to these 
cognitive behavioral factors. Treatments that include exposure or graded activity 
elements, for instance, aim at changing the patients' pain experience and disability 
by challenging their avoidance behavior through disproving the cognition that 
activity will lead to pain or an increment of pain. Furthermore, interventions have 
focused on curbing the negative interpretation of pain by challenging catastrophic 
cognitions through cognitive restructuring. Another approach suggests that 
involving a support person from the patient's social network in the intervention 
could help the patient to deal with reinforcements of their pain behavior that they 
receive from their social networks and facilitate the implementation of coping 
skills. Exercise training exploits muscle-strengthening and aerobic exercises in 
order to break the deconditioning cycle. Most studies on non-pharmacological
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interventions in FM include one or more of the aforementioned therapeutic 
elements.37 However, a major problem in the treatment of patients with FM is that 
most of the non-pharmacological treatments are thus far not systematically based 
on this rationale. In general studies include a broad range of unspecified CBT 
techniques that are not directly focused on specific dysfunctional cognitive 
behavioral mechanisms for patients with FM.
Purpose of this study
Meta-analyses have shown that the effects of non-pharmacological interventions 
for patients with FM are, in general, limited and there appears to be a high 
individual response variation.1213 This underlines the need for a better 
understanding of the factors that predict and enhance the efficacy of the 
treatment for FM. To evaluate the merit of CBT and exercise training in FM and to 
identify patient and treatment characteristics that might contribute to an 
optimisation of treatment outcome, various strategies have been adopted. 
Experimental and prospective studies have been conducted to find empirical 
evidence for the theoretical rationale for CBT and exercise in FM. Other designs 
have evaluated the effectiveness of randomized, controlled trials of CBT and 
exercise in FM, and yet others have tried to identify factors that help predict the 
success of treatment. In this review, we provide an overview of empirical studies 
of non-pharmacological treatment in patients with FM. The effects of CBT and 
exercise training targeting patients with FM are described for the main outcomes 
of pain, disability and mood. Furthermore, we have screened the studies included 
in our review for specific treatment or patient characteristics that may enhance 
the efficacy of the treatment. We elaborate on this issue by proposing and 
discussing other potentially promising aspects of future non-pharmacological FM 
interventions based on recent developments in other populations with chronic 
pain, and providing recommendations for future research.
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Methods
The electronic bibliographic databases we used in our search for relevant studies 
for the review included MEDLINE (1966-January 2006), PsychlNFO (1806-January 
2006), EMBASE (1980-January 2006) and Cochrane Library (1993-January 2006). 
The keyword 'fibromyalgia' was used in combination with the terms 'randomized', 
'clinical controlled trial', 'clinical trial', 'randomized controlled trial', 'cognitive 
therapy', 'CBT' and 'exercise'. In addition, reference sections and review papers on 
non-pharmacological treatments of FM were screened manually. To be included 
in our review, the following criteria were needed to be met: (1) evaluation of non- 
pharmacological interventions for patients with FM founded on recognised 
diagnostic criteria;38 (2) interventions comprising elements of CBT and/or exercise 
programmes; (3) a randomized, controlled study design with a control group that 
received no treatment, a standard default treatment or an intervention that was 
not expected to yield clinically relevant effects (e.g., non-specific treatment 
group/placebo control group); and (4) effect analyses of interaction effects or 
separate f-tests based on the three outcome measures, namely, pain, disability 
and mood. If a research group published more than one article evaluating the 
same intervention, the most recent publication was included in the review. In all, 
30 studies met the inclusion criteria (Table I),39'68 and their findings were evaluated 
by reviewing the short-term and long-term effects on the three specified outcome 
measures. The factor pain was assessed by means of various instruments, including 
visual analogue scales (VAS), myalgic scores, tender points and subscales of 
questionnaires (e.g., the Fibromyalgia Impact Questionnaire (FIQ) and the Multi­
dimensional Pain Inventory (MPI)). Disability was determined using tests of 
physical fitness (e.g., 6 m in walk, perceived extortion, flexibility test) and subscales 
of questionnaires such as the FIQ physical functioning scale and the physical 
activity sea le of the Arthritis Impact Measurement Scales (AIMS). Finally, assessment 
of the outcome variable mood included VAS, questionnaires for psychological 
distress in general, such as the Beck Depression Inventory and the Symptom 
Checklist-90-Revised, and subscales of questionnaires for FM and other chronic 
pain conditions (e.g., FIQ depression and anxiety scale, AIMS depression and 
anxiety scales, MPI affective distress scale).
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Table 1 Randomized, controlled trials of non-pharmacological interventions 
for patients with fibromyalgia
Author, year
Buckelew, 199842
n (completing). Follow-up Control group. Intervention 
mean age (years), assessment n (completing)
%  women
119(101),44.0,
91
Post 
3 mo
1 yr
2 yr
Education,
30 (27)
Relaxation 
(biofeed back)
Exercise training 
(aerobic and 
strength)
Relaxation + 
exercise training
Burckhardt, 1994”  99 (86), 46.5, 
100
Post Waiting list,
35 (30)
Education
Education + exercise 
training (aerobic)
Cedraschi, 2004“  164 (129), 49.3, 6 mo 
93
Waiting list,
80 (68)
Education + exercise 
training (aerobic)
Da Costa, 2005“  80 (61), 50.8, 
100
Post 
3 mo 
9 mo
Treatment as 
usual,
41 (33)
Exercise training 
(aerobic, strength 
and flexibility)
Ferraciocioli, 1987« 12 (12), 57.0, 
100
Post False
biofeedback 
relaxation, 6 (6)
Relaxation 
(biofeed back)
Gowans, 19996: 45 (41), 45.5, 
78
Post Waiting list,
22 (21)
Education + 
exercise training
Gowans,200149 51 (31), 47.9, 
90
Post Treatment as 
usual, 24 (16)
Exercise training 
(aerobic, pool 
exercises)
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Treatment characteristics: Intervention Outcome Effects Comments
individual/group; inpatient/ group measures Post Follow-
outpatient; duration n (completing) up
Individual and group;outpatient; 29 (25) Pain + 0 Long-term effect of
1xw kfor6w kindivand Ixm o Disability 0 0 relaxation + exercise
for 2 yrs group Mood 0 0 on pain was only
evident at 3 mo, not
Individual and group; outpatient; 30 (26) Pain + 0 at the 1-yr and 2-yr
f r j l l r j \ A / - i  i n ?
1xw kfor6w kindivand Ixm o Disability + +
1 VJ1 i u w  u p )
for 2 yrs group Mood 0 0
Individual and group; outpatient; 30 (23) Pain + +
1xw kfor6w kindivand Ixm o Disability + +
for 2 yrs group Mood 0 0
Group; outpatient; 1x wk for 6 wk 31 (28) Pain 0 NA
Disability 0 NA
Mood 0 NA
Group; outpatient; 1x wk for 6 wk 33 (28) Pain 0 NA
Disability 0 NA
Mood 0 NA
Group; outpatient; 2x wkfor 6 wk 84 (61) Pain NA + Drop-out >20%:
Disability NA + control 15%,
Mood NA + intervention 27.4%
Individual; home-based; 12 wk 39 (28) Pain + + Drop-out >20%:
and 4 sessions with physical Disability 0 + control 19.5%,
therapist Mood 0 0 intervention 28.2%
Group; outpatient; 2x wk, 6(6) Pain + NA No between-group
15 sessions in total Disability 0 NA analyses
Mood 0 NA
Group; outpatient; 2x wkfor 6 wk 23 (20) Pain 0 NA
Disability + NA
Mood 0 NA
Group; outpatient; 3x wk for 27(15) Pain 0 NA Drop-out >20%:
23 wk Disability + NA control 33.3%,
Mood + NA intervention 44.4%
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Table 1 Continued
Author, year
Jones, 200257
n (completing). Follow-up Control group, 
mean age (years), assessment n (completing) 
%  women
68 (56), 47.8,100 Post Flexibility
exercises, 
34 (28)
Intervention
Exercise training 
(strength)
Keel, 19986‘ 32 (27), 49.0,89 Post 
3 mo
Relaxation,
16(13)
CBT + exercise 
training (stretching 
and aerobic)
King, 20 0241 170(95),46.1,100 Post 
3 mo
Waiting list,
39(18)
Education (1)
Exercise training 
(aerobic) (2)
Education + exercise 
training (aerobic)
(3)
Kingsley, 200558 29 (20), 46.0,100 Post Waiting list, 
14(12)
Exercise training 
(strength)
Lemstra, 2005“  79 (72), 49.4,84.8 Post Treatment 
as usual,
36 (36)
CBT +
exercise
training
Mannerkorpi, 200064 69 (58), 46.0,100 Post Treatment 
as usual,
32 (30)
Education +exercise 
training (pool 
exercise)
Martin, 1996“  60 (38), 44.8,97 Post Relaxation,
30 (20)
Exercise training 
(aerobic and 
strength)
McCain, 19885' 42 (38), 42.2, Post
% unknown
Flexibility
exercises, 
22 (20)
Exercise training 
(aerobic)
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Treatment characteristics: Intervention Outcome Effects Comments
individual/group; inpatient/ group measures Post Follow-
outpatient; duration n (completing) up
Group; outpatient; 2xwk for 12 wk 34 (28) Pain 0 NA
Disability 0 NA
Mood 0 NA
Group;outpatient; Ixw kfor 15 wk 16(14) Pain 0 + a) Positive post­
Disability 0 0 treatment trend for
Mood NA NA pain, significant at
follow-up;
b) Predictor of
treatment success:
shorter duration of
complaints
Group;outpatient; Ixw kfor 12 wk 48(21) Pain 0 0 Drop-out >20%:
Disability 0 0 control 53.8%,
Mood NA NA intervention (1) 56.3%
Group; outpatient; 3xwk for 12 wk 46 (30) Pain 0 0 (2) 34.8%
Disability 0 0
Mood NA NA
Group; outpatient; 3xwk for 12 wk 37 (26) Pain 0 0 (3) 29.7%
Disability 0 0
Mood NA NA
Group; outpatient; 2x wkfor 12 wk 15(8) Pain 0 NA Drop-out >20%:
Disability + NA control 14.3%,
Mood NA NA intervention 46.7%
Group; outpatient; 24 sessions in 43 (36) Pain + NA
6 wk Disability + NA
Mood + NA
Group; outpatient; education 1x mo 37 (28) Pain + NA
for 6 mo, exercise Ix wk for 6 mo Disability + NA
Mood + NA
Group; outpatient; 3x wk for 6 wk 30(18) Pain + NA Drop-out >20%:
Disability + NA control 33.3%,
Mood NA NA intervention 30%
Group; outpatient; 2x wk for 20 wk 20(18) Pain + NA
Disability + NA
Mood 0 NA
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Table 1 Continued
Author, year n (completing). Follow-up Control group. Intervention
mean age (years), assessment n (completing)
%  women
Mengshoel, 199251 35 (25), 33.7, 
100
Post Treatment Exercise training
as usual, 17 (14) (aerobic)
Nicassio, 199745 86 (71), 53.1, Post
89 6 mo
Education,
38 (35)
CBT
Nichols, 199452 24 (19), 49.4, 
92
Post Treatment 
as usual, 
12(9)
Exercise training 
(aerobic)
Norregaard, 199754 38 (23), 49.1, 
% unknown
Post Thermotherapy, Exercise training
8 (7) (aerobic) (1)
Exercise training 
(gymnastic exercises 
and stretching) (2)
Richards, 200255 136 (112), 46.5, 
92.6
van Santen, 200244 143 (118), 44.7, 
100
Post 
3 mo 
9 mo
Post
Relaxation 
and flexibility
exercises,
67 (55)
Treatment 
as usual,
29 (28)
Exercise training 
(aerobic)
Relaxation 
(biofeed back)
Exercise training 
(aerobic and strength)
Schachter, 200353 143 (102), 41.8, Post 
100
Discussion
group,
36 (31)
Exercise training 
(aerobic, long bout of 
exercise)
Exercise training 
(aerobic, short bout 
of exercise)
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Treatment characteristics: Intervention Outcome Effects Comments
individual/group; inpatient/ group measures Post Follow-
outpatient; duration n (completing) up
Group; outpatient; 2x wk for 20 wk 18(11) Pain 0 NA Drop-out >20%:
Disability + NA control 17.6%,
Mood NA NA intervention 38.9%
Group; outpatient; Ixw kfor 10 wk 48 (36) Pain 0 0
Disability 0 0
Mood 0 0
Group; outpatient; 3x wk for 8 wk 12(10) Pain 0 NA
Disability - NA
Mood + NA
Group; outpatient; 3xwk for 12 wk 15(5) Pain 0 NA Drop-out >20%:
Disability 0 NA control 12.5%,
Mood 0 NA intervention (1) 66.7%
Group; outpatient; 2xwk for 12 wk 15(11) Pain 0 NA (2) 26.7%
Disability 0 NA
Mood 0 NA
Group; outpatient; 2x wk for 12 wk 69 (57) Pain 0 +
Disability 0 +
Mood NA NA
Individual; outpatient; 2x wk for 8 wk 56 (43) Pain 0 NA
Disability 0 NA
Mood 0 NA
Group; outpatient; 2x wk for 24 wk 58 (47) Pain 0 NA
Disability + NA
Mood 0 NA
Individual; home-based; 1x 51 (36) Pain 0 NA Drop-out >20%:
day, 10-30 min,3-5 times wk for Disability 0 NA control 13.9%,
16 wk (1) Mood 0 NA intervention (1) 29.4%
Individual; home-based; 2x 56 (35) Pain 0 NA (2) 37.5%
day, 5-15 min, 3-5 times wk for Disability + NA
16 wk (2) Mood 0 NA
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Table 1 Continued
Author, year n (completing), 
mean age (years), 
%  women
Follow-up
assessment
Control group, 
n (completing)
Intervention
Thieme, 200348 63 (61), 47.3,100 Post 
6 mo 
15 mo
Standard 
treatment: 
education and 
relaxation, 21 (21)
CBT
Valkeinen, 2005® 26 (26), 59.5,100 Post Treatment 
as usual, 
13(13)
Exercise traini 
(strength)
Valim, 2003“ 76 (60), 45.9,100 Post Flexibility
exercises, 
38 (28)
Exercise
training
(aerobic)
Verstappen, 199761 87 (72), 45.2,100 Post Treatment 
as usual, 
29 (27)
Exercise 
training 
(aerobic and 
strength)
Vlaeyen, 199640 131 (105), 44.0,88 Post 
6 mo 
12 mo
Waiting list,
43 (39)
CBT
Education
Wigers, 199646 60 (44), 44.0,92 Post Treatment CBT
4yrs as usual,
20(16)
Exercise training 
(aerobic)
Williams, 200247 145 (122), 47.4,90 1 yr Treatment 
as usual, 
69 (60)
CBT
Zijlstra, 2005“  134 (113), 47.4,95.5 3 mo Treatment
6 mo as usual,
1 yr 76 (61)
Spa therapy, 
education + exercise 
training (aerobic 
exercise)
CBT = cognitive behavioral therapy; mo = months; wk = week; yr = year; NA = not assessed; 
post = post-treatment; follow-up = minimum of three months after treatment;
+ = positive effect on at least one of the outcome measures (pain, disability and mood);
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Treatment characteristics: Intervention Outcome Effects Comments
individual/group; inpatient/ group measures Post Follow-
outpatient; duration n (completing) up
Group; inpatient; daily during 5 wk 42 (40) Pain + + Predictor of treatment
(75 h total) Disability + + success: group of
Mood + + highly distressed
patients
Group; outpatient; 13(13) Pain 0 NA
2x wkfor 21 wk Disability + NA
Mood NA NA
Group; outpatient; 38 (32) Pain + NA
3x wk for 20 wk Disability + NA
Mood + NA
Group; outpatient; 58 (45) Pain 0 NA
2x wkfor 6 mo Disability + NA
Mood NA NA
Group; outpatient; 49 (36) Pain 0 0 Follow-up effects
2x wkfor 6 wk Disability 0 0 of CBT only in
Mood 0 0 comparison with
education and not
Group; outpatient; 39 (30) Pain 0 0 with control group
2x wkfor 6 wk Disability 0 0
Mood 0 0
Group; outpatient; 20(13) Pain + 0 a) Positive effect of
2x wk for 6 wk, Disability 0 0 exercise training on
1xw kfor8w k Mood + 0 pain and disability in
comparison with both
Group; outpatient; 20(15) Pain + 0 the controls and CBT;
3x wkfor 14 wk Disability + 0 b) Predictor of
Mood 0 0 treatment success:
continued exercising
during follow-up
Group; outpatient; 76 (62) Pain NA 0
6 sessions in 4 wk Disability NA +
Mood NA NA
Group; inpatient (Tunisia), 7-8x 58 (52) Pain NA + Long-term effect
spa therapy, 7x exercise and 7x Disability NA + of intervention
education in 19 days Mood NA 0 on pain was only
evident at 3 mo, not 
at the 6-mo and 1-yr 
follow-ups
0 = no effects on the outcome measures (pain, disability and mood); - = negative effect on at least one of 
the outcome measures (pain, disability and mood). The results all concern completers' analyses with the 
exception of one study that solely conducted an intention-to-treat analysis.55
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Results
Effects of CBT and exercise program m es
To find empirical support for non-pharmacological treatments for patients with 
FM, studies have examined the efficacy of specific therapeutic approaches such 
as CBT and exercise training programmes, as well as combinations of the two 
approaches. The findings of the randomized controlled trials our search generated 
are reviewed below.
Cognitive behavioral therapy
CBT is one of the most prevalent treatments for patients with FM. A distinction 
can be made between single-method interventions such as education and 
relaxation programmes, and multimethod CBTs that incorporate various methods 
and skills from cognitive behavioral approaches.
Educational programmes provide information about active self-management 
of pain, coping, relaxation techniques, the importance of physical activity and 
social support, and individual strategies for behavioral change. Three studies 
investigated the effect of education as a single-method intervention39'41 and 
found the educational programmes to yield some benefits for the patients' self- 
efficacy39 and pain-coping skills.40 However, the programmes were not effective in 
diminishing pain and disability nor in improving mood. The only study that 
conducted a follow-up failed to find any treatment effect.41 Other single-method 
CBTs are relaxation techniques, for example, progressive relaxation, biofeedback 
and autogenic training, which are used in patients with FM to diminish muscular 
tension and interrupt the pain-tension cycle. The three studies that investigated 
the effects of relaxation failed to find any results for disability or mood;42'44 two 
studies reported improvements on pain4243 although the effect had not been 
maintained at follow-up.42 However, the study of Ferracioli et al43 may have been 
underpowered to detect effects due to its small sample size.
Multimethod CBT typically consists of a combination of various therapeutic 
elements, such as cognitive restructuring, pain-coping skills, problem-solving 
techniques, goal setting, increasing activity levels, activity pacing, stress 
management and adjustment of pain-related medication, and frequently also 
comprises educational and relaxation components. Five studies evaluated the 
outcome of multimethod CBTs.4045'48 Two studies found no effects on pain, 
disability and mood,4045 while three studies reported varying effects.46'48 Wigers 
et al46 reported the multimethod CBT to be initially effective in diminishing pain
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and depression, but this improvement was not sustained during the 4-year 
follow-up. Another CBT study aimed at improving physical functioning proved 
effective in reducing disability one year after treatment.47 Finally, Thieme et al48 
reported in their evaluation of a behavioral pain treatment for patients with FM 
that, compared with the control group, pain, disability and mood had all largely 
improved in the experimental group and the effects were maintained at the 
15-month follow-up.
Exercise training
In the past few decades many studies on effects of exercise training programmes 
in patients with FM have been conducted. Exercise training programmes include 
aerobic exercise, strength training, flexibility exercises and hydrotherapy. 
Although the programmes vary, all have some of the following basic elements: a 
gradual build-up of strength and endurance, emphasis on the importance of 
frequent exercise and a moderately intense exercise programme. Because they 
facilitate the exercises and minimize post-exercise pain, pool exercises and 
hydrotherapy are occasionally part of the training programmes.
Aerobic exercise is the most widely used exercise intervention and comprise 
various types of exercises such as cycling, walking and aerobic dancing. Ten 
studies investigated the effect of aerobic exercise,41'4649'56 and six of these found 
improvements on disability.46'49'51'53 56 Pain relief46'5056 and changes in mood49'52 56 
were rarely mentioned, and one study even reported an increase in disability.52 
Only three studies conducted follow-up assessments41 4655 of which one showed 
limited long-term improvements in pain and disability.55 Strength training has 
been investigated three times in randomized, controlled trials57 59 and positively 
affected disability in two of the three studies,5859 although no effects on mood or 
pain were found. However, the study of Kingsley et al58 could be biased, due to 
high drop-out rates in the experimental group. Finally, five studies evaluated 
aerobic exercise in combination with muscle-strength training and obtained 
mixed results.424460'62 Three studies demonstrated a decrease in pain and 
disability42’6062 and these effects were maintained at follow-up.42 62 In addition, two 
studies reported a lesser worsening of disability levels in the intervention group 
compared with the control group.4461
Combinations o f CBT and exercise training
Six studies examined the effectiveness of education in combination with 
exercise.39'4163'66 Two reported effects for disability, such as an enhanced physical
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condition.6364 Only in one study did patients also report of an improvement in 
pain andmood.64 Of the three studies that included follow-up assessments,41'6566 
two studies found long-term effects on pain and disability65 66 and one also on 
mood.65 The improvements on pain and disability in the study of Zijlstra and 
colleagues66 were only apparent at the 3-month follow-up and not at 6 and 12 
months. Relaxation combined with exercise training appeared to be effective in 
diminishing pain and disability in daily life, and the effects were maintained at the 
1-year follow-up.42 However, in this study, pain alleviation was largely accounted 
for by a deterioration of the control group. Although only two trials have been 
conducted with interventions that combined multimethod CBT and exercise 
training, the availablefindings look promising.6768 Patients reported post-treatment 
improvements on pain, disability and mood,68 and at the 3-month follow-up, they 
reported less pain.67
Predictors of treatm ent outcom e of CBT and exercise program m es
From this and previous reviews it appears that, overall, the effects of non-pharma- 
cological interventions in patients with FM are relatively limited. Various studies 
included in the review offered probable explanations for the lack of treatment 
effects: a large individual variation in patients' treatment response,4447 lack of 
long-term adherence to the exercise regimen,63 inclusion of patients with 
prolonged duration of symptoms,5465 and patients who were too severely 
depressed to respond to treatment.3943 Only four studies carried out additional 
analyses to identify treatment and patient characteristics that could predict 
treatment response.4648'6769 Thieme and coworkers48 conducted additional 
analyses to explain the gains on pain, disability and mood following their 
multimethod CBT, and showed that a subgroup of highly distressed patients with 
a high impact of the condition on daily life had responded best. This suggests that 
highly distressed patients with FM are most susceptible to the CBT intervention, 
and that treatment effects could be improved by selecting this specific group of 
patients. In their 4-year follow-up evaluation of an aerobic exercise programme, 
Wigers et al46 demonstrated that particularly those participants who had continued 
exercising reported the least pain. This would imply that long-term compliance is 
crucial in maintaining the positive effects of exercise training. Keel et a I67 assessing 
combined multimethod CBT and exercise, found that the individuals who 
benefited most from the treatment were patients with a significantly shorter 
history of complaints. These preliminary findings underline the importance of 
initiating treatment shortly after diagnosis. Sociodemographic and psychosocial
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variables appeared to be significant predictors of the success of treatment in the 
intervention study of King and colleagues.69 However, only a small percentage of 
the variance was explained by these variables, which may be due to the 
heterogeneity of FM. In addition, the percentage of responders was very low, 
suggesting that present treatments are not effective for a large group of patients. 
The results of this study should be interpreted with caution, due to the high 
drop-out rate.
Discussion
From this review of non-pharmacological treatment in patients with FM, it is 
apparent that interventions such as CBT and exercise training have a limited effect 
on the outcome measures, namely, pain, disability and mood. Only a few studies 
showed improvement after CBT methods and techniques, and even then the 
positive effects frequently disappeared in the long run. It was mostly multimethod 
CBT treatments that yielded improvements, suggesting that these are more 
effective than specific CBTs such as education and relaxation programmes. A 
recent study by Thieme et al48 which evaluated a multimethod CBT programme 
aimed at behavioral pain treatment, is potentially promising. Their patients 
reported less pain, disability and psychological distress after treatment, and these 
results were sustained in the longer term. The findings on exercise programmes 
indicate that exercise may be useful in reducing disability in daily life on account 
of patients' enhanced physical fitness. However, the technique seems less effective 
in decreasing pain and psychological distress, although trials did show that the 
fear of patients with FM that exercising will exacerbate their pain was not justified. 
Exercise training seems to be effective in diminishing disability in daily life but it 
is unclear whether these effects are maintained for extended periods. Additional 
psychological maintenance training could help establish long-term compliance 
with the exercise regimens. Although no evidence was found for the efficacy of a 
combination of exercise training and CBT been higher than that of interventions 
of only exercise training or only CBT, combination treatments have only been 
incidentally studied. Moreover, the outcomes might be improved if more targeted 
psychological interventions such as multimethod CBT are used in addition to 
exercise training.68 Four studies conducted additional analyses to identify those 
factors that could be vital to improve treatment outcomes. King and coworkers69 
showed that sociodemographic and psychosocial variables were relevant in
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predicting the success of treatment, but the explained variance was relatively 
small. The other studies found that early intervention,67 selection of patients with 
high levels of distress and tailored treatment48 as well as continued exercising46 
are promising indicators of the success of treatment.
As for methodological issues, the distinction between singlemethod 
interventions such as education and relaxation programmes and multimethod 
CBT is somewhat artificial. Some of the education programmes, for example, were 
more comprehensive than others and also trained patients in relaxation and 
coping techniques. Furthermore, comparing the evaluated studies was difficult 
due to many differences in content and timing, outcome measures and statistical 
analyses. Other methodological characteristics also varied greatly between the 
studies reviewed, for example, description of the content of the treatment, 
therapist training, quality of control condition.70 In addition, a publication bias 
towards positive results cannot be completely ruled out, although in general the 
primary effects of the studies reported were rather limited. With regard to the 
methodological quality of the studies, the small sample size and hence low 
statistical power of some studies makes it hard to detect significant 
effects.43'51'52'54'58'5967 Results could also be biased due to high drop-out rates, 
particularly in treatment groups, suggesting that the treatment was not matched 
to the patient's needs.41'49'51'53'54'58'60'62 65 In addition, the majority of the studies did 
not include long-term follow-up assessments. However, as all the studies included 
in the review fulfilled the inclusion criteria of a randomized, controlled design, 
they generally meet the minimum standard for methodological quality. 
Furthermore, according to the criteria of the quality of clinical trials stipulated by 
Jaded et al71 (e.g., randomization, doubleblind conditions, description of 
withdrawals and drop-outs), the studies included in the review had sufficient 
quality overall except for the double-blind condition, which is unfeasible under 
active treatment conditions.
The effect sizes of randomized, controlled trials in FM in general show small to 
moderate effect sizes.10The clinical relevance of the studies reviewed is limited, as 
the overall effects found are rather small and the percentage of patients showing 
significant clinical improvement is minimal. Moreover, if encouraging effects are 
reported, a lack of longterm follow-up assessments, small sample sizes and 
treatments that encompass multiple unspecified CBT techniques limits their 
possible implications for clinical practice.
Nevertheless, what this review did clarify is that standardized non-pharmaco- 
logical interventions are inadequate in sufficiently reducing symptoms and
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psychological distress in patients with FM. To improve treatment outcomes, more 
evidence is needed from experimental and prospective studies to unravel the 
specific cognitive behavioral mechanisms responsible for the development and 
maintenance of chronic pain and disability that function as mediators of treatment 
effects, such as avoidance behavior, hypervigilance and painrelated fear. There is 
also an urgent need to delineate patient and treatment characteristics better to 
allow subgroups of patients that respond best to a specific treatment to be 
identified. Several studies on FM have suggested that the limited treatment 
outcomes are due to the large individual differences in treatment response. It is 
apparent that not all patients will show the same response to the same treatment, 
and this disparity is likely to be related to the heterogeneity of the condition and 
the variability within patients.864 The current problem could be that all patients 
with FM are treated with the same commonly accepted interventions, resulting in 
small overall treatment effects and high drop-out rates.
In the next section we will elaborate on the potentially predictive features 
that may help to enhance the efficacy of non-pharmacological treatments for 
patients with FM separately, and in relation to studies of other chronic pain 
conditions. We will conclude the review by offering suggestions for more targeted 
treatments and future research.
Future directions
Early intervention
The significance of early detection and treatment of patients who are at risk of 
developing persistent pain and related problems is increasingly recognized.72 
Timing is important for several reasons. Firstly, FM is a condition associated with 
high levels of pain, disabilities in daily life, psychological distress and diminished 
quality of life. Intervening early in the course of a pain condition may help prevent 
the vicious cycle of long-term physical and psychological suffering. Secondly, 
patients who have had FM for an extended period might have ingrained, 
maladaptive patterns of pain-coping and illness behaviors that are resistant to 
treatment, making it more difficult for patients to change their behavior. Finally, 
early intervention has the potential to reduce or prevent disability in patients with 
chronic pain, which, in turn, will reduce societal and medical costs. It follows that 
early intervention is far more likely to be effective than interventions administered 
in the later stages of the condition. Non-pharmacological treatments that are
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initiated shortly after a patient has been diagnosed with FM can help prevent 
long-term dysfunction and chronicity.
There has been preliminary evidence indicating that early intervention is 
indeed an important factor in improving non-pharmacological treatment 
outcomes in FM. Keel et al67 showed that a subgroup with a shorter duration of 
complaints responded best to treatment. Similar results are also found in other 
chronic pain conditions. Marhold73 showed that a cognitive behavioral 
return-to-work programme proved effective for those patients with chronic pain 
who were on short-term sick leave but notfor patients who had been out of work 
for longer periods of time. In addition, two interventions for recently diagnosed 
patients with rheumatoid arthritis (RA) were shown to be effective.7475 Other 
retrospective findings of studies in RA also demonstrated that, patients who were 
treated shortly after diagnosis responded best to non-pharmacological 
treatment.7677 Collectively, these findings suggest that early intervention can 
enhance the efficacy of cognitive behavioral therapies, also for FM.
Patient selection
As stated earlier, the limited effects of non-pharmacological interventions for 
patients with FM have also been attributed to the variability within patients. Gains 
in treatment outcome could be achieved if subgroups of patients with FM who are 
most likely to benefit from a specific treatment are identified. Evidence to this 
effect has already been reported for RA, showing that specific cognitive behavioral 
factors are disturbed in patients with a high degree of psychological distress, and 
that this subgroup of patients benefited from CBT addressing these cognitive 
behavioral factors.74'7879 On the basis of psychosocial and behavioral characteris­
tics, specific subgroups can be identified, for example, a dysfunctional group that 
is characterised by low levels of activity, high levels of pain interference and 
psychological distress.8081 Previous research revealed that treatment gains could 
indeed be predominantly attributed to the effects found for such a dysfunctional 
group, that is, the patients in whom the condition had a higher daily-life impact.82 83 
Furthermore, in this review, dysfunctional subgroups of patients with FM also 
showed the best outcomes during the course of the treatment in three studies48 82 83 
but not in one.69 Overall, it seems to imply that patients with FM with a relatively 
high level of psychological distress and impact of the condition on daily living are 
likely to benefit most from non-pharmacological interventions.
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Tailoring treatment to the patient's risk profile
There is some evidence that targeted non-pharmacological interventions that 
address the specific needs of a particular subgroup are more effective. In his 
recent overview, Turk84supports the notion that results of treatment in patients 
with chronic pain can be enhanced if treatment is tailored to the patient charac­
teristics, which, according to Thieme and her team,85 also applies to patients with 
FM. Treatment can be tailored in various ways, allowing for, among other factors, 
the demographic, medical, psychological or psychosocial factors of the patients.72 
In patients with chronic pain, including FM, outcomes of pain, disability and 
psychological distress tend to be affected by specific cognitive behavioral factors 
such as passive pain coping and helplessness.2686 Only patients with FM who are 
characterized by these specific cognitive behavioral factors might benefit from 
interventions that focus on these factors. However, it has to be taken into 
consideration that in order to improve treatment effects, interventions need to be 
systematically based on the cognitive behavioral mechanisms proven to be 
important in FM and chronic pa in. More recent CBT interventions that systematically 
modify key elements of the fear-avoidance model through exposure in vivo, for 
instance, have yielded promising results in patients with chronic low-back pain.87-89 
Moreover, the factors typical of specific subgroups may need to be taken into 
account. For example, in chronic pain, including FM, besides patients characterized 
by disuse syndrome and passive pain coping, there is also a subgroup of patients 
that have demanding, nonaccepting cognitions and possible overuse, and tailored 
treatments directed at their specific risk factors might be promising.90 Recent 
developments of approaches aimed at pain acceptance proved relevant in chronic 
pain,9192 and the subgroup characterized by overuse could particularly benefit 
from such an approach. Research into other chronic physical symptoms also 
indicates that treatment tailored to the shared cognitive behavioral factors of 
subgroups of patients may enhance treatment effects.93 94 Based on these 
preliminary but promising findings, we conclude that if patients with FM were to 
be subdivided consistent with their distinctive cognitive behavioral patterns and 
if interventions were subsequently modified to match these specific risk profiles, 
the efficacy of non-pharmacological treatment programmes could be substantially 
taken forward. Future research needs to explore the cognitive behavioral 
mechanisms relevant in subgroups of patients and develop tailored treatments 
accordingly.
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Conclusion
In summary, in spite of wide theoretical and selective empirical support of the 
rationale of non-pharmacological treatment programmes for patients diagnosed 
with FM, the studies that were evaluated in this review show their effects to be 
limited. Preliminary evidence suggests that treatment outcomes could be 
improved if tailored interventions are offered early to patients at risk of developing 
chronic physical and psychological impairments. Future research and the clinical 
practice should respect the heterogeneity and individual variability in patients 
with FM and should aim at developing non-pharmacological interventions that 
best match the needs of the individual patient.
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Abstract
Background. The heterogeneity of patients regarding pain-related cognitive 
behavioral mechanisms, such as pain-avoidance and pain-persistence patterns, 
has been proposed to underlie varying treatment outcomes in patients with 
fibromyalgia (FM).
Purpose. To investigate the validity of a screening instrument to discriminate 
between pain-avoidance and pain-persistence patterns in FM.
Method. In a three-part study, a self-reported screening instrument that assesses 
pain-avoidance behavior was used to distinguish patients with pain-avoidance 
and pain-persistence patterns. The resultant groups were compared with regard 
to several pain-related cognitive behavioral factors, performance on a physical 
fitness test, and with regard to the judgments of trained therapists based on a 
semi-structured interview.
Results. The validity of the screening instrument to distinguish between pain- 
avoidance and
pain-persistence patterns was supported by other validated self-report questionnaires 
for pain-related cognitive behavioral factors, physical exercise tests, as well as by 
a high correspondence with blinded therapist judgment after intake assessments. 
Conclusion. These findings suggest that a short self-report screening instrument 
can be used to distinguish between pain-avoidance and pain-persistence patterns 
within the heterogeneous population of FM patients, which offers promising 
possibilities to improve treatment efficacy by tailoring treatment to specific 
patient patterns.
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Introduction
In the frequently studied fear-avoidance models of chronic pain, cognitive, 
behavioral, physiological, and social processes are proposed to account for the 
maintenance and exacerbation of pain and disability. Fear of pain is postulated to 
contribute to chronic pain and long-term disability through perpetuating 
mechanisms such as avoidance of activities, catastrophizing, heightened attention 
for pain (hypervigilance), and social reinforcement.1'4 Longterm avoidance of 
activities can finally lead to physical deconditioning, also called the 'disuse 
syndrome'.5 Although in various chronic-pain conditions, broad support was 
found for the fear-avoidance models, they seem less applicable for patients 
presenting pain-persistence mechanisms.6-10 Phenomena of pain-persistence are 
often described in patients with fibromyalgia (FM), a chronic musculoskeletal pain 
disorder characterized by widespread pain, symptoms of fatigue, functional 
disability, and a heightened level of psychological distress.1112 Recent studies 
suggest the existence of distinctive cognitive behavioral patterns in FM and other 
chronic symptoms. One group of patients is characterized by fear of pain and 
pain-avoidance behavior as specified in the fear-avoidance models. In contrast, 
there is also preliminary evidence of FM patients and patients with other chronic 
symptoms that are distinguished by overactivity and task persistence, i.e., patients 
that try to ignore pain sensations, suppress pain-related thoughts, and tend to 
persist in their activities in spite of the pain (Figure 1 ) .6-1013-15 Preliminary evidence 
shows that these pain-persistence mechanisms could be risk factors for the 
development and maintenance of chronic pain.6'8'91617
Figure 1 Overview of the proposed perpetuating factors for the two 
patient patterns in fibromyalgia
Pain-avoidance pattern
- High level of pain-avoidance behavior
- Preoccupation with or high attention 
to pain stimuli
- Pain-related worrying
- Fear of pain and movement
Pain-persistence pattern
- Low level of pain-avoidance behavior
- Active despite pain
- Ignoring pain and (physical) limits
- Non-accepting and demanding 
cognitions about limitations
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These cognitive behavioral patterns are specifically a problem in dysfunctional 
patients with heightened levels of distress, and offering those patients tailored 
interventions could improve treatment outcomes. Cognitive behavioral therapy 
(CBT) in FM and chronic pain is usually aimed at the dysfunctional mechanisms 
specified in fear-avoidance models, but its effectiveness in FM appears to be 
limited.18'21 Nevertheless, there is increasing evidence that the efficacy of 
interventions improves when treatments are matched to the patient's main 
cognitive behavioral mechanisms.171922'25 Specifically, patients characterized by 
high-level pain-avoidance behavior and fear of pain are likely to benefit most 
from treatment aimed at changing their avoidance behavior, whereas cognitive 
restructuring of high self-demands and acceptance-based approaches could be 
more beneficial for patients distinguished by task persistence.1723 25 Consequently, 
screening FM patients to establish their specific patterns followed by tailored 
interventions might be a promising strategy to enhance treatment outcomes. 
However, for the tailored treatment to be successful requires a reliable, valid 
screening procedure and in-depth knowledge of the patient's underlying 
cognitive behavioral mechanisms and level of physical fitness. In addition, it needs 
to be demonstrated that the screening instrument that is founded on self-reported 
measures is consistent with therapist judgments.
The main aim of the three studies presented below was to distinguish between 
pain-avoidance and pain-persistence patterns in a cohort of FM patients by means 
of a screening instrument consisting of a short self-report questionnaire assessing 
pain-avoidance behavior. In the first study, we evaluated the tool's validity by 
comparing the pain-avoidance and pain-persistence patterns with regard to 
several cognitive behavioral factors that have shown to be pain-perpetuating 
factors in FM and chronic pain, and in the second study with measures of physical 
fitness. In the third study, we evaluated the level of correspondence between two 
screening methods, one based on our self-report questionnaire and one based on 
the judgm ents of a blinded therapist following a semi-structured interview. We 
hypothesized that pain-avoidance patterns would highly correspond to 
pain-related retreating, worrying about pain, fear of pain, hypervigilance, social 
reinforcement, and a diminished level of physical fitness as proposed by 
fear-avoidance models, in contrast to pain-persistence patterns that would be 
strongly correlated to ignoring pain sensations, persistence statements, and a 
higher level of physical fitness, since fear-avoidance models seem less applicable. 
A high level of correspondence was expected between the two screening methods 
in the third study.
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Study 1: Relating patient patterns to pain-related 
cognitive behavioral factors
The objective of our first study was to investigate the pain-avoidance and pain- 
persistence patterns of FM patients, as assessed by a relatively low and high level 
of pain-avoidance behavior, respectively, with respect to several pain-related 
cognitive behavioral factors. We hypothesized that patients with pain-avoidance 
patterns would score higher on the pain-avoidance factors of pain-related 
retreating, worrying about pain, hypervigilance, fear of pain, and social 
reinforcement, and that pain-persistence patients would score higher on the 
pain-persistence factors of persistence statements and ignoring pain.
Methods
Participants and procedure
A total of 359 adult FM patients was randomly recruited through the Netherlands 
association for FM patients. Inclusion criteria were a diagnosis of FM as confirmed 
by a rheumatologist based on the diagnostic criteria of the American College of 
Rheumatology (ACR)12 and age above 18 years. Exclusion criteria were severe 
physical and psychological comorbidity assessed by a standardized selfreport 
questionnaire on comorbidity and a diagnostic interview as well as by regular 
clinical and laboratory assessments by the rheumatologist, FM secondary to 
another rheumatic condition, illiteracy and inability to communicate in Dutch. 
Patients completed a set of validated self-report questionnaires measuring socio­
demographic variables, physical and psychological functioning, and a number of 
pain-related cognitive behavioral factors, including the screening instrument of 
pain-avoidance behavior.
The patients' mean age was 48.4 years (SD = 9.0). The greater majority was 
female (92.7%), and more than 80% was married or cohabiting. Of this sample, 
5.5%, 79.7%, and 14.8% had a primary, secondary, or tertiary educational level, 
respectively, representing on average 7, 12, and 17 years of formal education. 
The mean duration of FM symptoms was 15.8 years (SD = 9.3). Based on socio­
demographic variables and measures of physical and psychological functioning, 
our sample was comparable to other representative samples of the FM 
population.26-30
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Table 1 Means (standard deviations) or percentages of sociodemographic 
variables and indicators of physical and psychological functioning 
for the two patient patterns in fibromyalgia (Study 1)
Pain-avoidance Pain-persistence
pattern pattern
(n = 145) (n = 214)
■ociodemographic variables
Age (years) 48.8 (9.3) 48.1 (8.8)
Sex 92% 93%
Married / cohabiting 85% 80%
Educational level
Primary 6% 4%
Secondary 79% 80%
Tertiary 15% 16%
’hysical and psychological functioning
Fatigue 46.1 (7.9) 43.4 (8.5)
Disability 1.5 (0.5) 1.1 (0.6)
Pain 20.0 (3.4) 18.7(3.7)
Anxiety 21.4 (6.1) 21.3 (6.3)
Depression 5.7 (4.8) 5.1 (4.3)
Measures
All measures have been shown to be reliable and valid in previous FM studies, 
with a Cronbach's a of at least .74 in the present study.
Screening instrument
A distinction was made between pain-avoidance and pain-persistence patterns 
based on their level of pain-avoidance behavior as the main component of 
fear-avoidance models. Pain-avoidance behavior was assessed with the 5-item scale 
'resting when in pain' of the Pain Coping Inventory (PCI),3132 which reflects the level 
of pain-avoidance behavior when coping with pain in daily life (item examples: 
"I stop my activities," "I do not exert myself physically," "I rest sitting or lying down"). 
The Cronbach's a was .74 in this study. The mean score on this scale 'resting when in 
pain' for several chronic-pain populations (including patients with rheumatoid 
arthritis, chronic headache, and pain clinic patients)31 was used as the cut-off score 
to distinguish between pain-avoidance (above the mean) and pain-persistence 
patterns (below the mean). In addition, this specific cutoff score was supported by a 
median-split procedure as well as the mean on this scale in Study 1.
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Dem ographic variables
Sociodem ographic variables were assessed with a general checklist, assessing 
patient's gender, age, marital status, educational level, and medical history. 
Physical and psychological functioning
Functional disability within the past week was assessed on a subscale of the 
Fibromyalgia Impact Questionnaire (FIQ).26-33“35 The 11 items reflecting physical 
functioning in daily life are rated on a 4-point Likert scale ranging from "always" 
to "never" with a Cronbach's a of .87 in this study. Pain was assessed using the 
6-item pain scale of the Impact Rheumatic Diseases on General Health and 
Lifestyle (IRGL), which assesses physical, psychological, and social health in 
patients with rheumatic diseases.3637 Patients indicate the severity and frequency 
of painful episodes and the duration of morning stiffness within the last month. 
The Cronbach's a was .76 in this study. Fatigue for the previous two weeks was 
assessed with the 8-item fatigue scale of the Checklist Individual Strength (CIS),38 39 
with a Cronbach's a of .82 in this study. Psychological functioning was assessed 
with the anxiety and negative m ood  scales of the IRGL. The 10-item anxiety scale 
assesses the respondent's anxiety levels in the last month and the 6-item negative 
mood scale the various negative mood states over the previous week. The 
Cronbach's a fo r the anxiety scale was .88 and for the negative mood scale .92. 
Pain-avoidance factors
Pain-related retreating was assessed with the 7-item scale 'retreating' of the PCI, 
reflecting behavioral tendencies to avoid environmental stimuli on a 4-point 
Likert scale, ranging from "rarely or never" to "very frequently" with a Cronbach's 
a of .75 in this study. Worrying about pain  was assessed with the 9-item scale 
'worrying'of the PCI measuring catastrophic cognitions about pain. The Cronbach's 
a was .82 this study. Hypervigilance was assessed with the Dutch version of the 
Pain Vigilance and Awareness Questionnaire (PVAQ), a 16-item measure of 
attention to pain in chronic pain patients.40'42 The Cronbach's a was .82 in this 
study. Fear of pain was assessed with the recently adjusted Tampa Scale of 
Kinesophobia (TSK), which determines fear of increasing pain and (re)injury by 
physical activity.43'45 Its 13 items are scored on a 4-point Likert scale, ranging from 
"totally disagree" to "totally agree." The Cronbach's a was .81 in this study. 
Social reinforcem ent was assessed with the scale 'solicitous responses' of the 
Multidimensional Pain Inventory (MPI), which measures concerned reactions of 
significant others when in pain.46'48 The 6 items are rated on a 7-point Likert scale 
ranging from "never" to "very often." The Cronbach's a was .77 in this study.
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Pain-persistence factors
Ignoring pain  was assessed by the 6-item scale 'ignoring pain sensations' of the 
Dutch version of the Coping Strategies Questionnaire (CSQ)4950 that is used to 
establish the cognitive coping strategy of denying that the pain hurts or affects 
oneself. The Cronbach's a was .79 in this study. Persistence statements were 
assessed by the 6-item scale 'coping self-statements' of the CSQ that measures 
the coping style in which patients use self-statements to tell themselves to cope 
with the condition and to continue activities despite the pain (item example: 
"Although it hurts, I just keep on going"). The Cronbach's a was .80 in this study. 
To facilitate comparison to the pain-coping strategies of the PCI, response 
categories of the CSQ were slightly adjusted (4-point Likert scales ranging from 
"rarely or never" to "very frequently").
Statistical analysis
The screening instrument described above was used to distinguish between 
patients with pain-avoidance (high-level pain-avoidance behavior) and pain-per- 
sistence patterns (low-level pain-avoidance behavior). Differences between the 
two groups of patients were tested with chi-square analyses for categorical data 
and Student's f-testfor continuous variables with a threshold ofp < .05 (two-tailed). 
To determine the specific factors that discriminated patients with pain-avoidance 
and pain-persistence patterns best, an analysis of groups was undertaken using a 
stepwise discriminant function procedure in SPSS (Statistical Package for the 
Social Sciences, SPSS, Chicago, IL). High-level and low-level pain-avoidance 
behavior were used as outcome variables, the variables that yielded significant 
differences in the initial f-test analyses were entered in the analysis as predictor 
variables to produce a model and the percentage patients correctly classified by 
this solution. In the stepwise procedure, variables are entered in successive steps, 
minimizing the overall Wilks' lambda until no variables fulfill this criterion, thereby 
producing an optimal model.
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Results
Based on the screening criterion of pain-avoidance behavior, 145 patients (40.4%) 
had a pain-avoidance (high-level pain-avoidance behavior) and 214 patients 
(59.6%) a pain-persistence pattern (low-level of pain-avoidance behavior). Means 
and standard deviations of sociodemographic variables and indicators of physical 
and psychological functioning are presented for the pain-avoidance and pain- 
persistence patterns in Table 1. No significant differences on sociodemographic 
variables (e.g., gender, age, marital status, educational level) were found between 
these groups. With regard to the level of physical and psychological functioning, 
the patients with pain-avoidance patterns had significant higher levels of 
functional disability (f = -6.94, p < .001), pain (f = -3.40, p < .001) and more (severe) 
symptoms of fatigue (f = -3.06, p < .001) relative to the patients with pain- 
persistence patterns, but no differences were found for anxiety and depressive 
symptoms.
Results for the pain-related cognitive behavioral factors are presented in 
Table 2 and demonstrated that patients with a pain-avoidance pattern had 
significantly higher scores on the behavioral component of pain-related retreating, 
cognitive aspects of worrying when in pain, heightened attention of pain stimuli 
(hypervigilance), fear of pain, and social aspects of reinforcement. In contrast, the 
pain-persistence group had significantly higher scores on the pain-coping 
strategies of persistence statements and ignoring pain. Furthermore, after 
controlling for multiple testing by means of the Bonferroni correction, the 
differences on all the cognitive behavioral factors remained significant, exceptfor 
ignoring pain. Subsequently, stepwise discriminant analyses were performed to 
determine distinguishing pain-related cognitive behavioral variables for the two 
groups. The predictor variables entered into the discriminant analysis were the 
cognitive behavioral factors that yielded significant differences between the 
two groups in the former f-tests. The discriminant analysis was significant 
(Wilks' lambda = .770, p < .001), and 71.9% of the patients were correctly 
classified, compared to a chance level of 50%. The discriminant analysis showed 
that the variables (1) pain-related retreating, (2) social reinforcement, and (3) 
persistence statements discriminated the pain-avoidance and pain-persistence 
patterns best.
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Table 2 Means (standard deviations) and results of the f-tests of the pain- 
related cognitive behavioral factors for the two patient patterns in 
fibromyalgia (Study 1)
Pain-avoidance Pain-persistence f-test p
pattern
(n = 145)
pattern
(n = 214)
Pain-avoidance factors
Pain-related retreating 2.2 (0.6) 1.7 (0.5) -7.98 .000
Worrying about pain 2.0 (0.6) 1.8 (0.5) -3.12 .002
Hypervigilance 39.2 (10.8) 35.1 (11.1) -3.49 .001
Fear of pain 27.9 (6.5) 25.7 (6.4) -3.20 .002
Social reinforcement 3.6 (1.1) 3.0 (1.1) -4.72 .000
Pain-persistence factors
Persistence statements 2.2 (0.5) 2.5 (0.6) 4.04 .000
Ignoring pain sensations 1.9 (0.5) 2.1 (0.6) 2.03 .043
Study 2: Relating patient patterns to physical fitness
This goal of this study was to investigate whether the patients with pain-avoidance 
and those with pain-persistence patterns, as assessed by a relatively high and low 
level of pain-avoidance behavior, respectively, differed on the level of physical 
fitness, measured by a shuttle walking test. We hypothesized that patients with 
pain-persistence patterns would have a higher level of physical fitness than 
patients with pain-avoidance patterns.
Methods
Participants and procedure
Patients with FM, who had been referred by their rheumatologists for a randomized, 
controlled trial, testing the effect of a tailored cognitive behavioral intervention, 
were invited to participate in our second study. The same inclusion and exclusion 
criteria were used as in Study 1, although here the patients' diagnoses of FM 
needed to have been made no longer than five years prior to the study to ensure 
a relative early intervention for the trial. In addition, only patients with a risk 
profile of heightened distress were selected for the trial and thus included in this
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study to indicate the maladaptive function of the cognitive behavioral patterns.22 
Patients filled out several questions to establish sociodemographic variables and 
the screening instrument of pain-avoidance behavior. Before their inclusion in the 
tailored treatment program, patients took part in an intake procedure conducted 
by a physical therapist who was blind to the patients' scores on the screening 
instrument, during which they performed a shuttle walking test to establish their 
level of physical fitness.
The study sample comprised 112 FM patients with a mean age of 41.2 years 
(SD = 10.9, range 18-71). Participants were predominantly female (93.8%) and 76% 
was married or co-habited. Of the total sample, 2%, 85%, and 13% had a primary, 
secondary, or tertiary educational level, respectively. In comparison to the sample 
of Study 1, the group's mean age was slightly younger (f = 6.31, p < .001).
Measures
Physical fitness was assessed with a shuttle walking test, a standardized, 
progressive, maximal test of walking speed and endurance. The difference with a 
conventional treadmill test is that this test is incremental and externally paced.5152 
Outcome measures were distance walked in meters and perceived exertion as 
measured by the Borg scale rated from 0 (no perceived exertion) to 10 (maximum 
perceived exertion).53
Statistical analysis
As in Study 1, the screening instrument consisting of pain-avoidance behavior 
was used to distinguish the patients. Performance differences with regard to the 
distance walked and the perceived exertion between the patients with 
pain-avoidance (high-level pain-avoidance behavior) and pain-persistence 
patterns (low level pain-avoidance behavior) were tested with Student's f-test 
with a threshold of p < .05 (two-tailed).
Results
Based on the screening criterion of pain-avoidance behavior, 58 patients (51%) 
had a pain-avoidance (high-level pain-avoidance behavior) and 54 patients (49%) 
a pain-persistence pattern (low-level of pain-avoidance behavior). The shuttle 
walking test revealed significant group differences in the total distance walked 
(f = 2.64, p < .05) (Table 3). The patients with a pain-persistence pattern walked
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longer than those with a pain-avoidance pattern. These results remained 
significant after controlling for multiple testing by means of the Bonferroni 
correction. No pattern-related differences were found for the level of perceived 
exertion (Table 3).
Table 3 Means (standard deviations) and results of the t-tests of the
shuttle walking test for the two patient patterns in fibromyalgia 
(Study 2)
Physical test Pain-avoidance Pain-persistence f-test p
pattern pattern
(n = 58) (n = 54)
Distance walked (meter) 239.7(134.5) 307.0(122.6) 2.77 .007
Perceived exertion (Borg) 4.2 (1.8) 4.0 (1.9) -0.67 .503
Study 3: Self-report-based patient patterns versus 
interview-based therapist patterns
The aim of ourthird study wasto investigate the level of correspondence between 
two screening methods for pain-avoidance and pain-persistence patterns in FM: 
the first based on our self-reported screening instrument of pain-avoidance 
behavior and the second founded on the judgm ent of a therapist following a 
semi-structured interview. A relatively high level of correspondence was expected 
between the two screening methods.
Methods
Participants and procedure
For this study, a subsample of consecutive patients of Study 2 was used consisting 
of 77 patients. Consequently, the sample consisted of FM patients who had been 
referred by their rheumatologists for a randomized, controlled trial, and the 
inclusion and exclusion criteria were the same as in Study 2. Before inclusion in 
the treatment program, patients filled out a questionnaire on sociodemographic
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data and the screening instrument of pain-avoidance behavior. As part of the 
intake procedure for the treatment program, patients were also seen by a trained 
psychologist who was experienced with the pain-avoidance and pain-persistence 
patterns. The therapist, blind for the scores on the self-reported screening 
instrument, conducted a semi-structured, diagnostic interview with the patient 
with regard to relevant pain-related cognitive behavioral factors, including 
pain-avoidance behavior, social reinforcement, hypervigilance, and fear of pain. 
In addition, the 7-day record of daily activities the patients had been asked to 
keep prior to the interview was discussed.
The present FM sample consisted of 77 patients with a mean age of 41.7 (SD = 
11.7). Patients were predominantly female (93.5%) and 76.3% was married or 
co-habited. Of the total sample, 2.9%, 88.4%, and 8.7% had a primary, secondary, 
or tertiary educational level, respectively. Again, the sample was slightly younger 
(f = 7.04, p < .001) relative to the sample in Study 1. No sociodemographic 
differences were found in comparison with the patients of Study 2.
Measures
After the interview, the therapist indicated on two separate 10-point visual 
analogue scales (VAS) the degree to which they judged the patients to be 
characterized by pain-avoidance patterns and by pain-persistence patterns. 
Patients were classified as pain-persistent if the relevant VAS score was > 5 and 
the difference with the pain-avoidance VAS was > 1, and vice versa for the 
pain-avoidant group. As the pain-persistence and pain-avoidance VAS scores of 
six patients were equal, they were subsequently excluded from further analyses.
Statistical analysis
As in both previousstudies.thescreening instrument consisting of pain-avoidance 
behavior was used to distinguish the patients with a pain-avoidance (high-level 
pa in-avoidance behavior) and a pain-persistence pattern (low-level pain-avoidance 
behavior). Crosstabs percentages and the Cohen's kappa test (chance corrected 
proportional agreement) were computed to compare the therapists' results and 
the results based on the self-reported screening instrument.
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Results
The comparison of the self-report-based and the therapists-based patient patterns 
yielded a correspondence of 80% for the pain-avoidance patterns and 75.6% for 
the pain-persistence patterns (Table 4). Cohen's kappa was significant (K =  .546), 
indicating a moderate to good agreement.54 For 16 of the 71 patients (22.5%) no 
agreement was found.
Table 4 Percentage agreement between the therapists' interview-based 
patient patterns and the patterns as derived from the self-report 
screening instrument (Study 3)
Screening instrument
Therapist
judgm ent
Pain-avoidance
pattern
Pain-persistence
pattern
Total
Pain-avoidance
pattern
24
80%
10
24.4%
34
Pain-persistence Total 
pattern
6
20%
31
75.6%
37
30
41
71
Discussion
With our three-part study, we set out to gain a deeper insight into the discrim ¡native 
value of pain-avoidance behavior to distinguish specific cognitive behavioral 
patterns in FM patients. In our first study, we found that pain-avoidant patients 
retreated more when in pain, worried more about their pain, paid more attention 
to pain sensations, and were more afraid that movement would cause (more) pain. 
In addition, their social environment reinforced their avoidance behavior more 
strongly. These findings are consistent with fear-avoidance models that postulate 
that factors of pain-avoidance behavior, heightened attention to pain, pain-related 
fear, and catastrophizing are interrelated.1-4 In contrast, patients characterized by 
pain-persistence patterns showed higher scores on persistence statements and 
ignoring pain, providing preliminary support for the recent findings of a distinct
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group of patients characterized by overuse and demanding cognitions, where 
fear-avoidance models seem less applicable.6'71013'15 The discriminant factors of 
these patterns, namely pain-related retreating, persistence statements, and social 
reinforcement, underscore the relevance of cognitive, behavioral, and social 
mechanisms in distinguishing patient patterns.55'57 Furthermore, the preliminary 
findings with regard to the physical fitness test in Study 2 seem to deliver 
additional support that long-lasting pain-avoidance behavior can seriously 
compromise the physical condition of FM patients.5'5859 Future studies might also 
clarify whether internal stop-rules and motives play a role in the persistence or 
avoidance behavior during physical fitness examination.10 Finally, the findings of 
the third study suggest that a screening instrument consisting of only a short 
self-report can be used as a clinically valid instrument for the discrimination of FM 
patients with dissimilar cognitive behavioral patterns.
As different perpetuating cognitive behavioral mechanisms for the 
maintenance of pain and disability appear relevant in these two groups, offering 
FM patients CBT that is tailored to their specific dysfunctional mechanisms seem 
to be promising to augment treatment effects and to reduce the number of 
patients dropping out. Studies on in vivo exposure specifically aimed at 
diminishing the patient's fear of pain and movement, for example, have reported 
encouraging results, particularly in chronic pain patients exhibiting high 
fear-of-pain levels.6061 Thieme and colleagues23 have further shown the benefits 
of specific operant-behavioral and cognitive behavioral treatment options for FM 
patients, which offer promising possibilities for tailored interventions. Patients 
with pain-avoidance patterns are likely to benefit most from operant-behavioral 
interventions aimed at changing their pain-avoidance patterns and fear of pain, 
whereas for patients with pain-persistence patterns, cognitive restructuring and 
acceptance-based approaches might be more appropriate.23'25 62
Some limitations of the present study have to be mentioned. As to our choice 
of participants, we cannot rule out a possible selection bias. Although the results 
were largely consistent to our expectations in all the different samples, the 
patients in Study 1 were a random sample recruited through our national FM 
patient association comparable to other representative FM samples, whereas the 
samples of Study 2 and Study 3 comprised distressed patients that were specifically 
interested in CBT and who probably demonstrate maladaptive patterns of 
pain-avoidance and pain-persistence. Second, although the agreement between 
the therapist-based and screening-based patient patterns was relatively high, 
there was still a group with no concord, which may indicate some overlap between
75
Chapter 3
the two patterns. Furthermore, one therapist was involved in the rating of the 
patient patterns, and future research should aim at investigating the inter-rater 
reliability of this procedure. Third, the level of physical functioning differed 
between the patients with pain-avoidance and persistence patterns, and it could 
be argued that the differences we found on the pain-related cognitive behavioral 
factors might also be attributable to the patients' level of functioning. However, 
also when adding indicators of physical and psychological functioning as 
covariates in post-hoc analyses, the differences between the pain-avoidance and 
pain-persistence patterns remained significant or borderline significant. 
Nevertheless, prospective and experimental studies are clearly needed to 
investigate this relationship in more detail. Fourth, the factors of ignoring pain 
and persistence statements assessed with a slightly adjusted self-report 
questionnaire were used to explore patterns of pain-persistence. Behavioral 
methods such as selfobservation lists or measures of actual activity levels 
(actometer) are also important in the assessment of pain-persistence patterns, 
and factors that could influence physical functioning should be taken into 
consideration (e.g., age, body mass index). In this study, we found preliminary 
evidence that patients characterized by pain-persistence patterns had a higher 
level of physical fitness than pain-avoidance patients, suggesting this group is not 
just claiming pain-persistence behavior. Future research should aim at developing 
more self-report and behavioral methods to explore pain-persistence patterns. 
Finally, the clinical relevance of the two FM patterns should additionally be 
established, for example, by comparing the efficacy of CBT programs that are 
tailored to specific patient patterns with the effects of regular CBT interventions. 
Taken together, this three-part study suggests that the short self-report screening 
instrument based on pain-avoidance behavior in FM patients is a valid method to 
distinguish between two specific cognitive behavioral patterns supported by 
physical fitness tests and consistent with interview-based therapist judgments. 
Furthermore, it supports the notion that pain-avoidance behavior can be used to 
discriminate between patients characterized by pain-avoidance patterns and 
those characterized by pain-persistence patterns. Future prospective and 
experimental research should aim at delineating underlying mechanisms of these 
patterns further, in particular, the less explored factor of pain-persistence as 
cognitive behavioral mechanism in FM patients. Although more prospective and 
experimental research is clearly needed, preliminary findings suggest that pain- 
persistence mechanisms can be a risk factor for the development and maintenance 
of chronic pain.6'8'91617 However, more research is needed to differentiate between
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functional active pain coping strategies that are taught in CBT to patients with 
pain-avoidance patterns and the dysfunctional patterns of pain-persistence and 
overuse that can lead to exhaustion and more complaints in the long-term. For 
example, in our study, patients with heightened levels of distress were enrolled to 
ensure the maladaptive function of pain-avoidance and pain-persistence patterns. 
In addition, overt behavioral methods can be used in addition to self-report 
measures to ensure the selection of patients with actual pain-persistence 
patterns.63 Furthermore, more research is needed on the possible underlying 
mechanisms of pain-persistence patterns, e.g., fear of failing to function in daily 
life as a result of the pain, low self-esteem, or personality characteristics of 
perfectionism.64 In addition, the long-term changes of these patient patterns 
should be further explored, while these patterns could be stages in a learning 
process. For example, it has been proposed that pain-persistence patterns might 
be particularly relevant in the phase from acute to chronic pain and could finally 
lead to exhaustion and pain-avoidance behavior in the long-term.89 Finally, there 
is also preliminary evidence that these cognitive behavioral patterns are relevant 
in other chronic (pain) conditions, for example in chronic fatigue syndrome,1315 
and additional research with regard to differences and correspondences to 
patients with FM is needed to investigate this in greater detail.
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Abstract
Objective. Psychological distress is a key risk factor for long-term complaints in 
fibromyalgia (FM). Prognostic factors for psychological distress might facilitate an 
early identification of patients at risk to help prevent long-term dysfunction, 
especially for the relatively well-functioning patients showing little distress who 
are usually not considered for treatment. This study hence examines potential 
prognostic factors in this subgroup.
Methods. Psychological distress, physical functioning, illness cognitions 
(helplessness, acceptance), pain-avoidance factors (passive pain-coping, fear of 
pain, hypervigilance), and social factors (social support, social reinforcement) 
were assessed in 78 low-distress FM patients at baseline and after a mean of 
9 months (SD = 3.3).
Results. Baseline physical functioning did not predict changes in psychological 
distress, whereas a higher level of hypervigilance, less acceptance, and less 
perceived social support predicted an increase in psychological distress at 
follow-up.
Conclusion. Illness cognitions, pain-avoidance factors, and social support can be 
considered as prognostic factors predicting changes in psychological distress in 
FM. More research is needed to investigate additional factors that could also be 
implicated (e.g., personality factors, stressful events).
Practice implications. Timely assessment of illness cognitions, pain-avoidance 
factors, and social support may help identify subgroups of relatively well- 
functioning FM patients at risk of longer term aggravated psychological distress.
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Introduction
Psychological distress has been shown to be an important riskfactorfor a negative 
long-term outcome in several chronic pain conditions including fibromyalgia 
(FM), a condition characterized by widespread musculoskeletal pain.1 It has, for 
example, been shown to be a prognostic factor for overall health status, including 
high levels of pain, fatigue and functional disability.2'4 Accordingly, psychological 
distress might be a key to the early identification for patients at risk of long-term 
dysfunction. Furthermore, high levels of distress have been shown to be an 
indicator of maladaptive cognitive behavioral patterns targeted in multi­
disciplinary cognitive behavioral treatments.5'7 Several multidisciplinary treatment 
studies indeed found relatively highly distressed FM patients to obtain the better 
outcomes.7'9 Many FM patients experience heightened distress at subclinical levels 
of anxiety and depression and treatment approaches have been developed for 
this subgroup that are effective in improving physical functioning (e.g.,functional 
disability) and psychological distress (e.g., negative mood).6'9 However, less 
attention has been paid to a seemingly wellfunctioning subgroup experiencing 
less psychological distress.71011 These patients appear to cope relatively well with 
their complaints, show few maladaptive cognitive behavioral patterns, and are 
hence rarely considered for multidisciplinary interventions despite their elevated 
levels of widespread musculoskeletal pain and functional limitations.5'78 
The long-term course for this group is, however, unknown; some of these well- 
functioning patients might become distressed over time and may thus be at risk 
of negative longer term outcomes in terms of both physical and psychological 
functioning. Consequently, it is important to establish prognostic factors to help 
identify these at-risk patients at an early stage and to thus prevent possible longer 
term dysfunction.
In FM and other chronic pain conditions, cognitive, behavioral, and social 
processes are considered to sustain and perpetuate symptoms, including 
psychological distress. Illness cognitions related to the concept of control, such as 
helplessness and acceptance, might play an important role here. Helplessness 
theories suggest that patients who feel unable to control their condition are more 
susceptible to depression.12 In general, a greater sense of helplessness has been 
shown to adversely affect psychological distress, but there is also evidence that 
attempts to control, rather than accept, uncontrollable conditions like chronic 
pain can be detrimental in the long run.1314 Furthermore, fear-avoidance models 
of chronic pain postulate that pain-avoidance behavior, fear of pain, and a
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heightened attention to pain (hypervigilance) are responsibleforthe maintenance 
and exacerbation of symptoms.15 Cross-sectional and prospective studies found 
these factors to unfavorably affect both the short and longterm psychological 
distress of patients with chronic pain, including FM.16 In contrast, social support 
(i.e. favorably perceived support or a large social network) can act as a protective 
factor by stimulating social activities,17 although social interaction can also have 
negative consequences when pain behaviors are reinforced.18 Yet, to date little is 
known about potentially predictive factors of psychological distress in these well- 
functioning FM patients.
In this longitudinal observational cohort study we report on our longer term 
follow-up of a group of relatively well-functioning FM patients earlier showing 
low levels of distress. Our goal was to determine the contribution of distinct 
illness cognitions, pain-avoidance factors, and social factors to the changes in 
psychological distress.
Methods
Participants and procedure
Rheumatologists of several regional hospitals referred their FM patients for 
participation in a randomized controlled trial of a tailored multidisciplinary 
intervention. A heightened level of distress was among the inclusion criteria, for 
which a screening instrument of anxiety and negative mood levels was used. 
We based the cut-off score on norm groups of psychiatric outpatients with 
subclinical levels of anxiety and/or depression.1920 The patients that did not fulfill 
this criterion and thus had relatively low levels of distress were subsequently 
invited to participate in the current longitudinal observational cohort study. 
Further inclusion criteria were age over 18 years, date of FM diagnosis within 
5 years (ACR),1 FM secondary to another rheumatic condition, absence of severe 
physical or psychiatric comorbidity, and an ability to communicate in Dutch. 
Informed consent was obtained from all participants.
Ninety-seven consecutive patients with FM agreed to participate and 
completed a questionnaire at study entry (baseline). At follow-up, which was a 
mean of 9 months later (SD = 3.3; range 5-17 months), data of 19 patients were not 
available, and thus the study sample consisted of 78 patients (95% female). 
No significant differences were found between the patients that did not complete 
the follow-up assessment and the patients that did with regard to sociodemo­
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graphic variables (age, sex, educational level, marital status, symptom duration), 
psychological distress (anxiety, negative mood), physical functioning (pain, 
fatigue, functional disability), and the cognitive behavioral factors (illness 
cognitions, pain-avoidance factors, social factors). The mean age of the completers 
was 42.9 (SD = 11.2; range 18-73 years); 81% were married or cohabiting and 2% 
had a primary, 83% a secondary and 15% a tertiary level of education (on average 
7,12, and 17years offormal education, respectively). Mean symptom duration was 
7.0 years (SD = 6.1; range 6 months-30 years).
Measures
All the questionnaires employed in this study were used in previous studies of 
FM and other chronic physical syndromes and all showed good validity and 
reliability.1921-31 
Psychological distress
Psychological distress was assessed with the standardized composite score of the 
Anxiety and Negative Mood subscales of the Impact of Rheumatic Diseases on 
General Health and Lifestyle questionnaire (IRGL).19The 10-item Anxiety subscale, 
a shortened version of the Dutch State Anxiety Scale, assesses the level of anxiety 
in the last month on a 4-point Likert scale. The 6-item Negative Mood subscale 
assesses depressed mood states over the previous week on a 5-point Likert scale. 
Norms for psychiatric outpatients are available to determine the cut-off score for 
subclinical levels of anxiety and/or depression.1920 
Physical functioning
Physical functioning  consisted of functional disability, pain, and fatigue. Functional 
disability was assessed using the 7-item Mobility subscale of the IRGL. Pain was 
assessed using the 6-item Pain subscale of the IRGL. Fatigue was assessed using 
the 8-item Fatigue subscale of the Checklist Individual Strength (CIS).23 
Illness cognitions
Helplessness was assessed using the 6-item Helplessness subscale of the Illness 
Cognitions Questionnaire (ICQ), with the scores reflecting the tendency to focus on 
the adverse aspects of the condition and to generalize them to daily functioning.24 
Acceptance was assessed using the 6-item Acceptance subscale of the ICQ, with the 
scores reflecting the tendency to recognize the need to adapt to a chronic condition 
while perceiving the ability to tolerate and manage its aversive consequences. 
Pain-avoidance factors
Passive pain-coping  was based on the standardized composite score of three scales 
of the Pain Coping Inventory (PCI); Resting (5 items reflecting pain-avoidance
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behavior when coping with pain). Retreating (7 items reflecting behavioral 
tendencies to avoid environmental stimuli), and Worrying (9 items reflecting 
catastrophic cognitions about pain).26 Fear of pain  was assessed using the 13-item 
Tampa Scale of Kinesophobia (TSK) which determines fear of increasing pain and 
(re)injury as a result of physical activity.30 Hypervigilance was assessed using the 
Dutch version of the Pain Vigilance and Awareness Questionnaire (PVAQ), a 
16-item measure of attention to pain in chronic pain patients.28 
Social factors
Perceived support was assessed using the 5-item Perceived Support subscale of 
the IRGL, reflecting the availability of emotional and instrumental support. Social 
network was assessed with the IRGL using the size of the respondent's social 
network. Social reinforcement was assessed using the 6-item Solicitous Responses 
subscale of the Multidimensional Pain Inventory (MPI), which determines the 
concerned reactions of significant others when the respondent is in pain.31
Statistical analyses
Pearson's correlation coefficients were calculated to explore the relationship 
between changes in psychological distress and the baseline levels of illness 
cognitions, pain-avoidance factors, and social factors. Residual gain scores were 
used as change scores for psychological distress.32 Sequential regression analyses 
were then performed for illness cognitions, pain-avoidance factors, and social 
factors separately with changes in psychological distress at follow-up as the 
dependent variable. Only the predictors that were significantly related to changes 
in psychological distress (residual gain score) were entered into the regression 
analyses. Beta coefficients were used to determine the contribution of the factors 
in predicting changes in distress at follow-up. Of the full sample of 78 patients, all 
analyses were conducted with a minimum of 75 patients with complete data sets.
Results
Correlates of changes in psychological distress
Pearson correlations between the various illness cognitions, pain-avoidance and 
social factors on the one hand, and changes in psychological distress on the other 
are presented in Table 1. Lower baseline levels of acceptance correlated with an 
increase in distress at follow-up, as did higher levels of passive pain-coping and 
hypervigilance and also less perceived support (Table 1). The other variables did
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not show any significant correlations with changes in distress, nor did any of the 
sociodemographic variables (age, sex, educational level, marital status, symptom 
duration) or baseline aspects of physical functioning (pain, functional disability, 
fatigue).
Predictors of changes in psychological distress
The predictors that were significantly related to changes in distress at follow-up, 
i.e., the illness cognition 'acceptance', the pain-avoidance factors 'passive 
pain-coping' and 'hypervigilance', and the social factor 'perceived support', were 
entered into the regression analyses with changes in distress as the dependent 
variable. Acceptance contributed 5% to the variance in distress (F change = 4.14, 
p < .05), passive pain-coping and hypervigilance 15% (F change = 6.51, p < .01), 
and perceived support 6% (F change = 5.02, p < .05). Examining the contribution 
of each of the predictors, the beta coefficients showed that less acceptance 
(f = 2.03,p < .05), more hypervigilance (f = 2.92,p < .01), and less perceived support 
(f = 2.24, p < .05), significantly predicted changes in distress at follow-up.
Table 1 Results of the sequential regression analyses predicting changes in 
psychological distress at follow-up
Changes in psychological distress
r C hange/?2 Beta
Illness cognitions .05*
Helplessness .13
Acceptance -.23* -.23*
Pain-avoidance factors .15**
Passive pain-coping .23* .08
Fear o f movement .19
Hypervigilance .38** .35**
Social factors .06*
Perceived support -.25* -.25*
Social network size -.01
Social reinforcement -.09
*p < .05; **p < .01
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Discussion
Discussion
The aim of th is study wasto identify prognosticfactors of changes in psychological 
distress in a well-functioning subgroup of FM patients with relatively low current 
levels of distress. We found no predictive role for pain, fatigue, and functional 
disability as indicators of psychological distress. In contrast, specific illness 
cognitions, pain-avoidance factors, and social aspects were associated with 
changes in distress at follow-up: a higher level of distress was predicted by lower 
levels of acceptance, higher levels of hypervigilance, and less perceived social 
support.
To our knowledge this is the first prospective study to examine predictors of 
changes in psychological distress in a group of FM patients with low levels of 
psychological distress. In addition, the specific cognitive behavioral factors (e.g., 
illness cognitions, pain-avoidance factors, social factors) examined in our study 
have not been collectively studied in a prospective design in FM before. Previous 
studies also delivered preliminary support for the relevance of these cognitive 
behavioral factors in various patient populations. For example, passive pain-coping 
behaviors have been shown to be related to more psychological distress.16'3334 
Our study also showed that pain-avoidance factors were related to increases in 
psychological distress: the factors 'passive pain-coping' and 'hypervigilance' 
both predicted changes at follow-up, which is consistent with existing theories 
proposing that passive pain-coping behaviors as well as an attentional bias to a 
feared stimulus (i.e., pain in patients with chronic pain) are related to more anxiety 
and possibly also depression.1535 Previous studies also showed that qualitative 
aspects of social support are more important than quantitative aspects, which 
was supported by our findings.36 Finally, we found a high level of acceptance to 
have a protective effect, confirming that, because attempts to control chronic 
pain usually fail, acceptance is important for maintaining a satisfactory level of 
well-being.1324 Surprisingly, despite its known association with clinical depression 
and consequently particularly relevant in patients with heightened levels of 
distress, helplessness did not predict increased psychological distress in our 
study.1237
Knowledge about factors contributing to psychological distress is essential 
for clinicians as it may enable them to identify patients most at risk of heightened 
distress at an early stage and thus possibly prevent long-term physical and 
psychological complaints. This is especially relevant for those patients that have
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adjusted themselves relatively well to their condition and hence show low levels 
of distress. It is this group that is seldom considered for multidisciplinary treatment. 
The results of our study suggest that it is possible to identify patients who are 
vulnerable to increased psychological distress in the longer term. Closely 
monitoring these patients over time and offering them early psycho-education or 
self-management interventions addressing potential risk factors for distress may 
help prevent distress from exacerbating and hence future dysfunction.
Some limitations of our study warrant mentioning. The mean follow-up period 
in our study was 9 months and the changes in distress we observed may simply 
reflect a natural fluctuation and not a long-term state. However, due to relatively 
stable patterns of physical functioning and psychological distress in chronic pain 
patients, a follow-up period of 6-12 months is regularly used as an indication of 
longer term functioning.2038 Nevertheless, more longitudinal studies are needed 
to investigate prognostic factors for changes in psychological distress using a 
longer follow-up period and at different stages of the condition. Furthermore, 
otherfactors than the ones in this study may also have contributed to the changes 
in distress. Stress vulnerability models, for instance, state that outcomes may be 
affected by both internal vulnerability factors of personality characteristics like 
neuroticism and external environmental factors like stressful events. Future 
research should aim at investigating the prognostic role of these factors as well as 
protective factors that might reduce the risk of longer term distress. Finally, such 
studies should look at potential risk factors for other relevant outcomes in FM, 
such as pain and functional disability.
Conclusion
The results of our study indicate that the illness cognition 'acceptance', the 
pain-avoidance factor 'hypervigilance', and the social aspect 'perceived support' 
can be considered as possible prognostic factors for longer term changes in 
psychological distress in fibromyalgia patients. Future studies will need to further 
delineate these and other potential prognostic factors before early interventions 
can be developed that specifically address these risk factors to prevent longer 
term dysfunction in this population.
Practice implications
Patients that have adapted relatively well to their symptoms and hence show low 
levels of psychological distress are seldom considered for intensive multi­
disciplinary treatment. However, it is essential for clinicians to be aware of risk
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factors contributing to changes in psychological distress to identify those well- 
functioning FM patients who are vulnerable to increased distress in the longer 
term. By identifying this subgroup in a relatively early stage, long-term physical 
and psychological complaints might be prevented. Our study showed that 
acceptance, hypervigilance, and perceived social support are possible risk factors 
for longer term distress that might be used in clinical practice for the monitoring 
of these patients over time. Furthermore, offering this group early psycho-educa- 
tion or self-management interventions addressing these potential risk factors 
may help prevent distress from exacerbating and hence future dysfunction.
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Abstract
Objective. To illustrate a multidisciplinary group treatment for patients with 
fibromyalgia (FM) tailored to the patient's cognitive behavioral pattern.
Method. In a case-study design the tailored treatment approaches of two FM 
patients were described. One patient characterized by avoidance behavior (pain- 
avoidance pattern) participated in a group treatment aimed at changing 
pain-avoidance mechanisms and one patient characterized by continuing with 
activities in spite of pain (pain-persistence pattern) participated in a group 
treatment aimed at changing pain-persistence mechanisms. Assessments were 
made at baseline, post-treatment and at 6-month follow-up.
Results. Comparison of the pre-test, post-test and follow-up scores on pain, 
functional disability, fatigue and psychological distress showed clinically 
significant improvements for both patients.
Conclusion. The heterogeneity of patients regarding pain-related cognitive 
behavioral mechanisms has been proposed to underlie varying treatment 
outcomes in FM patients. These results demonstrate that a group treatment 
tailored to pain-avoidance and pain-persistence patterns isfeasible and can result 
in clinically significant changes for FM patients.
Practice implications. FM offers a great challenge for clinicians due to the lack of 
effective treatment options. These case studies suggest that tailored CBT and 
exercise training directed at specific patient patterns can contribute to the 
improvement of the care of FM patients.
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Introduction
Fibromyalgia (FM) is a chronic pain disorder characterized by widespread pain of 
unknown origin.1 Furthermore, patients report substantial levels of functional 
disability, fatigue and affective distress. FM offers a great challenge for clinicians 
due to the lack of effective treatments, which could be due to the heterogeneity 
of patients.2'6 The treatment efficacy may be improved if subgroups that are most 
likely to benefit from a specific treatment are identified and offered tailored 
treatments.2
Treatment can be tailored in various ways, e.g., selection of specific patients, 
type of treatment and timing of treatment. FM patients with a relatively high level 
of distress and impact of the condition on daily life have been shown to obtain the 
best outcomes, suggesting that selecting this dysfunctional group could improve 
treatment efficacy.78 Within this distressed group, specific subgroups can be 
identified with distinctive cognitive behavioral patterns responsible for the 
maintenance of pain and disability. For example, the frequently studied 
fear-avoidance models of chronic pain postulate that mechanisms such as 
pain-avoidance behavior, fear of pain, catastrophizing and heightened attention 
for pain, account for the maintenance and exacerbation of complaints.9'15 However, 
preliminary evidence suggests a distinctive pattern in patients who tend to persist 
in their activities in spite of pain (Figure I).16'24 Patients with pain-avoidance 
patterns are most likely to benefit from operant-behavioral interventions aimed 
at diminishing fear of pain and increasing daily activities, whereas for pain-persis- 
tence patients changing pain-persistence cognitions and regulation of daily 
activities seems more appropriate.25'27 Finally, when considering the timing of 
treatment, offering treatment relatively early after diagnosis can help prevent 
long-term dysfunction and improve treatment efficacy.28'32
Currently, the efficacy of a tailored treatment approach for FM patients is 
studied in a randomized, controlled trial. The goal of the present case-study is to 
demonstrate the feasibility and possible treatment effectiveness and illustrate 
the tailored pain-avoidance and pain-persistence treatment approaches with two 
cases.
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Figure 1 Overview of the proposed perpetuating factors for the two 
patient patterns in fibromyalgia
Pain-avoidance pattern
- High level of pain-avoidance behavior
- Preoccupation with or high attention 
to pain stimuli
- Pain-related worrying
- Fear of pain and movement
Pain-persistence pattern
- Low level of pain-avoidance behavior
- Active despite pain
- Ignoring pain and (physical) limits
- Non-accepting and dem anding 
cognitions about limitations
Methods
Procedure and assessment
To be included in the trial, the diagnosis of FM had to be confirmed by a 
rheumatologist within the last 5 years to assure a relatively early intervention 
after diagnosis. Patients with heightened distress were selected based on their 
scores on the 'Anxiety' and 'Negative Mood' scales of the Impact of Rheumatic 
Diseases on General Health and Lifestyle (IRGL).33,34 Cut-off scores were based on 
anxiety and/or negative mood scores of norm g roups of psychiatric outpatients.3335 
Within this distressed group, a distinction was made between pain-avoidance and 
pain-persistence patterns, based on the level of pain-avoidance behavior (5-item 
scale 'Resting when in pain' of the Pain Coping Inventory (PCI).36 37 The mean score 
on this scale for several chronic pain populations (including, FM, rheumatoid 
arthritis, chronic headache and pain clinic patients) was used as the cut-off score 
to distinguish between pain-avoidance (above the mean) and pain-persistence 
patterns (below the mean).2437 This screening instrument has been validated in 
other studies.24 After the screening and intake procedure, patients were assigned 
to the pain-avoidance or pain-persistence group treatment, depending on their 
specific pattern. Assessments were made with valid and reliable instruments 
before treatment, post-treatment and at 6-month follow-up (3-month follow-up 
for the physical fitness tests). For both treatment approaches, we selected a 
patient who was representative for the participants in general with regard to the 
scores on the screening questionnaire (within 0.5 standard deviation (SD) of the 
mean of norm groups on pain-avoidance and pain-persistence factors and related
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risk factors),24 as well as an average treatment course in consultation with all the 
therapists involved with the treatment (psychologists, physiotherapists).
Case descriptions
Case 7: Pain-avoidance pattern
Mrs. A, aged 47 years, married, with three children in the age of 13,16 and 20 years, 
was diagnosed with FM half a year ago and referred for multidisciplinary treatment. 
She reports having severe pain complaints since 10 years. A pain-avoidance pattern 
was revealed. As a reaction to pain, cognitions such as "I have to be careful, because 
pain means that there is something wrong with my body" occur, evoking feelings of 
anxiety. Subsequently, she avoids physical activity and retreats from her daily 
activities. A daily activity registration showed that she rests about 6 hours a day. 
Furthermore, her housekeeping activities have been largely taken over by a 
housekeeper, husband and children. Other activities such as hobbies and social 
activities rarely take place. During the intake, the therapists noticed that Mrs. A has 
a tendency to display various pain behaviors. Her social environment reacts to this 
behavior by paying attention (e.g., husband brings her drinks and pain medication), 
which prevents her from having to communicate her needs directly. This avoidance 
behavior led to a decline in physical fitness in the long-term. Furthermore, her 
pleasant activities diminished, aggravating depressive feelings and low self-esteem. 
The screening instrument supported the pain-avoidance pattern, in addition to a 
heightened level of distress, fear of pain, social reinforcement and a low level of 
mobility in comparison to a norm group (Table I).24 The physical fitness tests 
indicated a poor physical condition and Mrs. A was also slightly overweight. 
According to this analysis, an important goal of treatment should be to increase the 
level of activities in Mrs. A's daily life and to refute her fear-avoidance beliefs.
Case 2: Pain-persistence pattern
Mrs. B, aged 40 years, married, with one 17-years old child, has had pain complaints 
since childhood. She was diagnosed with FM one year ago and referred for multi­
disciplinary treatment. She works at a flower shop 24 h a week. A pain-persistence 
pattern was revealed. Mrs. B reports that she tries to ignore her complaints and 
finds it difficult to guard her boundaries. Cognitions such as "I won't let the pain 
interfere with my life" occur as a reaction to pain, resulting in feelings of frustration. 
A daily activity registration revealed that she engages in outdoor activities at least 
3 hours a day, rests very little between activities and spends only a small amount 
of her time on pleasant activities. In the long-term, this leads to an increase of
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complaints. Whenever she has relatively few complaints, she is very active to make 
up arrears. However, these peaks of activity are generally followed by days of 
exhaustion. Mrs. B has difficulties with communicating her boundaries, dealing 
with conflicts and ask others for help. In the long run, by not respecting her 
(physical) limits, she has become exhausted and developed chronic pain 
complaints. Mrs. B had a burn-out 4 years ago and during treatment by a 
psychologist she learned to respect her limits better. However, due to the 
worsening of her FM complaints and the stressful period around her husband's 
burn-out one year ago, she failed to maintain this balance. The screening 
instrument supported the pain-persistence pattern, in addition to a heightened 
level of distress and a lower level of social reinforcement, fear of pain and 
acceptance, in comparison to a norm group of FM patients (Table I).24 Furthermore, 
the physical fitness tests showed a relatively good physical condition and few 
limitations. According to this analysis, an important goal of treatment should be 
to regulate her daily activities and refute her pain-persistence cognitions.
Treatment
Both treatment programs consisted of 16 sessions, twice a week, plus one 
follow-up session three months after treatment and took place in a group setting 
of 8 participants. Every session started with two hours of cognitive behavioral 
therapy (CBT) followed by two hours of exercise training. The exercise training 
included aerobic exercises (e.g., cycling, gymnastic exercises), anaerobic exercises 
(e.g., strength and flexibility exercises, functional walking training), hydrotherapy 
and relaxation therapy. For the third, ninth and fifteenth session the partner or 
another significant relation was invited. The overall goal of both treatments was 
to learn to cope with and diminish the consequences of FM in daily life. Treatment 
protocols for the pain-avoidance and pain-persistence group interventions were 
developed based on techniques from standardized treatment protocols for FM, 
chronic pain and chronicfatigue symptoms.29'32'38'40The pain-avoidance treatment 
is aimed at diminishing fear of pain and increasing the level of daily activities, in 
contrast to the pain-persistence treatment which focuses on changing pain- 
persistence cognitions and achieving a regulation of daily activities.
Rationale of treatment, goal setting and daily structure of activities (sessions 1-3)
In the pain-avoidance treatment, the therapists explained that a passive way of 
pain-coping will lead to muscle deconditioning and more complaints in the 
long-term. Mrs. A learned to not consider pain as a signal to stop with activities.
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Diminishing the intake of pain medication and systematically increasing activities 
in different daily life domains (i.e. selfcare, housekeeping, pleasant activities, 
social activities, work and study-related activities) were defined goals. For 
example, for the domain self-care, Mrs. A set the goal to shower and dress herself 
every day. In the pain-persistence treatment, the pain-stress cycle, as the rationale 
for the pain-persistence treatment, was illustrated with the gate control theory of 
Melzack and Wall. Individual goals were aimed at regulating daily activities. For 
example, one of Mrs. B's goals was to have more time and energy for pleasant 
activities. It was discussed how a structured daily routine with more pauses during 
the day could help to achieve this goal.
Changing cognitive behavioral patterns (sessions 4-10)
The most important goal for the pain-avoidance treatment was to gradually and 
systematically increase activities with the individual goals as the guiding principle. 
Mrs. A was taught to specify feasible and specific (sub)goals, to evaluate and 
record her progress, and the importance of self-reinforcement when a (sub)goal 
was accomplished. She reported difficulties with performing her activities despite 
her complaints. However, when she experienced the positive consequences of 
increasing her daily activities, she was motivated to change her behavior. Her 
progress towards her goals was a motivating factor for the other participants. In 
the pain-persistence treatment, several techniques were used to achieve a more 
balanced lifestyle. First, the importance of relaxation was discussed. Although her 
high achievement level made it hard for her to stop with her activities until these 
were finished, Mrs. B noticed that if she was able to stop in time, she felt more 
energetic. Furthermore, she was taught to make a plan for a systematic and 
gradual increase of activities so as to achieve goals. Attention was paid to the 
importance of self-reinforcement when accomplishing a (sub)goal. Various 
cognitions in stress situations and pain situations that could aggravate the pain 
and fatigue were discussed. Cognitive restructuring techniques were used to 
replace pain-persistence cognitions into cognitions which emphasize the 
regulation of daily activities, such as "If I stop in time with my activities, eventually 
I can do more."
Communication, social skills and the significant other (sessions 3, 9 and 15:12-14)
In the pain-avoidance treatment, the negative effects of communicating through 
pain behavior were explained. Mrs. A was usually silent when she had pain and 
her husband reacted by offering his help. A more assertive communication was
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practiced with role-plays with the other participants. Furthermore, during the 
three sessions when her husband was present, attention was paid to the negative 
effects of reinforcing pain behavior. Mr. A learned through role-playing to reinforce 
healthy behavior (i.e. activities) and ignore possible pain behavior. In the pain- 
persistence treatment, assertive communication was practiced with role-plays 
for specific situations, such as asking for help and communicating boundaries. 
Mrs. B's fear of angry reactions when refusing a request was refuted in those 
role-plays, as well as in several homework exercises in daily life.
Exercise training (sessions 1-16)
The main goal of the exercise training in the pain-avoidance treatment was to 
improve the physical condition by systematically and gradually increasing physical 
exercise (graded activity). The exercises had to be carried out regardless of the 
complaints. At first, Mrs. A reported an increase in pain after exercising and was 
afraid that she was damaging her body.The physiotherapists provided information 
on the consequences of increased activity and encouraged her to carry on. Over 
time, her physical fitness improved and the pain after exercising decreased. 
During the hydrotherapy, she learned to enjoy physical activity with brief 
competitive exercises in the water. The relaxation therapy included learning to 
recognize early signals of muscle tension and muscle-relaxing techniques. The 
primary goal of the exercise training during the pain-persistence treatment was 
to regulate and then increase the level of physical exercise. In contrast with the 
pain-avoidance treatment, the participants had the possibility to maintain a 
certain level of physical activity. Mrs. B learned to not go on until she was 
exhausted, but perform her exercises according to a systematic and gradual plan. 
Furthermore, attention was paid to relaxation techniques in order to diminish the 
negative effects of stress on FM symptoms. Relaxation exercises were also 
performed in the water during hydrotherapy.
Relapse prevention and future goals (sessions 14-16)
During the last sessions, relapse prevention and future goals were discussed. 
A relapse prevention plan was formulated for Mrs. A, including detecting early 
signs of relapse and several sources for support. In addition, she was taught to be 
more active and assertive in contact with health professionals and present herself 
less as a 'patient'. In the pain-persistence treatment, Mrs. B was taught how to deal 
with a relapse and preventive actions were formulated. For example, if she felt 
tense she would stop with her activities for a moment. In addition, her future goal
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of asking her husband and children to provide more help with household chores 
was discussed.
Table 1 Physical and psychological functioning on the outcome variables and 
treatment process variables of Mrs. A and Mrs. B prior to treatment, 
post-treatment and at 6-month follow-up compared to mean scores 
(standard deviations) of a norm group of FM patients24
Physical and psychological functioning Pre- Post- Follow-up Means (SD)
treatment treatment
Outcome variables
Pain (IRGL)33 34 Mrs. A 17 13 10
Mrs. B 20 13 7 19.2 (3.7)
Functional disability (FIQ)41-42 Mrs. A 1.6 1.2 0.9
Mrs. B 0.9 0 0 1.3 (0.6)
Mobility (IRGL)33 34 Mrs. A 10 15 18
Mrs. B 21 23 28 17.1 (5.2)
Fatigue (CIS)43 Mrs. A 54 29 23
Mrs. B 38.9 21 15 44.5 (8.3)
Negative mood (1RG L)33 34 Mrs. A 6 1 0
Mrs. B 15 0 0 5.3 (4.5)
Anxiety (IRGL)33 34 Mrs. A 27 19 20
Mrs. B 24 13 11 21.4(6.2)
Treatment process variables
Resting when in pain (PCI)36-37 M s. A 3.0 2.4 2.2
M s. B 1.6 2.4 2.2 2.4 (0.5)
W orrying when in pain (PCI)36-37 M s. A 2.6 1.7 1.4
M s. B 1.6 1.0 1.1 1.9 (0.5)
Fear of pain (TSK)44 46 M s. A 37.9 25 28
M s. B 24 18 17 26.6 (6.5)
Social reinforcement (MPI)47 M s. A 4.3 3.5 2.8
M s. B 1.7 2.3 2.8 3.3 (1.1)
Helplessness (ICQ)48 M s. A 17 8 7
M s. B 12 7 6 13.0(3.9)
Acceptance (ICQ)48 M s. A 9 20 17
M s. B 9 17 23 15.4(4.2)
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Table 2 Physical fitness assessed with a walking and cycling test
of Mrs. A and Mrs. B prior to treatment, post-treatment and at 
3-month follow-up.
Physical fitness Pre­ Post­ Follow-i
treatment treatment
Shuttle Mrs. A Distance walked (m) 140 460 490
walking test49 Speed (km/hour) 3.6 6.0 6.0
Perceived exertion (Borg)50 7 4 2
Mrs. B Distance walked (m) 420 550 760
Speed (km/hour) 5.4 6.6 7.8
Perceived exertion (Borg) 4 2 2
Subm axim al Mrs. A Tim e cycled (minutes) 3 14 16
cycling test Resistance (Watt) 35 90 100
Perceived exertion (Borg) 10 3 3
Mrs. B Tim e cycled (minutes) 3 11 12
Resistance (Watt) 35 75 80
Perceived exertion (Borg) 4 2 3
Results
The descriptive results of the treatment included changes in the expected 
direction for the pain-avoidance (Mrs. A) and the pain-persistence patient (Mrs. B). 
For example, Mrs. A reported that she was more active in her daily life (started 
cooking club, spent more time on her appearance, daily exercising), and as a 
consequence lost 9 kg. She reported that her complaints were greatly diminished 
and her marital relationship was improved, including the sexual relationship. Mrs. 
B reported to be better able to respect and communicate boundaries and to stop 
in time. Her improved walking pattern helped her to maintain her daily activities, 
including work and pleasant activities. Her complaints were greatly diminished 
and she no longer considered herself a FM patient.
The assessment of the outcome variables with validated self-report 
questionnaires supported these descriptive results by showing that the scores of
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both patients improved in the expected direction and this improvement continued 
during the follow-up with regard to the scores of the norm group (Table I).24 The 
change was more than 1 SD with a change of more than 1.5 SD for 4 of the 6 
outcome measures (pain,fatigue, negative mood, anxiety), suggesting a clinically, 
significant difference.51 Moreover, the physical fitness tests showed an improved 
physical functioning after treatment, which progressed further during the 
follow-up, while the perceived exertion after physical activity declined (Table 2).
Discussion
Over the last few years, researchers and clinicians have become more aware of the 
heterogeneity of patients and the importance of distinguishing subgroups of FM 
patients in order to improve the efficacy of treatment. The aim of this case-study 
was to illustrate a tailored treatment approach for dysfunctional FM patients at a 
relative early stage after diagnosis. The pain-avoidance treatment was aimed at 
increasing daily activities and diminishing fear-avoidance cognitions and the 
pain-persistence treatment was aimed at regulating daily activities and changing 
pain-persistence cognitions. Both patients reported that their complaints had 
decreased remarkably, and Mrs. B even stated that she considered herself no 
longer a FM patient. Physical and psychological functioning improved with regard 
to a norm group of FM patients, suggesting a clinically significant difference with 
changes of at least 1 SD, and frequently exceeding 1.5 SD.51
These results suggest that a theoretical- and empirical-based treatment 
approach of pain-avoidance and pain-persistence111622 is feasible and can result in 
clinically significant changes for FM patients. However, some comments have to 
be mentioned. The results of the cases do not prove the efficacy of this tailored 
treatment which is at the moment evaluated in a randomized, controlled trial. 
However, the two selected patients who were comparable for the participants in 
general with regard to their scores on the screening and the treatment course, 
showed clinically remarkable improvements, suggesting that such an approach 
can be promising. In addition to the use of self-report measures for evaluation as 
well as assessment, daily diaries or behavioral measures (actometer, step 
counter)3952 might be used to support the patient's self-reported results. Finally, in 
this uncontrolled case-study, non-specific factors such as therapist attention 
could have a confounding effect. For the tailored treatment consisting of a broad 
range of techniques, it is important to identify the working mechanisms and
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mediators of change. For example, the working mechanism in the pain-avoidance 
treatment could be graded activity or the confrontation with feared movements 
through exposure in vivo.4053 With regard to the pain-persistence treatment, the 
behavioral modification of regulating daily activities could be the working 
mechanism or the more cognitive component of acceptance of complaints.2654 
Considering the content of the treatment, external factors, such as including 
significant others, could have also contributed to the treatment gains. Furthermore, 
this treatment was designed as a group-based treatment, which offers several 
advantages, such as group support, positive reinforcement and social learning 
through, for example, modeling, that all have possibly contributed to the 
treatment gains.5556 Future research should aim at delineating the mediators of 
change of this tailored treatment for FM patients.
Conclusion
This case-study demonstrated the feasibility of distinguishing between FM 
patients with pain-avoidance and pain-persistence patterns and offering them a 
tailored group treatment. This approach resulted in clinically significant changes 
for both patients suggesting that the tailored treatment can be promising for FM 
patients.
Practice implications
The heterogeneous group of FM patients is usually treated with a standardized 
treatment resulting in limited effects. This case-study shows it could be promising 
to tailor treatment to pain-avoidance and pain-persistence patterns. At the 
moment, the efficacy of this newly developed tailored approach is being tested in 
a randomized controlled trial.
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Abstract
Objective. Increasing attention is devoted to the patient's perspective in clinical 
research and practice. However, the relationship between the patient's view on 
treatment progress and standardized pre-post changes in health outcomes is not 
well understood. The objective of this study was to investigate whether the 
patient's perception of treatment gain converges with pre-post treatment effects 
of a multidisciplinary treatment as assessed by standardized self-report measures. 
Methods. During a tailored multidisciplinary treatmentforfibromyalgia, validated 
self-report questionnaires were assessed at baseline and post-treatment on the 
outcome measures of pain, functional disability, fatigue, anxiety, and negative 
mood. In addition, the participants were asked to fill in a questionnaire at the end 
of the treatment assessing the patient's perception of improvement on core 
outcomes, as well as satisfaction and usefulness of the treatment.
Results. Moderate to relatively high correlations were found between the patient's 
perception of improvement and pre-post changes on the physical outcomes, 
in contrast to small or nonsignificant correlations for psychological outcomes. 
In addition, satisfaction and usefulness were significantly related to pre-post 
changes on physical outcomes, but no relationship was found with respect to 
psychological outcomes.
Conclusion. Results suggest that the patient's perception of treatment gain and 
pre-post changes in outcomes during treatment assess different aspects of the 
patient's treatment progress, particularly with regard to psychological functioning. 
Future research on clinical improvements should consider the patient's perception 
of treatment gain as an independent and clinically relevant outcome, in addition 
to standardized trial data of pre-post assessments of health outcomes.
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Introduction
The patient's perspective is becoming more important in clinical research and 
practice. In the view of increasing pharmacologic and non-pharmacologic 
treatment choices, patients are more intensively involved in decision making 
regarding treatment, resulting in improved communication and a more profound 
understanding of the impact of the condition.12 Moreover, patients are regarded 
more as active partners in self-care treatment, in particularfor non-pharmacolog- 
ic treatment, where the success largely depends on the active collaboration of the 
patient. Incorporating the patient's view on treatment can also improve the 
quality of care. For example, it has been found that tailoring treatment more 
specifically to the patient's needs and characteristics can enhance treatment 
effects.3'6
Due to the growing recognition of the importance of the patient's point of 
view in the care process, the prioritization of outcome variables has shifted. 
Concepts such as patient satisfaction and the patient's perception of improvement 
are more frequently applied as an indicator of treatment value, quality, and even 
outcome.78 However, it is not well understood to what extent the patient's 
perception of treatment gain is related to changes during treatment assessed 
with validated, standardized instruments before and after treatment. For example, 
with regard to self-reported outcome in syndromes with limited pathophysiologic 
findings such as fibromyalgia (FM), a chronic rheumatologic condition 
characterized by widespread pain,9 a difference can be found between the 
patient's view of treatment gain and more standardized assessments such as 
patient-reported pre-post changes in pain.10 Several explanations for this low to 
moderate association have been proposed. For example, it could be that 
statistically significant pre-post changes are not perceived as clinically relevant to 
the patient.11 The patient's perception of treatment gain might be viewed as a 
possible approach to judge whether the amount of change during treatment is 
large enough to be considered meaningful for the patient. Furthermore, issues 
other than reducing symptoms might be more important from the view of the 
patient, such as group support, reducing helplessness, improving self-efficacy, or 
the relationship with the therapist. For example, it has been shown that a positive 
communication between physicians and patients with rheumatic conditions and 
chronic low back pain contributed more to the patient's overall satisfaction with 
treatment than the improvement in physical functioning.1213 Another important 
factor that could explain low to moderate correlations between self-reported
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pre-post changes and retrospective reports of improvement is a change of 
perspective of health status, also known as response shift. Comparing self-reported 
pre- and post-assessments relies on the assumption that patients use the same 
internal standard of well-being. However, during treatment, this standard may 
shift in the direction of the improved functioning, which might interfere with 
self-reported pre-post assessments.1415 Indeed, studies investigating the influence 
of response shift during treatment in various conditions reported a significant 
difference between the actual baseline value and a retrospective estimate of the 
baseline value, indicating a change in the internal standard during treatment.16'18 
Retrospective reports might also be influenced by response shift tendencies in 
addition to specific factors such as difficulties with recalling the baseline status 
and the expectancy of gain during treatment.1920 Since self-report measures are 
used more regularly in research and clinical practice and several possible 
mechanisms of response tendencies might affect these outcomes, it is important 
to determine the level of correspondence between the patient's perception of 
treatment gain and patient-reported pre-post changes during treatment.
The goal of the present study was to examine the relationship between the 
patient's perception of treatment gain (improvement in core outcomes, 
satisfaction, and usefulness) and the patient-reported pre-post changes during 
treatment. During a tailored multidisciplinary treatment, the patient's perception 
of treatment gain and patientreported pre-post changes on the core outcome 
measures of pain, fatigue, functional disability, anxiety, and negative mood 
assessed with validated self-report measures are assessed. In line with theoretical 
models and earlier studies on the possible correspondences and differences 
between these concepts,10'20 we expected no more than moderate correlations 
between the patient's perception on treatment gain and pre-post changes.
Patients and methods
Participants and procedure
Patients with FM were referred by rheumatologistsfrom several regional hospitals 
for participation in a tailored multidisciplinary treatment that was evaluated in a 
randomized controlled trial. Inclusion criteria consisted of a diagnosis of FM as 
confirmed by a rheumatologist based on the diagnostic criteria of the American 
College of Rheumatology9 and age > 18 years. Furthermore.the patients' diagnoses 
of FM had to be made no more than 5 years prior to the study to ensure a relative
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early intervention and only the patients with heightened levels of psychological 
distress were included.3'2122 Exclusion criteria consisted of severe physical and 
psychiatric comorbidities that might interfere with the study protocol, FM 
secondary to another rheumatic condition, illiteracy, and inability to communicate 
in Dutch. Assessments of the outcome measures were made with valid instruments 
before treatment and at post-treatment. Furthermore, the participants in the 
treatment groups were asked to fill out a standardized evaluation questionnaire 
at the end of the treatment.
Data were collected from 84 consecutive women who participated in the 
treatment groups. The mean age of the participants was 41.8 (SD = 10.3 years; 
range 21-71 years). The majority of the participants were married or cohabiting 
(78.6%). With regard tothe educational level, 2.4% had a primary level of education, 
81.9% had a secondary level of educational, and 15.7% had a tertiary level of 
education, representing on average 7, 12, and 17 years of formal education, 
respectively. Between pre-treatment and the follow-up assessment, 5 patients 
(6%) dropped out. Reasons for dropping out were physical comorbidity that 
occurred during treatment for 3 patients and lack of sustained motivation to 
participate in the study for two patients. Furthermore, one patient who 
participated in the treatment was excluded due to an incomplete questionnaire 
assessment, resulting in a sample of 78 patients. When comparing these 6 patients 
with the total group of 84 patients at pre-treatment, no significant differences in 
demographic variables (e.g., age, marital status, educational level) were found 
between the groups.
Tailored cognitive behavioral therapy (CBT) treatment
The patients received an outpatient treatment tailored to their specific cognitive 
behavioral pattern.23 The treatment programme was highly structured and 
consisted of 16 sessions twice a week, plus one booster session 3 months after 
treatment. The treatments took place in a group setting of 8 participants. Every 
session started with two hours of CBT followed by two hours of exercise training. 
The goal of the treatment was to diminish the cognitive, emotional, behavioral, 
and social consequences of pain and accompanying symptoms in daily life. The 
CBT was led by a trained psychotherapist and social worker. On the third, ninth, 
and fifteenth session, the partner of or another significant relation to the patient 
attended the CBT. The goal of the exercise training was to increase endurance, 
flexibility, coordination, and relaxation. This training was supervised by 
experienced physiotherapists and included aerobic exercises (e.g., cycling.
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gymnastic exercises), anaerobic exercises (e.g., strength and flexibility exercises, 
functional walking training), hydrotherapy, and relaxation therapy. Throughout 
the treatment, patients and their spouses received homework assignments each 
session for the CBT and the exercise training. The final booster session dealt with 
relapse prevention and further improvement of the attained goals.
Measures
Patient's perspective on treatment
The questionnaire to evaluate the patient's perception of treatment gain was 
comprised of visual analog scales (score range 0-10, ranging from "not at all" to 
"very") to assess the level of satisfaction with the treatment and the overall 
usefulness of the treatment. Numerous investigators established the validity and 
reliability of visual analog scales in measuring constructs of primarily patient 
satisfaction, subjective improvement, and patient-reported quality of life.24-27 In 
addition, the patient's perception of improvement on the outcome measures pain, 
fatigue, functional disability, tension, and negative mood were assessed with 
specific questions on a 4-point Likert scale (where 1 = not, 2 = a little, 3 = fairly, 4 
= very). Items consisted of: "Due to the treatment, I have less pain/l feel less 
fatigued/l experience less disability in daily life (e.g., work, hobbies, social 
activities)/! feel less tensioned/l feel less depressed."
Pre-post measures
Pain was assessed using the 6-item pain scale of the Impact of Rheumatic diseases 
on General health and Lifestyle (IRGL), which assesses physical, psychological, 
and social health in patients with rheumatic diseases.2829 Patients indicate the 
severity and frequency of painful episodes and the duration of morning stiffness 
within the last month (sample item: "During the past month my condition caused 
pain."). The Cronbach's alpha was .75 in this study. Previous research has shown 
that the reliability and validity of this questionnaire are highly satisfactory.29 
Fatigue for the previous two weeks was assessed with the 8-item fatigue scale of 
the Checklist Individual Strength (sample item: "I feel fatigued.").3031 This 
questionnaire has good discriminative validity and good reliability, with a 
Cronbach's alpha of .89 in this study.3132 Functional disability  was assessed with the 
7-item mobility scale of the IRGL. The 7 items were rated on a 4-point Likert scale 
ranging from "always" to "never." A higher score on this scale indicates a lower 
level of functional disability (sample item: "The past month I was able to walk the 
stairs."). The Cronbach's alpha was .82 in this study. The im pact ofFM  on daily life 
was assessed with the Fibromyalgia Impact Questionnaire, which consists of 20
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items assessing physical impairment, pain, stiffness, fatigue, and anxiety and 
depressive symptoms (sample item: "How bad has your pain been?").33-35 Higher 
scores indicate greater impact of FM on daily functioning. The Cronbach's alpha 
was .85 in this study and earlier studies have shown that the reliability and validity 
are good.3336 Psychological functioning was assessed with the anxiety and negative 
m ood scales of the IRGL. The 10-item anxiety scale assesses the respondent's 
anxiety levels in the last month, with a Cronbach's alpha of .86 in this study (sample 
item: "I worry too much about unimportant matters."), and the 6-item negative 
mood scale assesses the various negative mood states over the previous week, 
with a Cronbach's alpha of .88 in this study (sample item: "How depressed were 
you during the past week?").
Statistical analysis
To give an indication of the results of the patient's perception of improvement, 
the percentage of patients reporting no improvement, little improvement, fair 
improvement, and strong improvement with regard to the core outcomes of 
physical functioning (pain, fatigue, disability in daily life) and psychological 
functioning (tension, negative mood) were calculated. In addition, the mean and 
SD for the levels of satisfaction and usefulness of the treatment were calculated. 
Furthermore, paired f-tests between pre- and post-treatment were conducted on 
the outcome measures of pain, fatigue, functional disability, and psychological 
functioning to get an indication of the change during treatment. Standardized 
residual gain scores were used to assess changes in physical and psychological 
functioning from pre- to post-treatment.37 These scores were calculated by 
regressing the outcome variables at the post-treatment assessments on the 
pre-treatment scores of the outcome measures. In order to study the relationship 
between the pre-post changes and the patient's perception of improvement, 
Pearson's correlation coefficients were calculated using the entire range of 
response categories of improvement on every outcome reported by the patients 
and the pre-post changes on the core outcomes (Table 1). Furthermore, Pearson's 
correlation coefficients were calculated between the pre-post changes and the 
patient's scores on usefulness and satisfaction (Table 2). Finally, Pearson's 
correlation coefficients were calculated between the patient's perception of 
improvement and their scores on usefulness and satisfaction (Table 3). After 
checking for possible outliers and normal distribution, the Pearson's correlation 
coefficients were calculated. All analyses were conducted with the entire sample 
of 78 patients, with the exception of satisfaction and usefulness. The question
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about the level of satisfaction was added to the evaluation questionnaire a few 
weeks after the start of the study, resulting in available data for 51 patients, and 
results on the level of usefulness were available for 72 patients due to missing 
data.
Results
Change during treatment
The results of the patient's perception of treatment gain showed a mean 
satisfaction score of 8.1 (SD = 1.4) and a mean score of 8.4 (SD = 1.4) on usefulness 
of the treatment. Furthermore, approximately 75% of the participants reported a 
subjective improvement on physical functioning (pain: 27% no improvement, 
36% little improvement, 28% fair improvement, 9% strong improvement; fatigue: 
27% no improvement, 50% little improvement, 18% fair improvement, 5% strong 
improvement;functional disability: 11% no improvement, 35% little improvement, 
45% fair improvement, 9% strong improvement). The majority of the participants 
reported an improvement on psychological functioning (tension: 10% no 
improvement, 31% little improvement, 44% fair improvement, 15% strong 
improvement; negative mood: 5% no improvement, 36% little improvement, 50% 
fair improvement, 9% strong improvement). With regard to the pre-post measures, 
paired f-tests showed a significant improvement at post-treatment on all of 
the outcome measures, specifically pain (mean change = -2.8 (SD = 4.3); f = 5.68, 
p < .001), fatigue (mean change = -10.6 (SD = 10.7); f = 8.70, p < .001), functional 
disability (mean change = 3.3 (SD = 3.6); f = -8.10, p < .001), negative mood 
(mean change = -2.7 (SD = 3.8); f = 6.23, p < .001), and anxiety (mean change = -3.3 
(SD = 4.8); f=  6.07, p <  .001).
Patient's perception of treatment gain and pre-post change
With regard to the relationship between the patient's perception of improvement 
and the pre-post change, Pearson's correlation coefficients revealed a significant 
correlation between the patient's perception of improvement on pain with the 
pre-post change score on pain (r = .69, p < .01), between the patient's perception 
of improvement on fatigue and the pre-post change score on fatigue (r = .53, 
p < .01), and also between the patient's perception of improvement on functional 
disability with the pre-post change scores on functional disability (r = -.41, p < .01) 
(Table 1). With regard to the impact of FM on daily life, significant correlations
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were also found between the patient's perception of improvement on all of the 
outcomes. A small but significant correlation was found between the patient's 
perception of improvement on negative mood with the pre-post change scores 
on this outcome measure (r = .27, p < .05), whereas the correlation between the 
patient's perception of improvement on tension with the pre-post change score 
on anxiety was not significant (r = .17, p > .05).
Table 1 Pearson's correlation coefficients between the patient's perception 
of improvement and the pre-post change scores on the outcome 
measures
Pre-post change scores on outcome criteria
Impact of
Patient's perception 
of improvement Pain Fatigue
Functional
disability
FM on daily 
life
Negative
mood Anxiety
Pain .69** .49** -.41** .57** .19 .22
Fatigue .50** .53** -.39** .55** .18 .32**
Functional disability .60** .56** -.41** .56** .15 .22
Negative mood .32** .42** -.39** .45** .27* .41**
Tension .32** .43** -.26* .35** .03 .17
*p < .05; **p < .01
In order to investigate the relationship between the level of satisfaction and 
usefulness with treatment and pre-post changes, Pearson's correlation coefficients 
were calculated (Table 2). The level of satisfaction was significantly correlated 
with the pre-post change scores on the impact of FM on daily life and the physical 
outcome measures of pain and fatigue (r = .30, p < .01). A trend was found for 
functional disability (r = -.25, p = .07). However, non-significant correlations were 
found on negative mood and anxiety. With regard to the level of usefulness, 
significant correlations were found with the impact of FM on daily life and the 
physical outcome measures of pain, fatigue, and functional disability. Non­
significant correlations were found for negative mood and anxiety.
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Table 2 Pearson's correlation coefficients between the levels of
satisfaction and usefulness with the treatment from the patient's 
perspective and pre-post change scores on the outcome criteria
Pre-post change scores on outcome criteria
Impact of 
Functional FM on daily Negative 
Patient's perspective Pain Fatigue disability life m ood Anxiety
Satisfaction .30** .30** -.25 .32* .19 .07
Usefulness .43** .46** -.31** .43* .08 .05
*p < .05; **p < .01
Patient's perception of improvement and satisfaction and usefulness
Finally, to study the relationship between the patient's perception of improvement 
on pain, fatigue, functional disability, negative mood, and anxiety, and the levels 
of satisfaction and usefulness, Pearson's correlation coefficients were calculated 
(Table 3). Significant correlations were found between satisfaction and usefulness 
and the patient's perception of improvement on all of the outcomes (satisfaction; 
r = .31-.46; usefulness; r =  .36-.47), with the exception of the relationship between 
satisfaction and pain, for which a trend was found (r = .27, p = .06).
Table 3 Pearson's correlation coefficients between the levels of usefulness 
and satisfaction with the treatment from the patient's perspective 
and the patient's perception of improvement on the outcome criteria
Patient's perception of improvement
Functional Negative 
Fatigue disability mood Anxiety
.33* .31* .46** .34*
42** .47** .46** .39**
*p < .05; **p < .01
Patient's perspective Pain
Satisfaction .27
Usefulness .36**
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Discussion
The main goal of this study was to investigate the relationship between the 
patient's perspective of treatment gain (patient's perception of improvement, 
satisfaction, and usefulness) and the pre-post change scores during treatment, 
assessed with the validated self-report outcome measures. The results showed 
moderate to relatively high significant correlations between the patient's 
perception of improvement and the pre-post change scores with regard to the 
physical outcomes (pain, fatigue, and functional disability) and for the impact of 
FM on daily life, whereas small significant or even non-significant correlations 
were found for the psychological outcomes (negative mood and anxiety). Similar 
results were found between the levels of satisfaction and usefulness and the 
pre-post change scores, i.e., significant correlations were found with regard to 
physical outcomes and nonsignificant correlations were found with regard to 
psychological outcomes. In conclusion, the patient's perception on treatment 
gain and patient- reported pre-post changes in outcome criteria should be 
considered as relatively independent constructs when investigating treatment 
efficacy, especially when examining psychological functioning.
Several explanations could be offered for this moderate association between 
the patient's perception of treatment gain and the pre-post change assessed with 
validated selfreport measures. First, other outcomes that emphasize the impact of 
FM on daily functioning or otherfactors such as the patient-doctor relationship or 
trust in treatment could be more important from the patient's point of view.7 This 
might be particularly relevant for psychological outcomes. Second, a change in 
how people perceive their health (response shift) might account for this finding 
because the internal standard of well-being might have shifted due to the 
improved functioning during treatment, interfering with the postassessment and 
making the comparison with retrospectively reported improvement difficult. In 
addition, patients received a cognitive behavioral intervention aimed at changing 
cognitions and behaviors, which might have directly influenced their internal 
standard of well-being. Our findings suggest that a response shift might be 
especially important when assessing psychological symptoms. Future research is 
needed to investigate the magnitude and significance of response mechanisms in 
both pharmacologic and non-pharmacologic interventions. Third, the patient's 
perception of treatment gain was assessed with a single question for every 
outcome, making the results more mood dependent and susceptible to subjective 
interpretations.38 For example, a significant correlation was found between the
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pre-post change in anxiety and the patient's perception of improvement in 
depressive symptoms and fatigue, but not the patient's perception of improvement 
in tension, suggesting that the single item on tension might not cover the key 
properties of the anxiety concept. Furthermore, the patient's perception of 
improvement is retrospectively reported, which could also be influenced by 
factors such as a recall bias or difficulties recalling the baseline status.19 Fourth, it 
is overall well known that concepts such as pain and functional disability show 
some conceptual overlap. For example, in this study, significant correlations were 
found across all of the dimensions, with small to moderate intercorrelations 
between indicators of physical and psychological functioning (.20 < r < .52). 
Although in the development of health status instruments the relative 
independence of these factors is shown through factor analyses, these results 
suggest that the concepts of pain, fatigue, functional disability, negative mood, 
and anxiety might be interpreted by the patients as a broader concept of overall 
symptoms or improvement. Furthermore, there could also be a discrepancy 
between the pre-post change score on validated instruments and the extent to 
which these changes are noticeable and meaningful for the patient. Finally, the 
discrepancy was especially apparent with regard to the psychological outcomes 
of distress and it could be argued that patients with conditions characterized by 
chronic physical symptoms are more reflective about their physical functioning 
than their psychological functioning.
The results of our study suggest that pre-post changes and the patient's 
perception of treatment gain encompass different constructs and are both 
relevant when investigating treatment efficacy. Pre-post measures are usually 
considered the gold standard in clinical research because they are assessed with 
validated, reliable measures that can be easily compared across studies. However, 
little is known about the magnitude and significance of response shifts, which 
could influence these assessments and the clinical relevance of these measures. 
Patient satisfaction and retrospective reports of improvement correspond closely 
to the patient's point of view, and are therefore clinically relevant. Furthermore, 
the patient's perception of treatment gain might also offer an important indicator 
for treatment adherence because studies have indicated that satisfied patients 
are more likely to be compliant with the treatment and maintain newly acquired 
behavior.24 The disadvantages of these measures are the possible influences of 
recall bias, social desirability, and response shift mechanisms.Therefore, including 
both the patient's perception of treatment gain and the self-reported pre-post 
outcomes seems to be particularly important with regard to the clarification of
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mechanisms influencing response tendencies, assessment of psychological 
functioning, and the feasibility of newly developed treatment approaches. In 
addition, there is a need for concepts that incorporate the patient's perception on 
treatment gain more clearly, such as the patient-perceived satisfactory 
improvement,39 which includes satisfactory and meaningful improvements for 
the individual. Overall, more research is needed to study these concepts and the 
clinical relevance from the perspective of the patient in more detail.
Some limitations of the present study can be mentioned. In our study, we 
found preliminary support that the patient's perception of treatment gainandthe 
pre-post changes encompass different constructs using self-report questionnaires. 
However, although concepts of patient satisfaction and the perception of 
treatment gain are increasingly applied, more research is needed to investigate 
the level of correspondence with other methods such as indepth interviews and 
behavioral measures or clinical judgments.4041 Furthermore, the relatively low 
level of correspondence could also be due to méthodologie issues of the 
questionnaires. For example, the validity and reliability of the evaluation 
questionnaire were not extensively studied and the questions on the patient's 
perception of improvement, such as the tension/anxiety concept, might be 
improved. Finally, the level of correspondence between the patient's perception 
of treatment gain and the standardized, self-reported outcome criteria should be 
investigated in other medical conditions and with other treatments.The repeatedly 
reported low to moderate correlations between the patient's perception of 
treatment gain and validated outcome measures in FM could be different in 
medical conditions with other pathology, such as rheumatoid arthritis.
In conclusion, the present study demonstrates that the patient's perception of 
treatment gain is only moderately related to pre-post changes on the outcome 
measures, suggesting that these are relatively distinctive concepts and should 
not be used interchangeably. Future research should aim at incorporating the 
patient's perspective in addition to validated measures for the assessment of 
outcome criteria.
Acknowledgments
This study was supported in part by grants from the Dutch Arthritis Association ('Reumafonds') 
and the Netherlands O rgan ization  for Health Research and Developm ent ('ZONMW'). 
We w ould like to thank M. Effting, H. Cats, T. van Helm ond, A. Vedder, H. van Hoorn, 
M. Lim borgh, A. J. L. de Jo n g , J. F. Haverm an, and K. J. Korff for their help in co lle ctin g  the 
research data.
127
Chapter 6
References
1. Neville C, Fortin PR, Fitzcharles MA, Baron M, Abrahamowitz M, Du Berger R, Esdaile JM.The needs 
of patients with arthritis: the patient's perspective. Arthritis Care Res 1999;12:85-95.
2. Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, Hazes M, Richards P, Saag K, 
Suarez Almazor M, Wells G, Hewlett S. Patient perspective: fatigue as a recommended patient 
centered outcome measure in rheumatoid arthritis. J Rheumatol 2007;34:1174-7.
3. Evers AW, Kraaimaat FW, van Riel PL, De Jong AJ. Tailored cognitive-behavioral therapy in early 
rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain 2002;100:141-53.
4. Thieme K, Flor H, Turk DC. Psychological pain treatment in fibromyalgia syndrome: efficacy of 
operant behavioural and cognitive behavioural treatments. Arthritis Res Ther 2006;8:R121.
5. Vlaeyen JW, de Jong J, Geilen M, Heuts PH, van Breukelen G. The treatment of fear of movement/ 
(re)injury in chronic low back pain: further evidence on the effectiveness of exposure in vivo. Clin 
J Pain 2002;18:251-61.
6. Turk DC, Okifuji A, Sinclair JD, Starz TW. Differential responses by psychosocial subgroups of 
fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res 1998;11:397-404.
7. Heller JE, Shadick NA. Outcomes in rheumatoid arthritis: incorporating the patient perspective. 
Curr Opin Rheumatol 2007;19:101-5.
8. Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB. Minimal clinically important 
difference in the Fibromyalgia Impact Questionnaire. J Rheumatol 2009;36:1-8.
9. Wolfe F, Smythe HA,Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell 
SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 criteria for the 
classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 
1990;33:160-72.
10. Jacobs JW, Rasker JJ, van der Heide A, Boersma JW, de Blecourt AC, Griep EN, van Rijswijk MH, 
Bijlsma JW. Lack of correlation between the mean tender point score and self-reported pain in 
fibromyalgia. Arthritis Care Res 1996;9:105-11.
11. Wells G, Anderson J, Beaton D, Bellamy N, Boers M, Bombardier C, Breedveld F, Carr A, Cranney A, 
Dougados M, Felson D, Kirwan J, Schiff M, Shea B, Simon L, Smolen J, Strand V, Tugwell P, van Riel 
P, Welch VA. Minimal clinically important difference module: summary, recommendations, and 
research agenda. J Rheumatol 2001;28:452-4.
12. Walker DJ, Griffiths ID, Leon CM. Referrals to a rheumatology unit: an evaluation of the views of 
patients, general practitioners, and consultants. Ann Rheum Dis 1991;50:926-9.
13. Shaw WS, Zaia A, Pransky G, Winters T, Patterson WB. Perceptions of provider communication and 
patient satisfaction for treatment of acute low back pain. J Occup Environ Med 2005;47:1036-43.
14. Osborne RH, Hawkins M, Sprangers MA. Change of perspective: a measurable and desired 
outcome of chronic disease self-management intervention programs that violates the premise of 
preintervention/postintervention assessment. Arthritis Rheu 2006;55:458-65.
15. Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM. The clinical significance of 
adaptation to changing health: a meta-analysis of response shift. Qual Life Res 2006;15:1533-50.
16. Razmjou H, Yee A, Ford M, Finkeistein JA. Response shift in outcome assessment in patients 
undergoing total knee arthroplasty. J Bone Joint Surg Am 2006;88:2590-5.
17. Korfage IJ, De Koning HJ, Essink Bot ML. Response shift due to diagnosis and primary treatment of 
localized prostate cancer: a then-test and a vignette study. Qual Life Res 2007;16:1627-34.
18. Ring L, Hofer S, Heuston F, Harris D, O'Boyle CA. Response shift masks the treatment impact on 
patient reported outcomes (PROs): the example of individual quality of life in edentulous patients. 
Health Qual Life Outcomes 2005;3:55.
19. Fischer D, Stewart AL, Bloch DA, Lorig K, Laurent D, Holman H. Capturing the patient's view of 
change as a clinical outcome measure. JAMA 1999;282:1157-62.
20. Lambert MJ. Implications of outcome research for psychotherapy integration. In: Norcross JC, 
Goldstein R, eds. Handbook of psychotherapy integration. New York: Basic Books 1992:94-129.
128
A patient's perspective on multidisciplinary treatment gain for fibromyalgia
21. van Koulil S, Kraaimaat FW, van Lankveld W, van Helmond T, Vedder A, van Hoorn H, Cats H, van 
Riel PLCM, Evers AWM. Screeningfor pain-persistence and pain-avoidance patterns in fibromyalgia. 
Int J Behav Med 2008;15:211-20.
22. Evers AW, Kraaimaat FW, Geenen R, Bijlsma JW. Determinants of psychological distress and its course 
in the first year after diagnosis in rheumatoid arthritis patients. J Behav Med 1997;20:489-504.
23. van Koulil S, van Lankveld W, Kraaimaat FW, van Helmond T, Vedder A, van Hoorn H, Cats H, van 
Riel PLCM, Evers AWM. Tailored cognitive-behavioral therapy for fibromyalgia: Two case studies. 
Patient Educ Couns 2008;71:308-14.
24. Hudak PL, Wright JG. The characteristics of patient satisfaction measures. Spine 2000;25:3167-77.
25. Miller MD, Ferris DG. Measurement of subjective phenomena in primary care research: the visual 
analogue scale. Fam Pract Res J 1993;13:15-24.
26. Price DD, Patel R, Robinson ME, Staud R. Characteristics of electronic visual analogue and 
numerical scales for ratings of experimental pain in healthy subjects and fibromyalgia patients. 
Pain 2008;140:158-66.
27. de Boer AG, van Lanschot JJ, Stalmeier PF, van Sandick JW, Hulscher JB, de Haes JC, Sprangers MA. 
Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in 
measuring quality of life? Qual Life Res 2004;13:311-20.
28. Huiskes CJ, Kraaimaat FW, Bijlsma JW. Development of a self-report questionnaire to assess the 
impact of rheumatic disease on health and lifestyle. J Rehabil Sci 1990;3:71-4.
29. Evers AW, Taal E, Kraaimaat FW, Jacobs JW, Abdel-Nasser A, Rasker JJ, Bijlsma JW. A comparison of 
two recently developed health status instruments for patients with arthritis: Dutch-AIMS2 and 
IRGL. Br J Rheumatol 1998;37:157-64.
30. Vercoulen JH, Hommes OR, Swanink CMA, Jongen PJH, Fennis JFM, Galama JMD, van der Meer 
JWM, Bleijenberg G. The measurement of fatigue in patients with multiple sclerosis: a multidi­
mensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch 
Neurol 1996;53:642-9.
31. Vercoulen JH, Alberts M, Bleijenberg G. The checklist individual strength (CIS). Gedragstherapie 
1999;32:131-6.
32. Beurskens AJ. Fatigue among working people: validity of a questionnaire measure. Occup Environ 
Med 2000;57:353-7.
33. Burckhardt CS. The Fibromyalgia Impact Questionnaire: developmentand validation. J Rheumatol 
1991;18:728-33.
34. Iversen MD. Fibromyalgia: the Fibromyalgia Impact Questionnaire (FIQ). Arthritis Rheum 
2003;49:S210-3.
35. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current 
version, operating characteristics and uses. Clin Exp Rheumatol 2005;23:S154-62.
36. Zijlstra TR, Taal E, van de Laar MA, Rasker JJ. Validation of a Dutch translation of the Fibromyalgia 
Impact Questionnaire. Rheumatology 2007;46:131-4.
37. Kerlinger F. Foundations of behavioral research. New York: Holt, Rinehart & Winston 1975.
38. DeSalvo KB, Fisher WP, Tran K, Bloser N, Merrill W, Peabody J. Assessing measurement properties 
of two single-item general health measures. Qual Life Res 2006;15:191-201.
39. Klooster PM, Drossaers Bakker KW, Taal E, van de Laar MA. Patient-perceived satisfactory 
improvement (PPSI): interpreting meaningful change in pain from the patient's perspective. Pain 
2006;121:151-7.
40. Arcury TA, Quandt SA. Qualitative methods in arthritis research: sampling and data analysis. 
Arthritis Care Res 1998;11:66-74.
41. Bradley LA. Pain measurement in arthritis. Arthritis Care Res 1993;6:178-86.
129

7 Tailored cognitive behavioral therapy and exercise training for high-risk fibromyalgia patients
van Koulil S, van Lankveld W, Kraaimaat FW, van Helmond T, Vedder A, 
van Hoorn H, Donders ART, de Jong AJL, Haverman JF, Korff KJ, van Riel PLCM, 
Cats HA, Evers AWM.
Tailored cognitive behavioral therapy and exercise training for high-risk 
fibromyalgia patients.
Arthritis Care and Research 2010; 62:1377-1385.
Chapter 7
Abstract
Objective. The treatment of patients with fibromyalgia (FM), a high-prevalence 
chronic pain condition with a high impact on both patients and society, poses a 
great challenge to clinicians due to a lack of effective treatments. In view of the 
large individual variability in outcome, selecting patients at risk of long-term 
dysfunction and offering tailored treatment may be promising for beneficial 
treatment effects.
Methods. High-risk patients were selected and classified into two groups (pain- 
avoidance and pain-persistence) and subsequently randomized in groups to 
either a treatment or a waiting list control condition. Treatment consisted of 16 
sessions of cognitive behavioral therapy (CBT) and exercise training in groups, 
tailored to the patient's specific cognitive behavioral pattern, delivered within 10 
weeks. Physical and psychological functioning and impact of FM was assessed at 
baseline, post-treatment and 6 month follow-up. Treatment effects were evaluated 
using a linear mixed model.
Results. The treatment effects were significant for all primary outcomes, showing 
significant differences in physical functioning (pain, fatigue,functional disability), 
psychological functioning (negative mood, anxiety), and impact of FM for the 
treatment condition in comparison to the controls. Effect sizes in the treatment 
condition were overall large and reliable change indices indicated a clinically 
relevant improvement among the treatment condition.
Conclusion. The presented results demonstrate for the first time that tailored CBT 
and exercise training for high-risk FM patients is effective in improving short- and 
long-term physical and psychological functioning, indicating that tailoring 
treatment is likely to promote beneficial outcomes in FM and reduce the burden 
for patients and society.
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Introduction
Fibromyalgia (FM) is a high-prevalence chronic pain condition without clear 
pathophysiological mechanisms and is estimated to have the highest impact and 
highest financial burden of all rheumatic and chronic pain conditions.1 In addition 
to chronic, widespread pain, patients report high levels of accompanying 
symptoms such as fatigue, functional disability, and psychological distress. Due to 
the lack of effective treatment options, treating patients with FM poses a great 
challenge to clinicians.2 To date, combinations of cognitive behavioral therapy 
(CBT) and physical exercise training have yielded the most promising results but, 
overall, effects were modest and showed large individual variability.3'5 In line with 
findings in various other conditions associated with chronic physical symptoms, 
recent developments in FM research suggest that the effective ness of interventions 
may be improved by taking the heterogeneity of the patient group into 
consideration, with tailored approaches yielding promising outcomes.6'9
Tailoring approaches may involve the selection of specific patient groups as 
well as customizing the type, content and timing of the intervention. Dysfunctional 
patients with FM reporting relatively high levels of psychological distress have 
been shown to be more likely to benefit from treatment.10'12 Furthermore, 
subgroups can be identified within this distressed group that present with specific 
cognitive behavioral patterns that are responsible for the maintenance of their 
pain and disability. Fear-avoidance models postulate that mechanisms such as 
pain-avoidance behavior, fear of pain, catastrophizing, and hypervigilance, 
account for the continuation and exacerbation of the complaints.1314 However, 
there is growing attention for mechanisms underlying pain that are not captured 
by the fear-avoidance model. Preliminary evidence suggests a distinctive pattern 
in patients who tend to persist in their activities in spite of the pain, which can 
lead to overuse and more complaints in the long run.15'17 Several studies have 
demonstrated the prognostic value of both pain-avoidance and pain-persistence 
factors for the development and maintenance of physical and psychological 
impairments in various chronic pain disorders, including FM.618'21 There is further 
evidence that tailoring treatment to these specific cognitive behavioral patterns 
could improve treatment outcomes. Thieme and colleagues,22 for example, found 
that the FM responders to a pain-avoidance treatment aimed at increasing daily 
activities and diminishing fear of pain reported higher levels of pain behavior, 
social reinforcement, and catastrophizing at baseline than the nonresponders, 
while responders to a pain-persistence treatment aimed at pacing activities and
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changing high self-demands reported less pain behavior and social reinforcement 
than the nonresponders. However, more direct evidence underscoring the efficacy 
of treatment approaches that are tailored to these specific cognitive behavioral 
patterns in improving physical and psychological functioning in FM is needed. 
Also, with regard to the timing of treatment, the significance of treatment in an 
early stage is increasingly recognized as being able to help prevent a worsening 
of the symptoms and long-term dysfunction. In addition, several studies have 
shown that chronic pain patients with shorter duration of symptoms benefit most 
from CBT.23 24
In sum, selecting high-risk patients and offering them a treatment consisting 
of CBT and exercise training tailored to their pain-avoidance or pain-persistence 
patterns at a relatively early stage after diagnosis is likely to promote beneficial 
treatment outcomes in FM. In the present study we evaluate the effects of such an 
approach in a randomized controlled trial. We hypothesized that, in comparison 
to a waiting list control condition, patients in the treatment condition would 
demonstrate statistically and clinically significant improvements in the primary 
outcome measures of physical functioning (pain, fatigue, functional disability) 
and psychological functioning (anxiety, negative mood), and overall impact of 
FM, with at least medium to large post-treatment and 6-month follow-up effects.
Method
Participants and procedure
Patients with FM were referred by their rheumatologists of six regional hospitals 
in the area of Nijmegen, The Netherlands. To ensure a relatively early 
intervention,6'2526 the inclusion criterion was a relatively recent diagnosis of FM 
(diagnosis < 5 years previously by the ACR criteria1). Exclusion criteria were age
< 18 years, severe physical and psychological comorbidity that might interfere 
with the study protocol, FM secondary to another rheumatic condition, pregnancy, 
illiteracy and difficulty/inability to communicate in Dutch, participation in other 
clinical trials, and current psychological treatments. The study was approved by 
the medical ethics committee and the trial was registered in a clinical trial 
registration (ClinicalTrials.gov ID NCT00268606).
A total of 457 eligible patients were sent a screening questionnaire assessing 
sociodem ographic variables (sex, age, marital status, and educational level), 
physical and psychological functioning, and the screening instrument of
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pain-avoidance behavior. The questionnaire was returned by 379 patients (83%) 
(Figure 1), of whom the greater majority were women (95%) and were married or 
cohabiting (89%). Their mean age was 41.7 (SD = 10.9) and 4% had a primary, 82% 
a secondary, and 14% a tertiary educational level, representing an average of 7,12, 
and 17 years of formal education, respectively. Of this sample, 242 patients (64%) 
had a risk profile of heightened psychological distress based on cut-off scores for 
negative mood and/or anxiety of norm groups with risk scores of distress 
previously validated in FM.1526'28 In addition, these high-risk patients had, in 
comparison to patients not at risk, significantly higher levels of pain, fatigue, 
functional disability, and impact of FM on daily life (all p < .001). These high-risk 
patients were sent a written invitation within 4 weeks to take part in a randomized 
controlled trial. Of these patients, 54 declined to participate, most because of a 
lack of interest or practical concerns, such as travelling distance and scheduling 
difficulties (inability to combine the treatment with work and other daily activities). 
During the intake procedure by the therapists who checked the in- and exclusion 
criteria, 30 patients failed to meet the inclusion criteria, due to severe physical and 
psychiatric comorbidity (n=27), pregnancy (n=1) and insufficient motivation (n=2) 
(Figure 1). No significant differences were found between the excluded 84 patients 
and the included patients (n=158) with regard to sociodemographic variables or 
physical and psychological functioning.
Subsequently, these 158 patients were assigned to a pain-avoidance (PA) or a 
pain-persistence (PP) group based on a previously validated procedure consisting 
of the judgm ent of a trained therapist based on a semi-structured interview and a 
screening instrument of pain-avoidance behavior.215 The therapist's judgment 
and the screening instrument were concordant with regard to the classification in 
PA and PP for the majority of patients, except for 17 patients (11%) who were 
assigned according to the judgm ent of the therapist.15 29 The cut-off score of the 
screening instrument was based on the previously assessed mean of pain-avoidance 
behavior in several chronic pain populations to distinguish between pain-avoidance 
and pain-persistence patterns, reflecting a level of pain-avoidance behavior 
above and below the cut-off, respectively.215 According to this procedure, 84 
patients (53%) were assigned to the PA and 74 patients (47%) to the PP group. 
Written informed consent was obtained from all participants. Subsequently, these 
158 patients included in the trial were randomized in clusters to the treatment 
condition (TC) or the waiting list control condition (WLC) separately for the PA and 
PP group. These randomization clusters consisted of eight patients because of the 
group size for the treatment, but the size of the clusters varied from 1 to 9 due to
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reasons such as the inclusion of WLC patients who were offered treatment at the 
end of theirfollow-up according to protocol and treatment that was scheduled on 
fixed months. For example, when 3 patients from the WLC were included in the 
next treatment group, the randomization cluster consisted of 5 patients due to 
the maximum group size of 8 patients for every treatment group. As a result of 
randomization, 39 patients (5 clusters) were allocated to TC PP, 45 patients 
(6 clusters) to the WLC PP, 29 patients (6 clusters) to the TC PA and 45 patients 
(6 clusters) to the WLC PA. The primary outcome measures were assessed pre­
treatment (T1), post-treatment (T2), and at 6-month follow-up (T3) in the TC and at 
corresponding intervals in the WLC, using validated self-report questionnaires.
Tailored treatment
The patients assigned to the TC received a highly structured outpatient treatment 
program in a group setting of eight participants. Patients received a PA or a PP 
treatment, depending on their specific cognitive behavioral pattern of 
pain-avoidance or pain-persistence (Figure 2). Both the PA and the PP treatment 
consisted of 16 twice-weekly sessions and one booster session three months after 
treatment completion, with every regular session starting with two hours of CBT 
followed by two hours of exercise training. The patient's partner (or another 
significant relation) attended the third, ninth and fifteenth session. The treatment 
protocols for the pain-avoidance and pain-persistence interventions were 
developed mainly based on techniques from standardized treatment protocols 
for FM and also on treatment protocols for other chronic physical conditions.68'10 
For both treatments, CBT was aimed at diminishing the daily perceived cognitive, 
behavioral, emotional, and social consequences of pain and accompanying 
complaints. Every CBT session started with the discussion of the homework, then 
the specific topic of the session was introduced and practiced with the other 
participants, and finally the homework for the next session was explained. Exercise 
training was aimed at increasing the level of physical fitness and flexibility. 
Each exercise session consisted of relaxation training, aerobic exercises (e.g., cycling, 
gymnastic exercises), and hydrotherapy or anaerobic exercises (e.g., strength and 
flexibility exercises,functional walking training). The PA treatment was specifically 
aimed at increasing the patients' level of daily activities and diminishing their 
pain-avoidance behaviors by stimulating them to gradually and systematically 
increase their daily activities with individual goals and exposure to fear-related 
situations as the guiding principle. During the CBT, patients learned to set goals 
with regard to specific daily life domains and to increase their daily activities
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Figure 1 Flow chart showing participant selection and loss to post-test 
(T2) and follow-up (T3) for the two study conditions.
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regardless of the complaints. In the sessions during which the patient's partner 
was present, the importance of reinforcing healthy behaviors and ignoring 
possible pain behaviors was discussed and practiced. During the exercise training, 
patients also learned to gradually and systematically increase their daily exercises. 
The PP treatment first focused on regulating and diminishing their pain- 
persistence behaviors by teaching the participants to pace their activities and to 
alternate between activity and inactivity, followed by gradually increasing their 
daily activities. During the CBT, attention was paid to realistic goal setting, a 
balanced daily activity program, cognitive restructuring techniques and assertive 
social skills. During the exercise training, patients learned to perform their 
exercises according to a systematic and gradual plan. In both the PA and PP 
treatments, the patients received consolidating homework assignments (e.g., 
performing exercises at home, working on their individual goals, reading texts) 
supporting the CBT and exercise sessions, which took about 1.5 hours a day. 
The booster session focused on relapse prevention and a further improvement of 
the attained goals (for a more detailed treatment description, see van Koulil et al25). 
CBT was delivered by cognitive behavioral therapists (a psychotherapist and a 
social worker) and the exercise training was led by physiotherapists. All the 
therapists were experienced in CBT for rheumatologic conditions, including FM, 
and were specifically trained in our tailored multidisciplinary treatment using an 
elaborated written manual25 and regular supervision throughout the trial by 
senior cognitive behavioral therapists. Additionally, an independent judge 
experienced with the treatment protocol performed an integrity check of a 
random sample of 5% of all audio-recorded CBT sessions. With regard to patient 
adherence in the TC, with 94% of the completers attending at least 14 treatment 
sessions and the remaining 6% at least 11 treatment sessions, attendance was high. 
In addition, the patients who withdrew before the start of the treatment attended 
evidently none of the treatment sessions, and the three patients who dropped out 
during treatment attended on average three treatment sessions. The judgment of 
the therapists about the level of the patients' adherence to the treatment protocol 
and homework assignments in a subgroup of patients (47%) also showed a relatively 
high to very high adherence for at least 80% of the treated patients.
Measures
Sociodem oaraphic variables
Sociodem ographic variables were assessed with a general checklist that inquired 
about the patient's sex, age, marital status, education, and medical history.
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Figure 2 Overview of the treatment targets of the pain-avoidance and 
pain-persistence treatments
Changing pain-avoidance mechanisms:
>  Increasing daily activities
>  Reduction of pain-avoidance 
behaviors, pain-behavior, and fear 
of pain
>  Increasing the physical condition
Changing pain-persistence mechanisms:
>  Regulating and increasing daily 
activities
>  Increasing activity pacing and 
changing pain-persistence cognitions
>  Increasing the physical condition
Physical functioning
Physical functioning was determined based on the outcomes of pain, fatigue, and 
functional disability. Pain was assessed using the 6-item Pain scale (theoretical 
range 6-25, with higher scores indicating more pain) of the Impact Rheumatic 
Diseases on General Health and Lifestyle (IRGL).2728 The IRGL is derived from the 
Arthritis Impact Measurement Scales (AIMS)30 and assesses physical, psychological 
and social health in patients with rheumatic diseases, including patients with FM. 
Fatigue over the previous two weeks was measured with the 8-item Fatigue scale 
(theoretical range 8-56, with higher scores indicating more fatigue) of the 
Checklist Individual Strength (CIS).31 Functional disability was assessed with the
7-item Mobility scale (theoretical range 7-28) of the IRGL. A higher score on this 
latter scale indicates a lower level of functional disability.
Psychological functioning
Psychological functioning was determined based on the outcomes of negative mood 
and anxiety, assessed with the 6-item Negative Mood Scale (theoretical range 0-24, 
with higher scores indicating a higher level of negative mood) and the 10-item Anxiety 
scale (theoretical range 10-40, with higher scores indicating more anxiety) of the 
IRGL.
Im pact ofFM  on daily life
Im pact of FM on daily life was assessed with the 10-item Fibromyalgia Impact 
Questionnaire (FIQ) assessing physical impairment, pain, stiffness,fatigue, anxiety, 
and depressive symptoms (theoretical range 0-100, with higher scores indicating 
a greater impact of FM on daily functioning).32 33
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Screening instrument
The screening instrument for pain-avoidance behavior consisted of the 5-item 
'Resting when in pain' scale (theoretical range 0-4, with a higher score indicating 
a higher level of pain-avoidance behavior) of the Pain Coping Inventory (PCI), 
which identifies cognitive and behavioral patterns to limit pain in daily life.28
Statistical analyses
Differences between subgroups were tested with chi-square analyses for 
categorical data and with Student's f-test for continuous variables with a 
significance level of p < .05 (two-tailed). Treatment effects were evaluated using a 
linear mixed model, taking into account the specific design features of this trial. 
For each of the six primary outcomes, the post- and follow-up measurements 
were used as dependent variables, and treatment, baseline measurement, patient 
pattern (PA or PP), and time were used as independent variables in the primary 
analyses. Random effects were added for randomization groups and an 
unstructured covariance matrix was used to model the dependence of the post- 
and follow-up measurements. Secondary analyses contained pattern by treatment 
interactions (to testfor a homogeneous treatment effect in both patient patterns) 
and time by treatment interactions (to test for a stable treatment effect over the 
two post treatment measurements). All analyses were performed using the 
Intention To Treat (ITT) principle. Although much effort was invested in obtaining 
all possible measurements (for example, in patients who developed comorbidity 
during the trial), some missing values did occur. In total, 2546 observations (298 
missing of a maximum of 2844 observations) for the six primary outcome measures 
were evaluated in 158 participants, with complete data sets for 90% of all 
assessments at the three assessment points. For the 137 completers, data sets 
were complete for 98% of all assessments (55 missing of a maximum of 2466 
observations) at the three assessment points. Because we used a mixed model 
and missing data only occurred on the dependent variables, our present analyses 
can only be guaranteed to be valid when missing values occurred as Missing At 
Random (MAR). Therefore, we also performed an analysis using Last Observation 
Carried Forward (LOCF) as a sensitivity analysis. To give an indication for the 
clinical relevance of the results, effect sizes were calculated for the PA and the PP 
separately by computing the difference between the means of the assessment 
points divided by the pooled standard deviation (SD) at baseline.34 Furthermore, 
the mean effect sizes for the outcomes of physical and psychological functioning 
were calculated for each of the groups. Additionally, we calculated a reliable
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change index (RC) for the PA and the PP separately to determine the percentage 
of patients who showed a clinically relevant improvement (reliable change > 1.64, 
p < .05), and also the mean percentage for physical and psychological functioning 
was calculated.8'3536
Table 1 Baseline sociodemographic characteristics of the participants for 
each of the study conditions
Pain--avoidance Pain-persistence
TC (n=29) WLC (n=45) TC (n=39) WLC (n=45)
Sex (% female) 93% 96% 97% 89%
Married / cohabiting 72% 76% 82% 77%
Age (years) 42.3 (12.4) 39.4(10.4) 41.1 (9.4) 40.9 (10.4)
Educational level3
Primary 4% 2% 9% 5%
Secondary 81% 93% 77% 71%
Tertiary 15% 5% 14% 24%
aPrimary, secondary, and tertiary education represents an average of 7,12, and 17 years of formal 
education, respectively
Results
Baseline comparisons and drop-outs
Baseline comparisons of the treatment condition and the waiting list control 
condition revealed no significant differences with regard to their sociodemo­
graphic variables and primary outcomes. In addition, baseline comparisons of the 
pain-avoidance treatment condition (TC PA) with the waiting list control condition 
(WLC PA) and the pain-persistence treatment condition (TC PP) with the pain- 
persistence waiting list control condition (WLC PP) also revealed no significant 
differences with regard to their sociodemographic variables and primary 
outcomes, with the exception of a slightly higher score on fatigue (f = -.25, 
p = .028) for the PATC compared to the PA WLC (Tables 1 and 2). With regard to the 
drop-outs, five patients withdrew shortly after the randomization due to treatment 
elsewhere (PA WLC n=2) or practical concerns (PA TC n=1; PP TC n=1; PP WLC n=1). 
In addition, one patient (PP TC) was excluded due to psychiatric comorbidity that 
was discovered between the randomization and the first assessment. Between
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baseline (T1) and post-assessment (T2) seven patients dropped out. Reasons for 
dropping out were pregnancy (PA WLC n=1), newly acquired physical comorbidity 
(PA TC n=1), lack of sustained motivation to participate in the trial (PA TC n=2; PA 
WLC n=2), and treatment elsewhere (PP WLC n=1). Between post-assessment (T2) 
and follow-up (T3) eight patients dropped out. Reasons for dropping out during 
follow-up were lack of sustained motivation to participate in the trial (PA TC n=1; 
PA WLC n=1; PP TC n=2; PP WLC n=1), treatment elsewhere (PA WLC n=1), and 
newly acquired physical comorbidity (PA TC n=1; PP TC n=1). No differences were 
found with regard to sociodemographic variables and the primary outcomes 
between the drop-outs and the completers for the PA and the PP, with the 
exception of higher scores on pain (f = -2.84, p = .007) and impact of FM (f = -.242, 
p = .018) for the drop-outs compared to the completers in the PA group.
Primary analyses of outcome in physical and psychological functioning and 
impact of FM
With regard to physical functioning, a significant effect of condition wasfound for 
pain (F (1,18.00) = 16.48, p < .001); the TC showed a 2.30 point lower post- and 
follow-up assessment score compared to the WLC; for fatigue (F (1,134.95) = 55.85, 
p < .001), the TC showed a 9.68 point lower post-treatment score compared to the 
WLC; and for functional disability (F (1,16.28) = 48.96, p < .001); the TC showed a 
3.15 point lower post- and follow-up assessment score compared to the WLC. With 
regard to psychological functioning, a significant effect of condition was found 
for negative mood (F (1,15.87) = 19.92, p < .001); the TC showed a 2.62 point lower 
post- and follow-up assessment score compared to the WLC; and for anxiety 
(F (1,14.33) = 18.76, p < .001); the TC showed a 3.33 point lower post- and follow-up 
assessment score compared to the WLC. Finally, a significant effect of condition 
was found for the impact of FM on daily life (F (1,17.36) = 25.53, p < .001); the TC 
showed a 11.07 point lower post- and follow-up assessment score compared to 
the WLC. The mean scores of the TC and the WLC for the PA and the PP groups, 
separately, are shown in Table 2.
Secondary analyses of outcome in physical and psychological functioning 
and impact of FM
The Pattern x Condition interaction effects were not significant for the primary 
outcomes, with the exception of one significant Pattern x Condition interaction 
that was found for pain (F (1,134.17) = 5.26, p < .05). In the PA group, the TC showed 
a 3.72 point lower post- and follow-up assessment score compared to the WLC
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and in the PP group, the TC showed a 1.21 point lower post- and follow-up 
assessment score compared to the WLC. With regard to the Time x Treatment 
interaction effects a significant effect was found for anxiety (F (1,130.52) = 4.73, 
p < .05). Directly foil owing treatment, the TC score was 2.35 points lower compared 
to the WLC, but at follow-up this differences was even larger, 3.96 points. 
The sensitivity analysis showed that the results of the analyses on the complete 
dataset obtained after using the LOCF method were comparable to results 
presented above.
Clinical relevance
Effectsizesof all primaryoutcomes indicated overall relatively large post-treatment 
and follow-up effects (in most cases > .70) for the TC condition and overall small 
effect sizes (in most cases < .30) for the WLC for both the PA and the PP group 
(Table 2).33 In addition, the RC index indicated a higher proportion of patients with 
clinically significant improvements on pain, fatigue, functional disability, anxiety 
and negative mood in the TC relative to WLC at post-treatment (Table 3).8'35 36
143
Chapter 7
Table 2 Mean (SD), number of patients (n), and effect sizes (ES) of the
primary outcome measures for the treatment (TC) and the waiting 
list control condition (WLC) at baseline (T1), post-assessment (T2) 
and 6-month follow-up (T3)
Physical functioning
T1 T2 T3 ES
T1-T2
ES
T1-T3
Pain PA TC 20.3 (2.4) n=28 16.0(3.2) n=25 17.2 (3.3) n=21 1.56 1.13
WLC 19.8 (3.1) n=37 20.0 (4.3) n=39 20.4 (3.4) n=36 -0.07 -0.22
PP TC 19.1 (3.7) n=37 15.9(3.8) n=36 16.4(5.1) n=34 0.90 0.76
WLC 17.6(3.4) n=43 17.4(3.5) n=42 16.4(3.6) n=42 0.06 0.34
TC" 1.23 0.95
WLCb 0.01 0.06
Fatigue PA TC 50.5 (5.3) n=28 35.7 (9.9) n=25 39.4(11.6) n=23 2.24 1.68
WLC 46.9 (7.9) n=39 47.0 (6.7) n=40 46.4 (6.5) n=37 0.02 0.08
PP TC 44.2 (9.1) n=37 34.4 (9.7) n=36 34.1 (12.6) n=33 1.14 1.17
WLC 44.7 (8.1) n=43 43.7 (8.2) n=42 42.6 (9.4) n=42 0.12 0.24
TO 1.69 1.43
WLCb 0.07 0.16
Disability PA TC 13.6(3.0) n=28 18.4(3.5) n=25 19.3 (3.8) n=22 1.60 1.90
WLC 13.6(3.0) n=40 14.5 (4.3) n=39 14.5 (4.2) n=37 0.30 0.30
PP TC 18.6(4.5) n=37 21.4(4.0) n=36 22.2 (4.8) n=34 0.64 0.82
WLC 18.7(4.3) n=43 19.4(4.1) n=42 19.8 (4.4) n=42 0.16 0.25
TO 1.12 1.36
W LO 0.23 0.28
T C 1.35 1.25
W LC 0.10 0.17
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Table 2 Continued 
Physical functioning
Negative PA TC 8.9 (3.8) n=28 4.7 (3.7) n=25 5.0 (3.5) n=23 0.88
m° ° d  WLC 10.5 (5.7) n=40 8.8 (6.2) n=40 8.4(5 .2)n=36 0.36
PP TC 5.9 (3.3) n=37 4.0 (3.5) n=36 3.5 (2.6) n=34 0.54
WLC 5.6 (3.6) n=43 6.3 (3.7) n=42 6.1 (4.5) n=42 -0.20
TCa 0.71
WLCb 0.08
Anxiety PA TC 26.3 (5.9) n=28 21.6 (5.9) n=25 20.3 (5.6) n=23 0.76
WLC 27.0 (6.4) n=39 25.6 (6.7) n=40 26.0 (5.4) n=37 0.23
PP TC 23.2 (4.3) n=37 20.7 (4.3) n=35 19.0 (4.4) n=33 0.53
WLC 23.9 (5.1) n=43 23.6 (5.2) n=42 22.7 (5.4) n=41 0.06
TCa 0.65
WLCb 0.15
TCd 0.68
WLCd 0.12
Impact ofFM on daily life
PA TC 66.3 (11.6) n=28 47.6 (14.7) n=25 50.0 (15.6) n=23 1.60
WLC 67.0 (11.8) n=40 63.6 (14.9) n=40 66.0 (13.9) n=37 0.29
PP TC 57.2 (11.0) n=37 46.8 (15.3) n=36 43.2 (18.5) n=34 0.81
WLC 54.1 (14.7) n=43 53.8 (12.8) n=42 50.8 (15.2) n=42 0.02
TCa 1.21
WLCb 0.16
NB: Negative effect sizes indicates increases in symptoms, positive effect sizes indicates
decreases in symptoms.
amean effect size for the TC PA and PP
bmean effect size for the WLC PA en PP
'mean effect size for physical functioning (pain, fatigue, and functional disability) 
dmean effect size for psychological functioning (negative mood and anxiety)
0.82
0.44
0.69
-0.14
0.78
0.15
0.98
0.16
0.88
0.26
0.93
0.21
0.86
0.18
1.39
0.09
1.09
0.26
1.24
0.18
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Table 3 N u m b e r o f p a tie n ts  w ith  c lin ic a lly  s ig n if ic a n t  im p ro v e m e n ts  in th e  
tre a tm e n t (TC) an d  in th e  w a it in g - lis t  co n tro l c o n d it io n  (W LC) at T3 
fo r p h y s ica l a n d  p s y c h o lo g ic a l fu n c t io n in g  a n d  im p a c t  o f FM 
on  d a ily  life
Number of patients with 
improvement /total
Physical functioning
TC WLC
Pain PA
PP
13/21 (62%) 
19/34 (56%) 
59%
8/32 (25%) 
23/41 (56%) 
40.5%
Fatigue PA
PP
16/23 (70%) 
23/33 (70%) 
70%
6/34(18%) 
12/41 (29%) 
23.5%
Functional disability PA
PP
19/22 (86%) 
20/34 (59%) 
72.5%
12/35 (34%) 
15/41 (37%) 
35.5%
Responders physical functioninga 67.2% 33.2%
Psychological functioning
Negative mood PA
PP
15/23 (65%) 
15/34 (44%) 
54.5%
15/35 (43%) 
9/41 (22%) 
32.5%
Anxiety PA
PP
17/23 (74%) 
21/33 (64%) 
69%
9/34 (27%) 
16/40 (40%) 
33.5%
Responders psychological functioningb 61.8% 33%
Impact FM on daily life
PA
PP
16/23 (70%) 
17/34 (50%)
5/35 (14%) 
14/41 (34%)
Responders impact FM 60% 24%
aMean percentage of patients with clinically significant improvement on physical functioning 
(pain, fatigue, functional disability)
bMean percentage of patients with clinically significant improvement on psychological 
functioning (negative mood and anxiety)
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Discussion
Effects sizes were overall large at post-treatment and follow-up for the TC, and 
reliable change indices indicated that a significant larger proportion of patients in 
the TC showed a clinically relevant change. The present results demonstrate that 
offering high-risk patients with FM a treatment tailored to their cognitive 
behavioral patterns in a relatively early stage after the diagnosis is effective in 
improving both short- and long-term physical and psychological outcomes. 
Supporting evidence of the effectiveness of our tailored treatment was found 
with regard to the follow-up assessments and the low drop-out rates. The effects 
were maintained at six months, suggesting that patients continued to benefit 
from the treatment. In contrast to previous studies, the drop-out in our study was 
relatively low, indicating that our intervention was well accepted by the patients.
Although earlier studies have shown that multidisciplinary interventions 
combining CBT with exercise training improved functioning in patients with FM, 
the generally small to moderate effects and high drop-out rates have proved a 
problem. Modest results were suggested to be due to the heterogeneity of the 
population.3'437 Several studies identified specific patient characteristics that 
predict treatment success. For example, it was shown that patients with FM 
reporting high levels of distress and a high impact of the condition benefit most 
from CBT.10-12 With regard to specific CBT interventions, a pain-avoidance treatment 
(exposure in vivo) aimed at improving performance by diminishing the fear of 
pain was found to be particularly effective in highly fearful patients with chronic 
low back pain.7 Furthermore, Thieme et al22 recently reported that the responders 
to a pain-avoidance treatment for FM differed from the responders to a pain-per- 
sistence intervention. These findings offer promising possibilities for new 
treatments tailored to specific patient characteristics, which could enhance 
treatment outcomes. For example, Hasenbring and colleagues38 investigated the 
effectiveness of CBT tailored to the pain-avoidance or pain-persistence patterns 
in patients with acute sciatic pain and reported beneficial results. Building on 
these findings, we can now report, for the first time to our knowledge, relatively 
large physical and psychological improvements in high-risk patients with FM 
following a treatment specifically addressing pain-avoidance and pain-persis- 
tence patterns.
Some limitations should be kept in mind when interpreting our results. 
We did not directly test the hypothesis that our tailored intervention is more 
effective than a standard, non-tailored treatment. Future research should aim at
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demonstrating the possibly direct efficacy of the present tailored treatment 
approach by comparing the effects of tailored versus non-tailored treatments. 
However, being that previous meta-analyses and recent studies of non-tailored 
interventions in chronic physical conditions have overall shown not more than 
moderate effects, the results of this study suggests that a tailored approach is 
promising for improving treatment effects.3'439 Furthermore, we found small 
improvements in our waiting list control condition, which consisted of high-risk 
FM patients awaiting treatment. Because no change or a worsening of symptoms 
is usually observed in natural course studies in FM and waiting list conditions are 
well-known to have possible beneficial effects,4041 the small improvements might 
be due to the patient's expectation of treatment and the intake procedure in 
which also education about the treatment was provided. In addition, the low 
attrition rate in the WLC might be due to the fact that these patients were awaiting 
the treatment that was not provided elsewhere, which might provide a strong 
motivation to remain in the trial. We also note that the allocation to the conditions 
and the execution of the measurements were not performed blinded. The risk of 
information bias, however, is limited because the investigator had no influence on 
the decision to accept or reject participants, the participants were allocated in 
order of their enrollment of the trial, and the TC and the WLC received the same 
standardized assessments. Finally, future research should also establish the longer 
term effects of the treatment approaches.
In conclusion and supporting our earlier prediction, the present study 
demonstrates for the first time that tailored CBT in combination with exercise 
training for high-risk patients with FM delivered at a relatively early stage after the 
diagnosis is effective in improving and maintaining both the patients' physical 
and psychological functioning.
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Abstract
Objective. Patients with fibromyalgia (FM) have overall diminished levels of 
physical fitness, which may lead to functional disability and exacerbating 
complaints. Multidisciplinary treatment comprising cognitive behavioral therapy 
(CBT) and exercise training has been shown to be effective in improving physical 
fitness. However, due to the high drop-out rates and the large variability in the 
patients' physical and psychological functioning, it was proposed that a tailored 
treatment approach might yield more promising treatment outcomes.
Methods. High-risk FM patients were randomized to a waiting list control group 
(WLC) or a treatment condition (TC), with the treatment consisting of 16 
twice-weekly sessions of CBT and physical exercise training tailored to the 
patient's cognitive behavioral pattern. Physical fitness was assessed with two 
physical tests prior to and three months after treatment and at corresponding 
intervals in the WLC. Treatment effects were evaluated using linear mixed 
models.
Results.The level of physical fitness had improved significantly in theTC compared 
to the WLC. Attrition rates were low and effects sizes large for the TC, reflecting 
clinically relevant changes.
Conclusion. A tailored multidisciplinary treatment approach for FM consisting of 
CBT and physical exercise training is well-tolerated, yields clinically relevant 
changes, and accordingly appears a promising approach to improve the patients' 
physical fitness. Additional studies are needed to confirm its longer term 
efficacy.
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Introduction
Fibromyalgia (FM) is a high-prevalence rheumatological condition without clear 
pathophysiological mechanisms that is characterized by widespread pain and 
increased tenderness at palpation. Patients have difficulty remaining active or 
show an imbalance in activity and inactivity due to their complaints, which may 
eventually lead to deconditioning, functional disabilities in daily life, and 
exacerbating complaints.1 Physical exercise training aimed at increasing their 
levels of physical functioning and diminishing the severity of the self-reported 
complaints is one of the key components in the treatment of FM and generally 
includes aerobic exercise (e.g., walking, cycling), pool exercise, strength training, 
and flexibility exercises. Several meta-analyses have shown the benefits of this 
approach both in FM and other chronic pain conditions, especially in combination 
with cognitive behavioral therapy (CBT).2'4 However, the limited effects, high 
drop-out rates, and large variability in the patients' level of functioning suggest 
that a tailored approach might be more beneficial.5 Tailoring may comprise 
selecting specific homogeneous patient groups and customizing the type, 
content, and timing of the intervention. We previously showed that a multidisci­
plinary treatment for high-risk FM patients consisting of CBT and exercise training 
tailored to pain-avoidance and pain-persistence patterns was effective in 
improving self-reported physical and psychological functioning.6 The aim of the 
present study was to determine the effects of this approach at the level of physical 
fitness assessed with two physical tests.
Methods
Participants and procedure
The current study was conducted using the same sample we described in our 
previous effect study:6 patients with a relatively recent diagnosis of FM (diagnosis
< 5 years previously according to the ACR criteria7) all referred to our outpatient 
clinic by their rheumatologists. Exclusion criteria were age < 18 years, severe 
physical and psychological comorbidity that might interfere with the study 
protocol, FM secondary to another rheumatic condition, pregnancy, illiteracy and 
difficulty/inability to communicate in Dutch, participation in other clinical trials, 
and current psychological treatments. Included were patients that showed a risk 
profile of heightened psychological distress based on a self-report screening
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questionnaire. Subsequently, patients were assigned to a pain-avoidance (PA) or a 
pain-persistence (PP) group based on a previously validated procedure, consisting 
of the judgm ent of a trained therapist based on a semi-structured interview and a 
screening instrument of pain-avoidance behavior.8Consistent with our previous 
study,8 the baseline physical test assessment showed that patients with a PA 
pattern had significantly lower scores with regard to total distance walked and 
total minutes cycled (both p < .01), compared to the patients in the PP group. 
Subsequently, patients were randomized in clusters to the treatment (TC) or the 
waiting list control condition (WLC) separate for the PA and PP group. These 
randomization clusters consisted of eight patients because of the group size for 
the treatment, but the size of the clusters varied from 1-9 due to reasons such as 
the inclusion of WLC patients that were offered treatment at the end of their 
follow-up according to protocol and treatment that was scheduled on fixed 
months. For example, when 3 patients from the WLC were included in the next 
treatment group the randomization cluster consisted of 5 patients due to the 
maximum group size of 8 patients for every treatment group. For the complete 
inclusion procedure, see van Koulil et al 2010.s For this specific study of physical 
fitness, 29 patients that participated in the trial had missing data at both 
assessments or at follow-up due to a lack of motivation to come to the additional 
physical test assessment (PA TC n=2; PA WLC n=9; PP WLC n=18) and were not 
included in the analyses. No significant differences were found between these 29 
patients and the included patients (n=129) with regard to sociodemographic 
variables or physical and psychological functioning, with the exception that the 
29 patients were slightly younger (f = 2.39, p = .018). However, with regard to the 
final sample of 129 patients, no age differences were found between the WLC and 
TC. The majority of the final sample of 129 patients (PA TC n=27; PP TC n=39; PA 
WLC n=36; PP WLC n=27) was female (94%), married or cohabiting (87%). Their 
mean age was 41.7 (SD = 10.2) and 5% had a primary, 82% a secondary and 13% a 
tertiary educational level, representing an average of 7,12, and 17 years of formal 
education, respectively. Physical fitness was assessed prior to and three months 
after treatment for the patients in the treatment condition and at corresponding 
intervals for the patients in the waiting list control condition. The trial was 
registered in a clinical trial register (ClinicalTrials.gov ID NCT00268606).
Tailored treatment
The tailored outpatient group treatment consisted of 16 twice-weekly sessions of 
CBT and exercise training each lasting two hours and one booster session three
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months after treatment conclusion. CBT was aimed at diminishing the daily 
perceived cognitive, behavioral, emotional, and social consequences of pain and 
accompanying complaints, while the exercise training, which comprised aerobic 
exercises (e.g., cycling, gymnastic exercises), anaerobic exercises (e.g., strength 
and flexibility exercises, functional walking training), hydrotherapy, and relaxation 
therapy, aimed at increasing endurance and flexibility based on graded activity 
principles. Throughout, the patients received consolidating homework 
assignments. The PA treatment aimed at increasing the patients' level of daily 
activities and diminishing their pain-avoidance behaviors by stimulating them to 
gradually and systematically increase their daily activities with individual goals 
and exposure to fear-related situations as the guiding principle. The PP treatment 
first focused on regulating and diminishing their pain-persistence behaviors by 
teaching the participants to pace their activities and to alternate between activity 
and inactivity, followed by gradually increasing their daily activities. With regard 
to patient adherence in the TC, with 94% of the completers attending at least 14 
treatment sessions and the remaining 6% at least 11 treatment sessions, attendance 
was high. In addition, the patients who withdrew before the start of the treatment 
attended evidently none of the treatment session, and the three patients that 
dropped out during treatment attended on average three treatment sessions. 
The judgm ent of the therapists about the level of adherence of the patients to the 
treatment protocol and homework assignments in a subgroup of patients (47%) 
also showed a relatively high to very high adherence for at least 80% of the treated 
patients (for a more detailed treatment description, see van Koulil et al9).
Measures
Physical fitness was assessed by physical therapist examination including a shuttle 
walking and a cycling test. The shuttle walking test is a standardized maximal test 
assessing walking speed and endurance in terms of the total distance walked at a 
progressive pace set by audio signals until the patient reaches exhaustion.10 The 
cycling test is a submaximal test based on stepwise resistance increases and 
measures the total minutes cycled with a progressive resistance until the patient 
reaches exhaustion.11 For both tests perceived exertion after test completion was 
assessed using the Borg scale ranging from 0 (no perceived exertion) to 10 
(maximum perceived exertion).12 The measures described have all been used in 
previous studies of chronic physical symptoms and have shown good validity and 
reliability.101113
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Statistical analyses
Between-group differences were tested with chi-square analyses for categorical 
data and with Student's f-tests for continuous variables with significance level of 
p < .05 (two-tailed). Treatment effects were evaluated using a linear mixed model, 
taking into account the specific design features of this trial. For each of the 
outcomes, the post-treatment measurement was used as dependent variables, 
and treatment, baseline measurement, and patient pattern (PA or PP) were used 
as independent variables in the primary analyses. Random effects were added for 
randomization groups. Secondary analyses contained pattern by treatment 
interactions to test for a homogeneous treatment effect in both patient patterns. 
All analyses were performed using the Intention To Treat (ITT) principle. Although 
much effort was invested in obtaining all possible measurements (for example, in 
patients who developed comorbidity during the trial) some missing values did 
occur. For the total sample of 129 patients, data sets for the physical tests and 
perceived exertion were complete for 89%. For the 113 completers, data sets were 
complete for 99%. Because we used a mixed model and missing values only 
occurred on the dependentvariables, our present analyses can only be guaranteed 
to be valid when missing values occurred as Missing At Random (MAR). Therefore, 
we also performed an analysis using Last Observation Carried Forward (LOCF) as 
a sensitivity analysis. Effect sizes were calculated for the PA and the PP and the TC 
and WLC separately by computing the difference between the means of the 
assessment points divided by the pooled standard deviation (SD) at baseline.14
Results
Baseline comparisons and drop-outs
The baseline comparisons of the treatment condition (TC) and the waiting list 
control condition (WLC) revealed no significant differences for sociodemographic 
variables or level of physical fitness. Baseline comparisons of the pain-avoidance 
treatment condition (PA TC) with the pain-avoidance waiting list condition (PA 
WLC) and the pain-persistence treatment condition (PP TC) with the pain- 
persistence waiting list control condition (PP WLC) also revealed no significant 
differences with regard to their sociodemographic variables or level of physical 
fitness, with the exception that the PP WLC cycled somewhat longer than the PP 
TC (f = 3.00, p < .01) (Table 1). With regard to the drop-outs, five patients withdrew 
shortly after the randomization due to treatment elsewhere (PA WLC n=2) or
158
Tailored cognitive behavioral therapy and exercise training improves the physical fitness
practical concerns (PA TC n=1; PP TC n=1; PP WLC n=1). In addition, one patient 
(PP TC) was excluded due to psychiatric comorbidity that was discovered between 
the randomization and the first assessment. Between the baseline and the 
follow-up assessment 10 patients additionally dropped out. Reasons for dropping 
out were pregnancy (PA WLC n=1), newly acquired physical comorbidity (PA TC 
n=1; PP TC n=1), lack of sustained motivation to participate in the trial (PA TC n=1; 
PA WLC n=3; PP WLC n=1), treatment elsewhere (PP WLC n=1). No significant 
baseline differences were found with regard to sociodemographic variables and 
the physical tests outcomes between the drop-outs and the completers for the PA 
and the PP groups.
Changes in physical fitness
With regard to the level of physical fitness, a significant effect of condition was 
found for the total meters walked (F (1,19.12) = 58.51, p < .001); the TC walked 
163.10 meters longer at post-assessment compared to the WLC; and for the total 
minutes cycled (F (1,18.84) = 22.14, p < .001), the TC cycled 3.49 minutes longer at 
post-assessment compared to the WLC. With regard to the level of perceived 
exertion, a significant effect of condition was found for the shuttle walking test (F 
(1,15.70) = 20.42, p < .001); the TC showed a 1.88 point lower post-treatment score 
compared to the WLC; and for the cycling test (F (1,18.25) = 10.90, p < .01); the TC 
showed a 1.24 point lower post-treatment score compared to the WLC. In Table 1 
the mean scores of the TC and the WLC are presented for the PA and the PP, 
separately. The Pattern x Condition interaction effects were not significant for the 
level of physical fitness. In addition, no significant Pattern x Condition interaction 
effects were found for the level of perceived exertion after the shuttle walking 
test and the cycling test. The sensitivity analysis showed that the results of the 
analyses on the complete dataset obtained after using the LOCF method were 
comparable to results presented above. Effect sizes indicated large effects (1.36 
for the walking test and 0.97 for the cycling test) for the TC condition and small 
effect sizes (0.18 for the walking test and -0.03 for the cycling test) for the WLC 
condition (Table 1).
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Table 1 Mean (SD), number of patients (n) and effect sizes (ES) for the
outcomes of the physical tests and the perceived exertion after test 
completion at baseline and 3-month follow-up for the treatment 
condition (TC) and the waiting list control condition (WLC) of the 
pain-avoidance group (PA) and pain-persistence group (PP)
Baseline Follow-up ES
Walking test
Distance walked PA TC 259.6 (156.7) n=28 438.7 (128.9) n=23 1.23
WLC 245.5 (133.4) n=31 250.3 (136.9) n=30 0.03
PP TC
WLC
305.7 (122.8) n=37 
339.2 (133.7) n=24
496.9(149.9) n=36 
381.7 (150.8) n=24
1.49
0.33
TC"
WLCb
1.36
0.18
Perceived exertion PA TC 3.8(1.5)n=28 2.9(1.3)n=23
WLC 4.8 (1.5) n=30 5.3 (1.9)n=29
PP TC
WLC
3.9 (1.8) n=37 
4.6 (1.9) n=24
2.8 (1.4) n=36 
4.5 (1.5) n=24
Cycle test
Minutes cycled PA TC
WLC
7.8 (4.6) n=28
6.9 (3.7) n=30
12.5 (4.5) n=23 
7.1 (3.9) n=30
1.13
0.05
PP TC
WLC
8.9 (3.8) n=37 
12.3 (5.0) n=24
12.4(3.8) n=36 
12.0 (4.8) n=24
0.80
- 0.11
TCa
WLCb
0.97
-0.03
Perceived exertion PA TC
WLC
4.9 (2.1) n=27 
5.2 (2.0) n=30
3.8 (1.5) n=23 
5.6 (1.7) n=28
PP TC
WLC
amean effect size for the TC PA and PP 
bmean effect size for the WLC PA en PP
4.8 (1.5) n=36 
5.0 (1.6) n=24
4.0 (1.7) n=36 
4.9 (1.5) n=22
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Discussion
Examining the effects of a tailored multidisciplinary treatment for FM on the 
patients' level of physical fitness, we found that the level of physical fitness to 
have significantly improved in the treated patients relatively to the results of the 
waiting list control condition, which also held for the level of perceived exertion 
after physical activity. Thus, the patients in the treatment group cycled longer and 
walked further while reporting less exertion than those in the control group. 
Effect sizes were large ( > .80), suggesting a clinically relevant change.14 Although 
earlier studies already showed multidisciplinary interventions combining CBT 
with exercise training to be effective in improving functioning in FM patients, the 
generally small to moderate effects, high drop-out rates, and poor adherence 
proved a problem. With only two patients dropping out due to the lack of 
sustained motivation, the attrition rate in our study was very low and treatment 
attendance high, indicating that our intervention was well-tolerated. Several 
factors could have contributed to these results. Since the inclusion of a 
psychological component aimed at behavioral change is presumed to improve 
treatment adherence,515 our intervention accordingly comprised both exercise 
training and CBT. We additionally tailored the exercise programme to the 
individual patient's baseline condition and his/her specific pain-avoidance or 
pain-persistence pattern. Exercises were, moreover, performed at moderate 
intensity levels with intensity being gradually increased to prevent post-exertional 
pain and fear of movement, which approach has generally been shown more 
effective than high-intensity exercising.15 Long-term goals with regard to 
exercising and relapse prevention were systematically addressed throughout the 
treatment and during the booster session which might have also contributed to 
these treatment effects. It could be argued that the fact that subjects tend to 
improve their behavior in response to being studied, might be partially responsible 
for the findings, but the beneficial results and high effect sizes were found for the 
treated patients relatively to the control condition.
However, the following aspects should be kept in mind when interpreting our 
results. The physical tests were carried out by the physiotherapists who were also 
involved in the treatment. Furthermore, norms of the physical tests with regard to 
the level of physical fitness in several chronic pain conditions, including FM, merit 
further investigation. In addition, since our intervention comprised of both CBT 
and exercise training, we are unable to assess the relative contribution of these 
two components. Finally, although our study demonstrates that tailored multidis­
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ciplinary treatment for high-risk FM patients in a relatively early stage after 
diagnosis is effective in improving their physical fitness up to three months after 
treatment, longer term effects remain to be tested.
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Abstract
Background. The heterogeneity in cognitive behavioral patterns in patients with 
fibromyalgia (FM) has been proposed to underlie the variability in treatment 
outcomes. It has previously been shown that pain-avoidance and pain-persistence 
treatments tailored to the patient's cognitive behavioral pattern are effective in 
improving the physical and psychological functioning and overall impact in 
high-risk patients with heightened levels of psychological distress. In the present 
study, the cognitive behavioral effects of these treatments were evaluated to 
provide insight in the main proposed working mechanisms, specifically 
pain-avoidance behaviors and activity pacing in the pain-avoidance and pain- 
persistence treatments, respectively.
Methods. High-risk FM patients were classified into two groups, pain-avoidance 
(PA) and pain-persistence (PP), and randomized in groups to the relevant treatment 
or waiting list control condition. The PA and the PP treatment both comprised 16 
twice-weekly sessions of cognitive behavioral therapy and exercise training. 
Cognitive behavioral factors were assessed pre- and post-treatment and at 
6-month follow-up and evaluated using linear mixed models.
Results. A significant treatment effect was found for pain-avoidance behavior in 
the PA and activity pacing in the PP, showing improvements in the treatment 
condition relative to the controls. Furthermore, the effect on functioning was 
mediated by changes in pain-avoidance behavior in the PA and by activity pacing 
in the PP. Both treatments also showed significant improvements in several other 
cognitive behavioral factors.
Conclusions. Both the pain-avoidance and the pain-persistence treatment are 
effective in improving cognitive behavioral factors in high-risk FM patients. In 
addition, pain-avoidance behavior and activity pacing might be important 
mediating mechanisms for beneficial outcomes in the pain-avoidance and pain- 
persistence treatments, respectively.
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Introduction
Multidisciplinary chronic pain treatments are aimed at modifying maladaptive 
cognitive and behavioral responses to pain in order to improve the patients' 
physical and psychological functioning. Meta-analyses showed that combinations 
of cognitive behavioral therapy (CBT) and exercise training yield the most 
favorable results in fibromyalgia (FM), a chronic musculoskeletal pain disorder 
characterized by widespread pain, fatigue, functional disability, and heightened 
psychological distress.12 However, effects were limited and showed large 
individual variability.3 6 Supporting evidence has since been found showing that 
the efficacy of interventions improves when the heterogeneity of the patient 
group is taken into consideration and treatments are matched to the patient's 
cognitive behavioral mechanisms.7'13
Specific cognitive behavioral factors have been proposed to account for the 
maintenance and exacerbation of complaints in chronic pain patients. 
Fear-avoidance models postulate that factors such as pain-avoidance behavior, 
fear of pain, catastrophizing, hypervigilance, and social reinforcement, contribute 
to chronic pain and long-term disability.14'17 However, these pain-avoidance 
patterns seem less applicable for patients with pain-persistence patterns who 
tend to continuously persist in their activities despite of the pain and ignore 
pain-related signals.18'22 Various studies have demonstrated the prognostic value 
and independent contribution of both pain-avoidance and pain-persistence 
factors for the development and maintenance of physical and psychological 
impairments in various chronic pain disorders, including FM.171821'25 Preliminary 
evidence also suggests that adapting treatment to these specific cognitive 
behavioral factors may be promising.101126 As distress has been shown to be an 
indicator of maladaptive cognitive behavioral patterns targeted in multidisci­
plinary CBT, these patterns specifically pose a problem in high-risk patients with 
heightened levels of distress.727 Several studies indeed found relatively highly 
distressed FM patients to obtain the better outcomes during CBT.27'29 As to the 
timing of treatment, several studies demonstrated that chronic pain patients with 
shorter duration of complaints benefit most from CBT.3031 In sum, identifying 
high-risk patients in an early stage and offering them timely CBT and exercise 
training tailored to their specific pain-avoidance or pain-persistence pattern is 
likely to promote treatment outcomes in FM. In two previous reports we indeed 
showed this approach to be effective in improving self-reported physical and 
psychological functioning, the impact of FM, as well as the level of physical
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fitness.1332 These studies, however, did not address the cognitive behavioral 
mechanisms responsible for the obtained effects.
The aim of the present study accordingly was to examine the cognitive 
behavioral mechanisms of a pain-avoidance (PA) treatment and a pain-persistence 
(PP) treatment. Since pain-avoidance behaviors and activity pacing reflect the 
main cognitive behavioral mechanisms in the PA and the PP treatments, 
respectively, we expected the PA treatment to be effective in diminishing 
pain-avoidance behaviors and the PP treatment to be effective in improving 
activity pacing. We also explored whether the obtained improvements in physical 
and psychological functioning, which were shown in an earlier report on this 
study,13 were mediated by pain-avoidance behaviors in the PA group and activity 
pacing in the PP group. In addition, the effect of the PA and the PP treatments on 
other pain-related cognitive behavioral factors (pain-related retreating, worrying 
about pain, fear of pain, hypervigilance, social reinforcement, acceptance, 
helplessness, perceived social support) was explored.
Methods
The study reported here is part of a larger trial of which the methods have been 
extensively described elsewhere.13 This section is therefore restricted to those 
aspects that are relevant for the current study. The study was approved by the 
medical ethics committee and the trial was registered in a clinical trial registration 
(ClinicalTrials.gov ID NCT00268606).
Participants and procedure
Patients with a relatively recent diagnosis of FM (diagnosis < 5 years previously by 
the ACR criteria1) were referred to our outpatient clinic by their rheumatologists. 
Exclusion criteria were age < 18 years, severe physical and psychological 
comorbidity that might interfere with the study protocol, FM secondary to another 
rheumatic condition, pregnancy, illiteracy and difficulty/inability to communicate 
in Dutch, participation in other clinical trials, and current psychological treatments. 
In addition, only patients with a high risk profile of heightened self-reported 
distress (negative mood and/or anxiety) were invited to take part in the current 
trial (n = 242) (Figure I).733 34 High-risk patients were further characterized by 
significantly higher levels of pain, fatigue, functional disability, and impact of FM 
on daily life (all p < .001) compared to patients not at risk, while also scoring
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significantly higher on the cognitive behavioral factors of pain-avoidance 
behavior, pain-related retreating, worrying about pain, fear of pain, hypervigilance 
and helplessness and significantly lower on acceptance and perceived social 
support than the low-risk patients (all p < .001). No significant differences between 
high- and low-risk patients were found on the cognitive behavioral factors of 
social reinforcement and activity pacing.
The 158 patients that were interested to participate and were considered 
eligible after an intake procedure by the therapists who checked the in- and 
exclusion criteria, were assigned to a pain-avoidance or a pain-persistence group, 
based on a previously validated procedure, consisting of the judgm ent of a trained 
therapist based on a semi-structured interview and a screening instrument of 
pain-avoidance behavior. The therapist judgm ent and the screening instrument 
were concordant with regard to the classification in pain-avoidance and pain-per- 
sistence for the majority of patients, except for 17 patients (11%) who were 
assigned according to the judgm ent of the therapist. The cut-off score of the 
screening instrument was based on the previously assessed mean of pain-avoidance 
behavior in several chronic-pain populations to distinguish between pain- 
avoidance and pain-persistence patterns, reflecting a level of pain-avoidance 
behavior above and below the cut-off, respectively.3536 According to this 
procedure, 84 patients (53%) were assigned to the PA and 74 patients (47%) to the 
PP group. The baseline screening of the PA and the PP showed both groups to 
have similar sociodemographic backgrounds, but, consistent with our previous 
study,36 the patients with a PA pattern had significantly higher scores on functional 
disability, pain, negative mood, and impact of FM (all p < .05), as well as higher 
scores on the cognitive behavioral factors of pain-avoidance behavior, pain- 
related retreating, worrying about pain, fear of pain, hypervigilance, social 
reinforcement, helplessness, and activity pacing (all p < .05). No significant 
between-group differences were found for the cognitive behavioral factors of 
acceptance and perceived social support. Written informed consent was obtained 
from all participants.
Subsequently, these 158 patients were randomized in clusters to thetreatment 
(TC) or the waiting list control condition (WLC) separately for the PA and PP group 
(Figure 1). These randomization clusters consisted of eight patients because of the 
group size for the treatment, but the size of the clusters varied from 1-9 due to 
reasons such as the inclusion of WLC patients that were offered treatment at the 
end of theirfollow-up according to protocol and treatment that was scheduled on 
fixed months. For example, when three patients from the WLC were included in
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Figure 1 Flowchart showing participant selection and loss to pre-test (T1), 
post-test (T2) and follow-up (T3) for the pain-avoidance and the 
pain-persistence groups separately
Screening
n=457
Response 
n=379 (83%)
Non-response 
n=78 (17%)
Excluded (n=84) 
Refused to participate 
(n=54)
Not meeting inclusion 
criteria (n=30)
At risk Not at risk
n=242 (64%) n=137 (36%)
Randomized 
n=158
Pain-persistence 
n=84 (53%)
Pain-avoidance 
n=74 (47%)
Allocated toTC 
n=39
Allocated to WLC 
n=45
1 withdrew 
1 psychiatric 
comorbidity
1 withdrew
Completers T1 
n=37
Completers T1 
n=44
Allocated toTC 
n=29
Allocated to WLC 
n=45
- ►  1 withdrew 2 withdrew
Completers T1 
n=28
Completers 
T1 n=43
1 physical
1 withdrew ----- ►  comorbidity
2 withdrew
▼  ' r 1 f ▼
1 pregnant
2 withdrew
Completers T2 
n=37
Completers T2 
n=43
Completers T2 
n=25
Completers T2 
n=40
2 withdrew 
1 physical 
comorbidity
1 physical 
comorbidity 
1 withdrew
Completers T3 
n=34
Completers T3 
n=42
Completers T3 
n=23
Completers T3 
n=38
TC = treatment condition; WLC = waiting list control condition
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the next treatment group the randomization cluster consisted of five patients due 
to the maximum group size of eight patients for every treatment. Cognitive 
behavioral factors were assessed at baseline (T1), post-treatment (T2), and at 
6-month follow-up (T3) in the TC and at corresponding intervals in the WCL, using 
validated self-report questionnaires.
Treatment credibility of the PA and the PP treatment was assessed after the 
first session and at the end of the treatment. Using a 10-point scale, the patients 
were asked to rate the credibility of the treatment, their confidence in the success 
of the treatment, their willingness to recommend the treatment to others, and 
their expectations of a positive, lasting effect.3738 No significant differences were 
found between the two treatment groups, suggesting that both treatments were 
perceived equally credible.
Tailored treatments
The patients assigned to the TC received a highly structured outpatient treatment 
programme in a group setting of eight participants. Patients received a PA or a 
PP treatment, depending on their specific cognitive behavioral pattern of 
pain-avoidance or pain-persistence (Figure 2). Both the PA and the PP treatment 
consisted of 16 twice-weekly sessions and one booster session three months after 
treatment completion, with every regular session starting with two hours of CBT 
followed by two hours of exercise training. The patient's partner (or another 
significant relation) attended the third, ninth and fifteenth session. For both 
treatments, CBT was aimed at diminishing the daily perceived cognitive, 
behavioral, emotional, and social consequences of pain and accompanying 
complaints. Every CBT session started with the discussion of the homework, then 
the specific topic of the session was introduced and practiced with the other 
participants, and finally the homework for the next session was explained. Exercise 
training was aimed at increasing the level of physical fitness and flexibility. Each 
exercise session consisted of relaxation training, aerobic exercises (e.g., cycling, 
gymnastic exercises), and hydrotherapy or anaerobic exercises (e.g., strength and 
flexibility exercises,functional walking training). The PA treatment was specifically 
aimed at increasing the patients' level of daily activities and diminishing their 
pain-avoidance behaviors by stimulating them to gradually and systematically 
increase their daily activities with individual goals and exposure to fear-related 
situations as the guiding principle. During the CBT, patients learned to set goals 
with regard to specific daily life domains and to increase their daily activities 
regardless of the complaints. In the sessions during which the patient's partner
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was present, the importance of reinforcing healthy behaviors and ignoring 
possible pain behaviors was discussed and practiced. During the exercise training, 
patients also learned to gradually and systematically increase their daily exercises. 
The PP treatment first focused on regulating and diminishing their pain-persis- 
tence behaviors by teaching the participants to pace their activities and to 
alternate between activity and inactivity, followed by gradually increasing their 
daily activities. During the CBT, attention was paid to realistic goal setting, a 
balanced daily activity program, cognitive restructuring techniques and assertive 
social skills. During the exercise training, patients learned to perform their 
exercises according to a systematic and gradual plan. In both the PA and PP 
treatments, the patients received consolidating homework assignments (e.g., 
performing exercises at home, working on their individual goals, reading texts) 
supporting the CBT and exercise sessions, which took about 1.5 hours a day. The 
booster session focused on relapse prevention and a further improvement of the 
attained goals (for a more detailed treatment description, see van Koulil et al12).
CBT was delivered by cognitive behavioral therapists (a psychotherapist and 
a social worker) and the exercise training was led by physiotherapists. All the 
therapists were experienced in CBT for rheumatologic conditions, including FM, 
and specifically trained in our tailored multidisciplinary treatment, using an 
elaborated written manual and regular supervision throughout the trial by senior 
cognitive behavioral therapists. Additionally, an independent judge experienced 
with the treatment protocol performed an integrity check of a random sample of 
5% of all audio-recorded CBT sessions. With regard to patient adherence in the TC, 
with 94% of the completers attending at least 14 treatment sessions and the 
remaining 6% at least 11 treatment sessions, attendance was high. In addition, the 
patients who withdrew before the start of the treatment evidently attended none 
of the treatment sessions, and the three patients that dropped out during 
treatment attended on average three treatment sessions. The judgm ent of the 
therapists about the level of patients' adherence to the treatment protocol and 
homework assignments in a subgroup of patients (47%) also showed a relatively 
high to very high adherence for at least 80% of the treated patients.
Measures
Sociodem oaraphic variables
Sociodem ographic variables were assessed with a general checklist, inquiring after 
the patient's gender, age, marital status, education and medical history.
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Figure 2 Overview of the treatment targets of the pain-avoidance and 
pain-persistence treatments
Changing pain-avoidance mechanisms:
>  Increasing daily activities
>  Reduction of pain-avoidance 
behaviors, pain-behavior, and fear 
of pain
>  Increasing the physical condition
Changing pain-persistence mechanisms:
>  Regulating and increasing daily 
activities
>  Increasing activity pacing and 
changing pain-persistence cognitions
>  Increasing the physical condition
Cognitive behavioral factors
Pain-avoidance behavior was assessed with the 5-item Resting scale of the Pain 
Coping Inventory (PCI), reflecting pain-avoidance behavior when coping with 
pain.35 This scale also served as the screening instrument to distinguish between 
patients with pain-avoidance and those with pain-persistence patterns. Activity  
pacing  was assessed with the 6-item Pacing scale of the Chronic Pain Coping 
Inventory (CPCI), which assesses the use of activity pacing, such as taking breaks, 
slowing down, and breaking up tasks into manageable components.39 Response 
categories were slightly modified to 4-point Likert scales ranging from "rarely or 
never" to "very frequently". Pain-related retreating was assessed with the 7-item 
Retreating scale of the PCI, reflecting behavioral tendencies to avoid environmental 
stimuli. Worrying about pain  was assessed with the 9-item Worrying scale of the 
PCI, reflecting catastrophic cognitions about pain. Hypervigilance was assessed 
with the Pain Vigilance and Awareness Questionnaire (PVAQ), a 16-item measure 
of attention to pain.40 Fear of pain  was measured with the 13-item Tampa Scale of 
Kinesiophobia (TSK), which determines fear of increasing pain and (re)injury 
following physical activity.41 Social reinforcement was assessed with the 6-item 
Solicitous Responses scale of the Multidimensional Pain Inventory (MPI), which 
measures concerned reactions of significant others when the respondent is in 
pain,42Helplessness was assessed with the 6-item Helplessness scale of the Illness 
Cognitions Questionnaire (ICQ), which evaluates the tendency to focus on the 
adverse aspects of the condition and to generalize them to one's daily functioning.43 
Acceptance was assessed with the 6-item Acceptance scale of the ICQ, reflecting 
the tendency to recognize the need to adapt to a chronic condition while
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perceiving the ability to tolerate and manage its adverse consequences. Perceived 
support was assessed using the 5-item Perceived Support scale of the Impact 
Rheumatic Diseases on General Health and Lifestyle (IRGL), reflecting the 
availability of emotional and instrumental support.3344 The IRGL is derived from 
the Arthritis Impact Measurement Scales (AIMS) and assesses physical, 
psychological and social health in patients with rheumatic diseases, including FM.45 
Physical and psychological functioning
Physical functioning was determined based on a standardized composite score of 
pain, fatigue, and functional disability. Pain was assessed using the 6-item Pain 
scale of the IRGL. Fatigue over the previous two weeks was assessed with the
8-item Fatigue scale of the Checklist Individual Strength (CIS).4647 Functional 
disability was assessed using the 7-item Mobility scale of the IRGL. A higher score 
on this scale indicates a lower level of functional disability. Psychological 
functioning  was determined based on the standardized composite score of 
negative mood and anxiety, as assessed with the 6-item Negative Mood Scale and 
the 10-item Anxiety scale of the IRGL. All questionnaires had been used in previous 
FM studies, where they showed good reliability and validity.
Statistical analyses
Differences between subgroups were tested with chi-square analyses for 
categorical data and with Student's f-test for continuous variables with a 
significance level of p < .05 (two-tailed). Treatment effects were evaluated for the 
PA and the PP separately using a linear mixed model, taking into account the 
specific design features of this trial. For each of the ten cognitive behavioral 
factors, the post- and follow-up-assessments were used as dependent variables, 
and condition, baseline assessment of the cognitive behavioral factor and time as 
independent variables in the primary analyses. Random effects were added for 
randomization groups and an unstructured covariance matrix was used to model 
the dependence of the two post-treatment measurements. Secondary analyses 
contained time by treatment interactions to test for a stable treatment effect over 
the post- and follow-up measurements. All analyses were performed using the 
Intention To Treat (ITT) principle. Although much effort has been invested in 
obtaining all possible measurements (for example in patients who developed 
comorbidity during the trial), some missing values did occur. Data sets for the 
cognitive behavioral variables were complete for 89% of the total sample of 158 
patients and for 97% of the 137 completers. Since we used a mixed model and 
missing values only occurred on the dependent variables, our present analyses
174
Cognitive behavioral mechanisms in a pain-avoidance and a pain-persistence treatment
can only be guaranteed to be valid when missing values occurred as Missing At 
Random (MAR). Therefore, we also performed an analysis using Last Observation 
Carried Forward (LOCF) as a sensitivity analysis.
Mediation analyses were performed to examine the potential mediating role 
of pain-avoidance behavior in the PA and activity pacing in the PP. Mediation was 
examined by the joint significance test according to the procedures proposed by 
MacKinnon, which was shown to outperform other mediation tests with regard to 
Type 1 error and statistical power.4849 This test requires that the path from 
condition to mediator and the path from mediator to outcome to be both 
statistically significant in order to provide evidence for a mediation effect. 
Therefore, the effect of treatment on the mediators between pre- and post-as- 
sessment was first examined with mixed regression by using the post-treatment 
scores of the mediators as dependent variables and condition and baseline 
assessment of the mediator as independent variables. Random effects were added 
for randomization groups. Second, we tested the effect of the mediator on the 
primary outcomes of physical (standardized composite score of pain, fatigue, 
functional disability) and psychological functioning (standardized composite 
score of anxiety and negative mood) adjusted for treatment, by using the 
post-treatment scores of the outcome as dependent variable and condition, 
baseline assessments of the outcome and mediator as independent variables, and 
by adding the mediator as a within-subject covariate. The joint significance of the 
association between treatment and mediator, and the association between the 
mediator and outcome adjusted for treatment, provides evidence for mediation.48,49
Results
Baseline comparisons and drop-out
Baseline comparisons of the pain-avoidance treatment condition (PA TC) with the 
pain-avoidance waiting list control condition (PA WLC) and the pain-persistence 
treatment condition (PPTC) with the pain-persistence waiting list control condition 
(PP WLC) revealed no significant differences with regard to their sociodemo­
graphic variables and the cognitive behavioral outcomes and the primary 
outcomes of physical and psychological functioning. With regard to the drop-outs, 
five patients withdrew shortly after the randomization due to treatment elsewhere 
(PA WLC n=2) or practical concerns (PATC n=1; PPTC n=1; PP WLC n=1). In addition, 
one patient (PP TC) was excluded due to psychiatric comorbidity that was
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discovered between the randomization and the first assessment. Between 
baseline (T1) and post-assessment (T2) seven patients dropped out. Reasons for 
dropping out were pregnancy (PA WLC n=1), newly acquired physical comorbidity 
(PA TC n=1), lack of sustained motivation to participate in the trial (PA TC n=2; PA 
WLC n=2), and treatment elsewhere (PP WLC n=1). Between post-assessment (T2) 
and follow-up (T3) eight patients dropped out. Reasons for dropping out during 
follow-up were lack of sustained motivation to participate in the trial (PA TC n=1; 
PA WLC n=1; PP TC n=2; PP WLC n=1), treatment elsewhere (PA WLC n=1), and 
newly acquired physical comorbidity (PA TC n=1; PP TC n=1) (Figure 1).
Outcomes for the pain-avoidance group
As expected, a significant effect of condition was found for pain-avoidance 
behavior (F (1,57.62) = 4.09, p < .05), the TC showed a 0.17 point lower post- and 
follow-up assessment score compared to the WLC. Furthermore, also for the 
cognitive behavioral factors of fear of pain (F (1,55.89) = 10.59, p < .01), activity 
pacing (F (1,10.20) = 20.17, p < .01), acceptance (F (1,58.41) = 22.35, p < .001), and 
social reinforcement (F (1,57.35) = 4.66, p < .05) a significant effect of condition 
was found, with the TC showing a post- and follow-up assessment score that was 
compared to the WLC 3.34 points lower for fear of pain, 0.47 points higher for 
activity pacing, 3.49 points higher for acceptance, and 0.43 points lower for social 
reinforcement. In addition, trends were found for worrying about pain (F (1,9.72) = 
4.76, p = .06) and for hypervigilance (F (1,8.69) = 4.66, p = .06), with the TC showing 
a respectively 0.30 and 4.13 point lower post-and follow-up assessment score 
compared to the WLC. No significant condition effects were found with regard to 
pain-related retreating, helplessness, and perceived social support. Furthermore, 
no significant Time x Condition interaction effects were found, indicating a stable 
effect between post- and follow-up assessment. The sensitivity analysis showed 
that the results of the analyses on the complete dataset obtained using the LOCF 
method were comparable to results presented above (Table 1).
Outcomes for the pain-persistence group
As expected, a significant effect of condition was found for activity pacing 
(F (1,76.00) = 17.87, p < .001), the TC showed a 0.42 point higher post-and follow-up 
assessment score compared to the WLC. Furthermore, also for the cognitive 
behavioral factors of worrying about pain (F (1,8.37) = 17.37, p < .01), fear of pain 
(F (1,75.53) = 14.31, p < .001), hypervigilance (F (1,9.01) = 6.90, p < .05), acceptance 
(F (1,74.84) = 23.66, p < .001), and helplessness (F (1,76.89) = 12.81, p < .001) a
176
Cognitive behavioral mechanisms in a pain-avoidance and a pain-persistence treatment
significant effect of condition was found, with the TC showing a post- and 
follow-up assessment score that was compared to the WLC 0.27 points lower for 
worrying about pain, 2.57 points lower for fear of pain, 4.03 points lower for 
hypervigilance, 2.71 points higher for acceptance, and 2.04 points lower for 
helplessness. In addition, a trend was found for perceived social support (F (1,9.75) 
= 4.50,p = .06), the TC showed a 1.27 point higher post-and follow-up assessment 
score compared to the WLC. No significant effects of condition were found with 
regard to pain-avoidance behavior, pain-related retreating, and social 
reinforcement. Furthermore, no significant Time x Condition interaction effects 
were found, indicating a stable effect between post- and follow-up assessment. 
The sensitivity analysis showed that the results of the analyses on the complete 
dataset obtained after using last observation carried forward were comparable to 
results presented above (Table 1).
Mediating cognitive behavioral factors
Mediation was examined with regard to the primary outcomes of physical and 
psychological functioning by the joint significance test.48 In an earlier report of 
this study it was shown that both the PA and the PP were effective in improving 
the primary outcomes of physical and psychological functioning.13 For the PA 
group, we analyzed the mediating effect of pain-avoidance behavior on 
functioning. First, a significant effect was found of condition on the mediator 
pain-avoidance behavior (F (1,59) = 4.91,p < .05). Second, results on the relationship 
between the mediator and physical and psychological functioning when 
controlling for treatment showed that pain-avoidance behavior was significantly 
related to physical functioning (F (1,56) = 6.20, p < .05), but not to psychological 
functioning. These results show that the effect of the TC relative to the WLC on 
physical functioning but not on psychological functioning was mediated by 
pain-avoidance behavior in the PA group. For the PP group, we analyzed the 
mediating effect of activity pacing on physical and psychological functioning. 
First, the effect of condition on the mediator was examined. A significant effect 
was found of condition on the mediator activity pacing (F (1,77) = 17.44, p < .001). 
Second, results on the relationship between the mediator and physical and 
psychological functioning when controlling for treatment showed that activity 
pacing was significantly related to physical functioning (F (1,77) = 20.20, p < .001) 
and psychological functioning (F (1,76) = 5.06, p < .05), showing that the effect of 
theTC relative to the WLC on physical and psychological functioning was mediated 
by activity pacing in the PP group.
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Table 1 Mean (SD) and number of patients (n) for the cognitive behavioral 
factors in the treatment (TC) and the waiting list control condition 
(WLC) for the pain-avoidance (PA) and pain-persistence (PP) groups 
at baseline (T1), post-assessment (T2), and 6-month follow-up (T3)
T1 T2 T3
Pain-avoidance
behavior
PA TC
WLC
2.5 (0.5) n=28
2.5 (0.5) n=39
2.3 (0.4) n=24 
2.5 (0.4) n=38
2.3 (0.4) n=22 
2.5 (0.4) n=37
PP TC
WLC
2.1 (0.5) n=37
2.2 (0.5) n=42
2.2 (0.4) n=36
2.2 (0.5) n=42
2.1 (0.4) n=34
2.1 (0.5) n=41
Activity pacing PA TC
WLC
2.4 (0.5) n=28
2.4 (0.5) n=39
2.8 (0.5) n=24 
2.3 (0.5) n=39
2.7 (0.3) n=23 
2.3 (0.6) n=37
PP TC
WLC
2.1 (0.5) n=37
2.2 (0.5) n=42
2.6 (0.6) n=36 
2.2 (0.5) n=42
2.5 (0.6) n=33 
2.1 (0.6) n=42
Pain-related
retreating
PA TC
WLC
2.3 (0.4) n=28 
2.1 (0.5) n=39
2.2 (0.5) n=24
2.2 (0.5) n=38
2.2 (0.5) n=22 
2.1 (0.5) n=37
PP TC
WLC
1.9 (0.4) n=37 
1.8 (0.5) n=42
1.8 (0.3) n=36
1.8 (0.5) n=42
1.8 (0.4) n=34
1.8 (0.6) n=41
Worrying about pain PA TC
WLC
2.4 (0.5) n=28 
2.3 (0.6) n=39
1.8 (0.6) n=24 
2.2 (0.6) n=38
1.9 (0.6) n=22 
2.2 (0.6) n=37
PP TC
WLC
2.1 (0.5) n=37
2.1 (0.5) n=42
1.7 (0.3) n=36 
2.0 (0.4) n=42
1.7 (0.3) n=34 
1.9 (0.5) n=41
Fear of pain PA TC
WLC
28.5 (6.8) n=28 
28.0 (7.0) n=39
22.3 (5.3) n=24 
26.1 (5.7) n=38
24.3 (6.5) n=23 
26.1 (7.4) n=36
PP TC
WLC
23.3 (5.9) n=37 
24.0 (5.8) n=43
20.7 (5.0) n=36 
23.5 (6.0) n=41
20.5 (5.7) n=34 
24.0 (5.2) n=41
Hypervigilance PA TC
WLC
39.8 (9.2) n=28 
38.1 (11.6) n=39
30.7 (9.0) n=24 
36.2 (10.9) n=38
31.5 (11.3) n=23 
33.9 (9.4) n=36
PP TC
WLC
31.1 (9.1) n=37 
33.6 (10.5) n=43
27.3 (8.3) n=36 
32.6 (11.4) n=41
26.1 (8.8) n=34 
32.9 (12.1) n=42
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Table 1 Continued
T1 T2 T3
Social reinforcem ent PA TC 3.0 (1.2) n=28 2.5 (1.1) n=25 2.4 (1.4) n=22
WLC 3.2 (1.3) n=38 3.2 (1.3) n=40 3.1 (1.2) n=35
PP TC 2.7 (1.3) n= 37 2.7 (1.3) n=35 2.6 (1.2) n=33
WLC 2.5 (1.3) n=43 2.4 (1.4) n=40 2.6 (1.1) n=41
Acceptance PA TC 11.0(3.2) n=28 16.5 (4.6) n=25 16.0 (4.1) n=23
WLC 11.5 (3.1) n=39 12.1 (3.5) n=40 12.4 (3.8) n=36
PP TC 13.1 (3.8) n=36 16.3 (3.5) n=36 16.5 (3.5) n=34
WLC 12.8 (3.5) n=43 13.4(3.3) n=41 13.3 (3.8) n=42
Helplessness PA TC 16.9 (3.5) n=28 13.0(4.0) n=25 12.2 (3.8) n=23
WLC 16.6 (3.9) n=39 15.8 (3.7) n=40 15.7 (4.4) n=36
PP TC 14.4(3.8) n=36 11.3 (2.9) n=36 11.1 (3.1) n=34
WLC 13.4 (2.9) n=43 12.6(3.3) n=41 13.0 (3.4) n=42
Perceived social PA TC 13.1 (4.1) n=28 14.0 (3.7) n=25 14.0 (3.6) n=23
support WLC 12.8 (3.4) n=38 13.7 (3.8) n=40 13.3 (4.0) n=37
PP TC 14.4 (3.5) n=37 15.2 (3.8) n=35 15.2 (3.7) n=33
WLC 13.4(4.1) n=43 13.1 (3.4) n=41 13.2 (3.3) n=41
Discussion
In the present study we examined the effectiveness of a pain-avoidance (PA) 
treatment and a pain-persistence (PP) treatment for FM patients with regard to 
specific pain-related cognitive behavioral factors. In line with our hypothesis, 
relatively to the results of the waiting list control condition, the PA treatment was 
effective in changing pain-avoidance behavior and the PP treatment showed a 
significant condition effect with regard to activity pacing. In addition, our 
mediation analyses showed that changes in physical functioning were mediated 
by pain-avoidance behavior in the PA treatment and changes in physical and 
psychological functioning were mediated by activity pacing in the PP treatment, 
providing some preliminary support that these mechanisms partially account for
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the treatment effects obtained. With regard to the other cognitive behavioral 
factors, a significant effect was found in the PA treatment for social reinforcement 
and in the PP treatment with regard to worrying about pain, hypervigilance, and 
helplessness, while both treatments were effective in improving fear of pain and 
acceptance.
The PA and PP treatments evaluated in this study were based on specific 
pain-related cognitive behavioral mechanisms that have been shown to be 
important in the maintenance and exacerbation of chronic pain.1718 23'25 Preliminary 
evidence suggests that tailoring treatment to these maladaptive cognitive 
behavioral factors may be promising. Exposure in vivo, for example, a pain- 
avoidance approach aimed at improving functioning by diminishing fear of pain, 
was found to be particularly effective in highly fearful patients with chronic low 
back pain.26 Thieme and colleagues10 found that the FM patients that benefited 
from a pain-avoidance intervention aimed at increasing daily activities and 
diminishing fear of pain had higher baseline levels of pain behavior, social 
reinforcement, and catastrophizing than the patients who reported no change, 
while the patients who benefited from a pain-persistence treatment aimed at 
pacing activities and changing high self-demands had lower baseline levels of 
pain behavior and social reinforcement than those reporting no change. 
Accordingly, patients exhibiting pain-avoidance patterns appear to benefit most 
from interventions aimed at diminishing their pain-avoidance behavior and 
increasing their daily activities, whereas for patients showing pain-persistence 
patterns regulating their daily activities and restructuring of their pain-persistence 
cognitions seems more favorable.91028 In extending these findings, we offered 
patients a pain-avoidance or a pain-persistence treatment tailored to their 
cognitive behavioral pattern, with the PA treatment specifically being aimed at 
increasing daily activities and diminishing pain-avoidance behaviors, while the PP 
treatment specifically focused on regulating daily activities by teaching 
participants to pace their activities followed by gradually increasing them. Our 
results provide preliminary evidence that the PA and the PP treatments are 
effective in improving pain-avoidance behaviors and activity pacing, respectively, 
and that improvements in functioning are mediated by a decrease in pain- 
avoidance behaviors in the PA and by an improvement in activity pacing in the PP. 
In addition to previous studies in which we showed significant differences 
between patients with pain-avoidance and pain-persistence patterns with regard 
to several pain-related cognitive behavioral factors and the level of physical 
fitness36 and the relatively large effects of both treatments on the primary
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outcomes of physical and psychological functioning and the impact of FM,13 these 
results suggest that these specific mechanisms are indeed relevant and might 
justify separate approaches. In addition, the PA was also effective in improving 
other cognitive behavioral factors associated with pain-avoidance patterns, such 
as fear of pain, social reinforcement, worrying about pain and hypervigilance, 
providing some preliminary support for the importance of these factors in 
pain-avoidance patterns. However, both the PA and the PP interventions showed 
significant effects with regard to several cognitive behavioral factors, such as 
activity pacing, fear of pain and acceptance, indicating that both treatments also 
consist of generic treatment components. For example, in the PP treatment the 
programme was also dedicated to achieving a gradual increase in physical activity 
and decreasing fear of pain. In addition, the patients in the PA treatment learned 
to increase their daily activities, but activity pacing (balancing activity and 
inactivity) was also addressed. When studying the possible mediating effects of 
these generic factors in post-hoc analyses, results indeed showed that activity 
pacing also mediated changes in physical functioning in the PA treatment. These 
findings overall support the role of both generic and specific cognitive behavioral 
mechanisms that are responsible for the beneficial treatment effects. Future 
research might consequently focus on the specific working mechanisms of 
pain-avoidance and pain-persistence treatments in addition to the factors of 
pain-avoidance behaviors and activity pacing.
Our study is the first to specifically address PA and PP patterns in FM. 
Nevertheless, relevant questions about the two cognitive behavioral patterns 
remain. In a previous study we reported preliminary evidence of distinctive 
differences between these patterns, i.e. self-reported pain-avoidance and pain- 
persistence factors, physical fitness levels, and therapist judgm ent after a semi­
structured interview.36 However, prospective and experimental studies are clearly 
required to investigate these patterns in more detail. For example, in line with 
previous findings,1820 we found the patients with a pain-persistence pattern to 
report fewer and less severe complaints (including functional disability) than the 
patients with a pain-avoidance pattern, suggesting that the former pattern might 
be less maladaptive, at least in early stages of the condition. In this context it is 
important to underlinethatwe only enrolled patients reporting heightened levels 
of distress in whom the cognitive behavioral patterns had already shown to be 
maladaptive. The adverse effects of the cognitive behavioral patterns were 
supported by the fact that the pain-avoidance as well as the pain-persistence 
group reported more (serious) complaints than the patients we had assessed as
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not being at risk.13 Preliminary evidence also pointed to pain-persistence patterns 
as a risk factor for the development and maintenance of chronic pain.23 
Nevertheless, additional research is needed to further clarify the short- and 
long-term as well as the adaptive and maladaptive consequences of these two 
cognitive behavioral patterns in high- and low-risk patients. Also the stability of 
these patterns merits further investigation because it is plausible that some 
patients might change strategies at some stages. It has, for instance, been 
proposed that pain-persistence patterns might be particularly relevant in the 
earlier acute phase of the condition, which would then eventually lead to 
exhaustion and subsequent pain-avoidance behavior in the long-term when 
chronicity has set in.22 Finally, we need to learn more about the motivational 
mechanisms underlying pain-persistence patterns, such as pain-related fear of 
failure, low self-esteem, personality characteristics like perfectionism, and specific 
stop rules.2022
Some drawbacks of this study need mentioning. Ourtrial is, of course, limited 
in that we did not directly test whether our tailored interventions were more 
effective in improving cognitive behavioral mechanisms than a standard, 
non-tailored treatment. Secondly, we used cross-sectional data for our mediator 
analyses and therefore causality may be bidirectional. For example, augmented 
functioning might have elicited changes in pain-avoidance behavior. To establish 
whether changes in cognitive behavioral factors occur before or after changes in 
functioning, future studies might add several mid-treatment assessments or use 
cross-lagged analyses. Finally, next to self-reported instruments, there is a need 
for behavioral measures, like activity levels (actometer), to assess more objectively 
and accurately specific pain-avoidance and pain-persistence characteristics and 
to clarify the mechanisms of pain-avoidance behaviors and activity pacing during 
treatment.
In conclusion, the present study shows that a pain-avoidance and a pain- 
persistence treatment tailored to the patient's main cognitive behavioral pattern 
is effective in improving pain-avoidance behavior and activity pacing, 
respectively, and these factors in turn mediate the beneficial health outcomes 
of these treatments in FM. Future research should aim at further investigating 
specific cognitive behavioral mechanisms in pain-avoidance and pain-persistence 
treatments and their independent and common contribution to long-term 
treatment effects.
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Summary
Fibromyalgia is a highly prevalent musculoskeletal pain syndrome with limited 
biomedical evidence. In addition to chronic widespread pain, patients frequently 
report accompanying complaints, such as functional disability, fatigue, morning 
stiffness, sleep disturbances and psychological distress. Biopsychosocial models 
have proposed several factors that may account for the development, maintenance 
and exacerbation of the various symptoms reported. In the treatment of 
fibromyalgia, combined interventions consisting of cognitive behavioral therapy 
(CBT) and physical exercise training that are based on these biopsychosocial 
models have so far yielded the most promising outcomes, but overall effects are 
still modest and show large individual variability. In line with reports on various 
other chronic pain conditions, recent findings in fibromyalgia research suggest 
that the effective ness of interventions can be improved by taking the heterogeneity 
of the patients suffering from the condition into consideration. The main aim of 
the combined studies reported in this thesis, hence was to explore patient 
screening methods and to subsequently test interventions that are tailored to 
specific maladaptive cognitive behavioral patterns in patients with fibromyalgia.
After the introduction (Chapter 1), in Part I of this thesis (Chapter 2) the 
theoretical background, state of the art and future directions of CBT and exercise 
training in the treatment of fibromyalgia were discussed. Part II (Chapters 3 and 4) 
described the screening procedure for fibromyalgia patients to select patients for 
the tailored treatment approaches. It was our aim to gain a further understanding 
of specific risk profiles by looking at differences in the level of psychological 
distress and two distinct cognitive behavioral patterns: a pain-avoidance versus a 
pain-persistence pattern. In Part III (Chapters 5 to 9) we report on the results of 
the studies in which we examined the effectiveness of our tailored CBT and 
exercise training programmes delivered at a relatively early stage after the 
diagnosis in high-risk patients. In the present chapter the overall findings are 
summarized separately for the various sections.
Part I: Theoretical and empirical background of treatment in fibromyalgia
Chapter 2 comprised a review of the evidence on non-pharmacological 
interventions for fibromyalgia, including CBT, exercise training, and combinations 
of the two. Thirty studies meeting the terms of a randomized, controlled study 
design that were published before January 2006 were evaluated. In line with 
earlier reviews, we found combinations of CBT and exercise training to yield the
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most promising results, although, overall, effects were limited and positive 
outcomes frequently diminished in the long-term. The outcomes obtained, 
moreover, showed considerable individual variation underscoring the notion that 
not all patients will show the same response to the same treatment. This disparity 
is likely to be related to the variability in the condition as well as the heterogeneity 
of the patient population. In general, all patients diagnosed with fibromyalgia 
are currently treated with a rather similar set of widely accepted interventions, 
which, because of this lack in uniformity in symptoms and patient characteristics, 
may lead to high drop-out rates and small overall effects. Based on the 
preliminary evidence of retrospective treatment analyses, and consistent with 
earlier recommendations, we hypothesized that the treatment efficacy could be 
enhanced by offering tailored treatments at an relatively early stage after 
diagnosis to those patients at high risk of developing chronic physical and 
psychological impairment.
Part II: Screening for tailored fibromyalgia treatment
For tailored interventions to be successful, a reliable and valid screening procedure 
to help identify specific patient subgroups at risk for long-term dysfunction is a 
prerequisite. Generally, two main indicators of a worse outcome have been 
indentified in fibromyalgia, i.e. levels of psychological distress and cognitive 
behavioral patterns. The aim of the study presented in Chapter 3 therefore was to 
explore the validity of a newly developed screening instrument to distinguish 
between patients characterized by cognitive behavioral patterns of pa in-avoidance 
and pain-persistence. Its validity was supported by the significant differences we 
obtained in the patients with a pain-avoidance and those with a pain-persistence 
pattern, with regard to several pain-related cognitive behavioral factors, level of 
physical fitness, as well as by a high correspondence (75-80%) with the judgments 
of a blinded therapist following an intake assessment. Although warranting 
replication, the findings suggest that a screening instrument based on a short 
self-report questionnaire suffices to reliably discriminate patients with dissimilar 
cognitive behavioral patterns for tailored treatment, making it suitable for use in 
clinical practice.
In addition to screening for cognitive behavioral patterns, we also selected 
high-risk patients with heightened levels of psychological distress for treatment 
as there is preliminary evidence that this subgroup is at higher risk of exacerbation 
and long-term dysfunction. At the same time, it is relevant to identify possible risk 
factors for a maladaptive course in the patients currently reporting low levels of
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distress, given that these patients are rarely considered for multidisciplinary 
interventions. The study described in Chapter 4 accordingly served to identify 
factors predicting increases in psychological distress in this relatively well-func- 
tioning subgroup. We found specific illness cognitions as well as various 
pain-avoidance and social factors to be associated with changes in distress several 
months later, with a higher level of distress being predicted by higher levels of 
hypervigilance and lower levels of acceptance and perceived social support. 
These results suggest that these prognostic factors may be suitable for use in 
clinical practice to help identify these high-risk patients at an early stage and to 
thus possibly prevent longer-term dysfunction by offering them a prompt and 
targeted treatment.
Part III: Tailoring treatment of fibromyalgia
In the development of a treatment it is important to also test the feasibility and 
the possible potential in single cases. In Chapter 5 two case studies and the 
accompanying treatment protocols of the pain-avoidance and pain-persistence 
treatment were presented. The treatment courses for a patient with a pain- 
avoidance pattern and a patient with a pain-persistence pattern were described 
in detail to illustrate the content and progress achieved of the two tailored 
treatments. Both interventions were group treatments, each with about eight 
participants, consisting of CBT and exercise training scheduled twice a week and 
one follow-up session three months after treatment completion. The pain- 
avoidance treatment was aimed at increasing the patients' level of daily activities 
and diminishing the pain-avoidance behavior by encouraging participants to 
gradually and systematically increase their daily activities with individual goals 
and exposure to fear-related situations as the guiding principle. The pain-persis- 
tence treatment was aimed at diminishing the participants' pain-persistence 
behavior by helping them to pace their activities and to alternate between activity 
and inactivity, followed by gradually increasing their daily activities and to thus 
optimize overall functioning and well-being. Comparison of the pre-test, post­
test and 6-month follow-up scores for pain, functional disability, fatigue and 
psychological distress showed clinically significant improvements for both 
patients, while two physical fitness tests also showed an improved performance. 
Based on these positive results, it was concluded that our tailored CBT and exercise 
training programs were feasible and had potential to generate clinically significant 
improvements in high-risk patients with fibromyalgia.
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In clinical research and practice the patient's perspective has gained in 
importance and is increasingly applied as an indicator of treatment value, quality, 
and outcome. However, the relationship between the patient's view on treatment 
progress and standardized pre-post changes in health outcomes is not well 
understood. Therefore, in Chapter 6, we explored the patient's perspective with 
regard to the treatment outcome and compared these findings with pre-post 
changes in physical and psychological functioning using validated self-report 
measures. Correlations between the outcomes from the patient's perspective and 
the pre-post changes on the physical outcomes of pain, fatigue, and functional 
disability ranged from moderate to relatively high, while the correlations between 
the outcomes from the patient's perspective and pre-post changes in psychological 
outcomes of anxiety and negative mood were small or non-significant. 
These results thus suggested that the patient's perception of treatment gain 
and the pre-post changes in outcomes assess different aspects of the treatment 
progress.
In Chapter 7 we tested the effectiveness of our two tailored interventions in 
patients we enrolled in a relatively early stage after their fibromyalgia diagnosis. 
High-risk patients with heightened levels of distress were selected and randomized 
to a waiting list control condition or a treatment condition tailored to their specific 
pain-avoidance or pain-persistence pattern. We assessed the primary outcome 
measures of physical functioning (pain,fatigue, functional disability), psychological 
functioning (anxiety, negative mood), as well as the overall impact of fibromyalgia 
on daily life prior to and after completion of the treatment, and again at 6 month 
follow-up. Relative to the patients in the control condition, the patients in the 
treatment condition showed improved physical and psychological functioning. 
More specifically, pain, fatigue, functional disability, negative mood, anxiety, and 
impact of fibromyalgia on daily life had all significantly reduced and these results 
were maintained at follow-up. No differences were found between the 
pain-avoidance and the pain-persistence group. The clinical relevance of the 
results was assessed with effect sizes and the percentage responders in both 
conditions. Both the post-treatment and the follow-up effects sizes for the treated 
patients were overall large and the percentage responders was larger in the 
treatment conditions compared to the control condition, suggesting clinically 
relevant changes.
In Chapter 8 we evaluated the efficacy of our approach with regard to the 
patients' level of physical fitness. Performance results showed that following 
treatment, the level of physical fitness had significantly improved with large effect
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sizes, compared to the performance of the patients in the waiting list control 
condition. Furthermore, the treated patients reported significantly less perceived 
exertion after physical activity than the controls.
Finally, in Chapter 9, we studied the effects of our two interventions tailored 
to the patient's pain-avoidance and pain-persistence patterns with regard to 
several pain-related cognitive behavioral factors to provide insight in the working 
mechanisms of these treatments. We looked specifically at the effect of the 
pain-avoidance treatment on pain-avoidance behavior and of the pain-persis- 
tence treatment on activity pacing as the main proposed cognitive behavioral 
mechanisms of these patient patterns. The pain-avoidance treatment was effective 
in diminishing pain-avoidance behavior and the pain-persistence treatment in 
improving activity pacing. Our subsequent mediation analyses yielded support 
for a mediating effect of pain-avoidance behavior in the pain-avoidance treatment 
and activity pacing in the pain-persistence treatment. These results show that a 
pain-avoidance and a pain-persistence treatment tailored to the patient's main 
cognitive behavioral pattern is effective in improving pain-avoidance behavior 
and activity pacing, respectively, and these factors in turn mediate the beneficial 
health outcomes of these treatments in fibromyalgia.
In conclusion, the studies described in this thesis demonstrate that a 
systematic screening and multidisciplinary treatment consisting of CBT and 
exercise training tailored to the patients' cognitive behavioral patterns is effective 
in improving short- and long-term physical and psychological functioning in 
high-risk fibromyalgia patients. These findings indicate tailoring treatment is 
likely to promote beneficial outcomes in fibromyalgia and reduce the burden for 
patients and society. Future research should aim at investigating the long-term 
(cost-)effectiveness of this treatment and the specific cognitive behavioral 
mechanisms responsible for the treatment effects.
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General discussion
The treatment of patients with fibromyalgia poses a great challenge to clinicians 
due to the modest effects of current therapies. The studies in this thesis 
consequently focused on the research question how to optimize treatment effects 
in patients with fibromyalgia. In view of the large individual variability in outcomes 
and preliminary beneficial results of more targeted approaches, we tested the 
idea that the effectiveness of interventions may be considerably improved by 
taking the heterogeneity of the patient population into consideration. For this 
purpose, we explored the possibilities of a targeted screening procedure for the 
selection of distinct subgroups and treatment interventions tailored to patient 
characteristics for fibromyalgia patients in various studies. After having reviewed 
the theoretical background, current insights and practices and future directions 
for cognitive behavioral therapy (CBT) and exercise training in the treatment of 
fibromyalgia in Part I (Chapter 2), a stepwise screening method to select 
fibromyalgia patients for a tailored treatment was tested to gain a deeper 
understanding of possible patient types in terms of level of psychological distress 
and distinct cognitive behavioral patterns of pain-avoidance and pain-persistence 
within a high-distress group in Part II (Chapter 3 and 4). Part III (Chapters 5 to 9) 
described the results of the ensuing studies conducted to examine the 
effectiveness of our tailored interventions consisting of CBT and exercise training 
for high-risk fibromyalgia patients delivered at a relatively early stage after the 
diagnosis. In chapter 10, the overall findings were summarized separately for 
the various sections. In this final chapter, the results of these studies are 
discussed and put into context with regard to the main question of how to 
optimize treatment effects in fibromyalgia patients. The chapter concludes with 
additional recommendations for future research, clinical implications and overall 
conclusions.
Optimizing the treatment of fibromyalgia
Selecting patients for cognitive behavioral treatment in fibromyalgia
One way to augment current treatment effects is by gaining a better understanding 
of those patients who obtain the better treatment outcomes. Within the 
heterogeneous fibromyalgia patient population specific patient subgroups can 
be identified.12 Overall, patients characterized by relatively high levels of distress 
have been shown to have better treatment outcomes and selecting these patients
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for multidisciplinary targeted therapies may optimize treatment effectiveness.3'5 
Several studies have pinpointed heightened distress as an important risk factor 
predicting a negative long-term outcome.6,7 Moreover, distress has been shown to 
be indicative of maladaptive cognitive behavioral patterns that are in turn 
predictive for a worse long-term outcome in chronic pain patients, including 
fibromyalgia.3,8'9 In our studies, we identified high-risk patients with heightened 
distress levels by means of a screening instrument evaluating the level of negative 
mood and anxiety. In line with previous findings,36'9 we found that patients 
characterized by heightened levels of distress also had elevated negative scores 
on health outcomes regarding pain, fatigue, functional disability and impact of 
fibromyalgia on daily life (Chapter 7) compared to the patients with lower levels of 
distress. In addition, with regard to various cognitive behavioral factors high-risk 
patients scored significantly higher on pain-avoidance behavior, worrying about 
pain, pain-related retreating, fear of pain, and helplessness, and had lower scores 
on perceived social support, activity pacing and acceptance compared to the 
lower distressed patients (Chapter 9). These results suggest that screening for 
psychological distress helps identifying patients with a higher risk of exacerbation 
and long-term dysfunctioning. Our screening protocol offers additional practical 
advantages, because besides its ease of use, the assessment of psychological 
distress can be conducted with reliable and validated instruments already 
frequently used in clinical practice. However, we need more insight into the level 
of psychological distress and related risk factors during the course of the condition. 
In a longitudinal study (Chapter 4), for example, we followed the relatively well- 
functioning low -distress’ group that was not selected for treatment for several 
months and documented a number of prognostic factors, including a high level of 
hypervigilance, lack of acceptance and less perceived social support. These latter 
factors may facilitate an early identification of well-functioning patients with a 
higher risk of aggravated, longer-term distress.
In addition to the selection of high-risk fibromyalgia patients to augment 
treatment effects, we selected patients with a relatively recent diagnosis of 
fibromyalgia as it is increasingly recognized that an early intervention is vital for 
patients with an increased risk of developing chronic pain and pain-related 
problems.810'14 Since many patients have been suffering complaints for several 
years before fibromyalgia is diagnosed an early intervention is more or less 
arbitrary. The patients were enrolled in our trial within five years of receiving the 
diagnosisandthem eandurationofcom plaintswasabouteightyears. Nevertheless, 
post-hoc moderator analyses of overall treatment effects in the randomized.
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controlled trial revealed that psychological functioning had improved more in the 
patients with the more brief durations of complaints, underscoring the importance 
of a timely intervention. Fortunately, fibromyalgia is increasingly recognized 
nowadays and patients are being diagnosed at an earlier stage after the onset of 
the complaints, which will hopefully facilitate early intervention and enhance 
treatment efficacy.
Screening for differential cognitive behavioral patterns
In order to optimize treatment effects in patients with fibromyalgia it is important 
to unravel the cognitive behavioral mechanisms that account for the development, 
maintenance and exacerbation of health outcomes in chronic pain populations. 
When these factors are identified, treatment can be specifically customized to 
these mechanisms to augment treatment gains.
There is wide theoretical and empirical evidence for the relevance of the 
cognitive behavioral factors described in fear-avoidance models, including 
pain-avoidance behaviors, fear of pain, hypervigilance, worrying about pain, and 
social reinforcement.15 The studies reported in earlier chapters of this thesis 
underscored the relevance of these constructs. We found that patients who 
exhibited a pain-avoidance pattern, for instance, retreated more when in pain, 
worried more about their pain, paid more attention to pain sensations, were more 
fearful that any motor activity would cause (more) pain, and reported more that 
their social environment reinforced their avoidant behavior than was the case in 
patients that did not present with a pain-avoidance pattern (Chapter 3, 5 and 9). 
The results we obtained with physical tests (Chapter 3, 5 and 8) yielded additional 
support that long-lasting pain-avoidance behavior can seriously compromise the 
physical condition of fibromyalgia patients. In our longitudinal study (Chapter 4) 
we were further able to identify higher levels of hypervigilance as a prognostic 
factor predicting elevated psychological distress in relatively well-functioning 
fibromyalgia patients. In addition to the validation of pain-avoidance patterns, we 
found preliminary evidence of a distinct cognitive behavioral pattern that is 
characterized by relatively low levels of pain-avoidance behavior and activity 
pacing, persistence-related self-statements as well as a tendency to ignore 
pain-related signals. We found that patients with such a pain-persistence pattern 
tended to have higher scores on persistence-related self-statements and 
proneness to ignore pain than the patients with a pain-avoidance pattern (Chapter 
3). The distinction in these two different patterns is of special interest, since 
previous studies suggest that fibromyalgia patients who are characterized by a
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pain-avoidance or a pain-persistence cognitive behavioral pattern benefit from 
different treatment approaches.9
In our trial, we used a concise self-report screening instrument of pain- 
avoidance behavior in the second step of our screening protocol to discriminate 
between high-risk patients with a pain-avoidance and those with a pain- 
persistence pattern, as reflected by a score below and above the cut-off, 
respectively. The cut-off score was based on the mean score obtained in several 
chronic pain populations16 and corresponded to the median and means found in 
our samples (Chapter 3). Support of the validity of this screening instrument was 
further shown by the significant differences between patients with pain- 
avoidance and pain-persistence patterns with regard to several pain-related 
cognitive behavioral factors, level of physical fitness, and the consistency with the 
interview-based therapist judgm ents (Chapter 3).
Effects o f tailored treatment in fibromyalgia
In line with preliminary evidence for the selection of specific subgroups of patients 
with fibromyalgia that may benefit most from multidisciplinary treatment, we 
selected high-risk patients with current heightened levels of psychological 
distress for treatment in a relatively early stage after diagnosis. Given that our 
review of the evidence on non-pharmacological interventions for fibromyalgia 
showed that combinations of CBT and exercise training yielded the most promising 
results (Chapter 2), we offered these high-risk patients intensive multidisciplinary 
group interventions comprising CBT and exercise training tailored to the patients' 
pain-avoidance or pain-persistence patterns. With regard to the treatment 
efficacy, the feasibility and potential to generate clinically significant effects of 
our tailored treatment interventions were demonstrated in two case-studies. The 
results of our randomized, controlled trial showed that the tailored treatment 
approach was effective in improving the patients' physical and psychological 
functioning, the impact of fibromyalgia on their daily lives and the level of physical 
fitness. Whereas previous meta-analyses and recent studies of non-tailored 
interventions in chronic pain conditions had generated moderate effects,17'19 our 
overall effect sizes were relatively large and had been maintained during the 
6-month follow-up. Furthermore, the attrition rates in our study were relatively 
low compared to previous intervention studies in fibromyalgia. Finally, preliminary 
evidence was found that the supposed working mechanisms of pain-avoidance 
and pain-persistence treatments, namely avoidance behavior and activity pacing, 
mediated the tailored treatments effects. Given these favorable results, we
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tentatively conclude that tailored interventions in fibromyalgia are preferable to 
non-tailored treatment. The first results of an implementation project also show 
that both the screening protocol and tailored treatments are feasible for 
implementation in clinical practice, providing preliminary evidence for the 
external validity of these treatments.
Mediators o f tailored treatment in fibromyalgia
In order to foster targeted treatments for patients with fibromyalgia, the working 
mechanisms of this treatment and other approaches need to be better understood. 
The pain-avoidance treatment aims at increasing the level or intensity of daily 
activities and diminishing the pain-avoidance behavior, while the pain-persis- 
tence treatment focuses on regulating and pacing before increasing daily 
activities. In our studies that evaluate the effectiveness of a pain-avoidance and 
pain-persistence treatment with regard to cognitive behavioral mechanisms, we 
found significant treatment effects for the pain-avoidance treatment with regard 
to pain-avoidance behavior and other pain-avoidance related factors, such as fear 
of pain and social reinforcement (Chapter 9). We also found evidence to suggest 
that the improvements found with regard to physical functioning was mediated 
by pain-avoidance behavior, providing some preliminary support that 
pain-avoidance behavior is an important underlying mechanism to be targeted in 
a pain-avoidance treatment. With regard to the pain-persistence treatment, we 
found a significant treatment effect for activity pacing and further showed that 
the obtained treatment effects on physical and psychological functioning was 
mediated by activity pacing, suggesting that this is a relevant mediating 
mechanism for beneficial outcomes of a pain-persistence treatment. However, 
the two treatments also share some common elements. The patients in the 
pain-avoidance treatment, for example, primarily learned to increase their daily 
activities, but activity pacing was also addressed, while in the pain-persistence 
treatment patients were also encouraged to gradually increase exercise and 
activity levels which may reduce their fear of pain. Consequently, due to the 
overlap in the techniques and procedures of the two interventions there are also 
common mechanisms of change, such as an increased acceptance in both 
treatments. It is of interest to note that no significant differences were found 
between the two treatment groups with regard to treatment credibility, indicating 
that both treatments were perceived to be more or less equally credible by the 
participants.
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The patient's perspective o f tailored treatment in fibromyalgia
Since there is an increasing focus on the patient's perspective in clinical research, 
we also assessed the patient's perspective with respect to treatment gains and 
compared these outcomes with pre-post treatment effects as assessed by 
standardized self-report measures (Chapter 6). This comparison revealed a 
discrepancy, in particular with regard to psychological functioning. This may 
suggest that subjective outcomes that are not assessed with pre-post measures, 
such as outcomes emphasizing the subjective impact of fibromyalgia or other 
factors such as the patient-doctor relationship, are more important from the 
patient's point of view.2021 In addition, the pre-post change scores may have not 
been noticeable and hence not clinically meaningful for the patient. A change in 
how people perceive their health (response shift) may also account for the above 
mentioned discrepancy, as the internal standard of well-being may have shifted 
due to the patients' improved functioning during treatment which influenced 
their post-assessment scores.2223 Accordingly, the magnitude and significance of 
response mechanisms in interventions clearly merit further investigation, but 
research investigating clinical improvements in the interim future is best advised 
to consider the patient's perception of treatment gains as an independent and 
clinically relevant outcome, in addition to standardized pre-post assessments of 
health outcomes.
Limitations of the studies
Treatment effectiveness and mechanisms o f change
Although overall promising, the results of our studies still warrant careful 
consideration. Most importantly, we did not directly test whether our tailored 
approach was superior to a standard, non-tailored treatment. Moreover, 
comparisons with other trials with regard to the magnitude of effects are hindered 
by differences in intervention types, control groups and outcome measures. The 
efficacy of our tailored treatment approach hence needs to be substantiated by 
trials directly comparing the effects for high-risk and low-risk fibromyalgia 
patients and for patients with a recent diagnosis and those with longstanding 
diagnosis, as well as tailored versus non-tailored or mismatched treatments. Such 
comparative studies normally require large study samples, but single case studies 
may also suffice to clarify the research questions posed.2425 It should also be 
mentioned that physical and psychological functioning also improved in our 
waiting list control group, i.e. the high-risk patients awaiting treatment. Since no
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change or a deterioration of symptoms is usually observed in fibromyalgia in 
natural course studies and waiting list conditions are known to have beneficial 
effects,2627 the improved scores may be attributable to the patients' expectations 
of treatment and the intake interview in which all patients were informed about 
their prospective treatment. Furthermore, we did not systematically control for 
the effects of the patients' pharmacological regiments on their treatment 
outcomes. Although in fibromyalgia the combination of CBT and exercise training 
has been demonstrated to be more effective than merely pharmacological 
interventions, various studies showed that tricyclic antidepressants successfully 
reduced pain and sleep problems in various fibromyalgia cohorts.28 30 Although 
reducing the intake of pain medication was one of the formal treatment goals, 
patients in both conditions were permitted to continue their usual care in our 
study, including the use of antidepressant and pain medication. Future research 
should more directly aim at controlling for the potential effects of pharmacologi­
cal agents. Lastly, our two tailored treatments comprised of both CBT and exercise 
training with a broad range of evidence-based cognitive behavioral techniques. 
Therefore, it is not possible to pinpoint which specific components and working 
mechanisms of the CBT and/or exercise training are responsible for the treatment 
effects obtained.
Generalizability o f study samples
The studies described in this thesis applied data of different samples of 
fibromyalgia patients that were collected in the context of our research question 
on how to optimize treatment in fibromyalgia. For the studies described in Chapter 
3, we investigated the validity of our screening instrument to distinguish between 
pain-avoidance and pain-persistence patterns in a random sample that was 
obtained through the Dutch national fibromyalgia patient association and in a 
consecutive sample of patients who were selected to participate in the randomized, 
controlled trial and underwent an intake assessment. For the study described in 
Chapter 4, we asked a consecutive sample of low-risk patients who were excluded 
for participation in the randomized, controlled trial to fill in another self-report 
questionnaire after several months in order to get an indication of the long-term 
course of this specific group. For the relationship between the patient's perspective 
and pre-post treatment effects in patients who participated in the treatments 
(Chapter 6), we included the consecutive patients in the treatment groups, 
including patients from the waiting list control conditions that were offered 
treatment at the end of theirfollow-up assessment. In the Chapters 7 to 9, in which
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the effectiveness of the two tailored interventions was investigated, the data of 
the randomized trial patients were used. Overall, no sociodemographic differences 
were found between the specific samples used in the different studies presented 
in this thesis. Furthermore, sociodemographic variables and measures of physical 
and psychological functioning show that the recruited samples are comparable to 
other representative samples of the fibromyalgia patient population.31'35 However, 
several limitations with respect to the generalizability of the results can be 
mentioned. Because it was our goal to investigate the effect of our targeted 
approach in specific subgroups of fibromyalgia patients, we restricted our studies 
to high-risk patients with heightened levels of psychological distress who had 
been diagnosed with fibromyalgia for less than five years, while for example 
patients with severe physical and psychiatric comorbidities were excluded. These 
selection and inclusion criteria preclude a generalization of our findings for the 
entire fibromyalgia patient population. However, we were able to establish that 
our studies did not suffer from a selection bias as we did not find any significant 
differences in sociodemographic variables or physical and psychological 
functioning among the treatment completers and the patients that declined to 
participate and those that were excluded from participation or dropped out 
during the trial. Finally, since this study was performed in only one center, we are 
currently investigating the generalizability of the results for other centers and 
systematically implementing our screening procedure and tailored treatments in 
several centers in the Netherlands in an implementation project.
Assessment methods
The results reported in the studies in this thesis were mostly based on self-report 
questionnaires, all of which had been used in previous studies where they had 
shown good reliability and validity. We also applied two physical tests to 
complement the subjective outcomes on physical functioning. Norm scores of 
these tests still need to be established in several chronic pain conditions, including 
fibromyalgia. When evaluating physical test outcomes, we also recommend 
considering other factors that could affect physical fitness, such as age, body 
mass index, and the use of an independent assessor. In view of the known 
limitations of self-report measures, we recommend future effect studies to include 
a broader set of assessments to support the patients' self-reported health 
outcomes and cognitive behavioral patterns, such as daily self-observation lists to 
monitor symptom course, observer-rated activity tasks, and objective behavioral 
measures of activity levels (actometer, step counter).
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Screening procedures
In our studies we used a two-step screening protocol to select high-risk 
fibromyalgia patients with heightened distress scores and make a distinction 
between patients presenting pain-avoidance and those exhibiting pain-persis- 
tence patterns. Although the screening protocol has already been found to be 
suitable in clinical practice, some limitations for this procedure have to be 
mentioned. First, although the cut-off scores we used were based on anxiety and/ 
or negative mood scores of norm groups,3637 cut-off criteria are to some extent 
artificial boundaries and individuals scoring around the cut-off score run the 
greatest risk of being incorrectly categorized. Second, apart from dysfunctional 
cognitive behavioral patterns other factors such as negative life events and 
physical comorbidity, for instance, may influence distress levels. In order to 
exclude false positives, it is therefore preferable that patient selection based on 
the proposed self-report screening procedure in clinical practice is complemented 
by a more extensive assessment, such as a standardized, semi-structured interview 
conducted by a cognitive behavioral therapist.
With regard to the screening of the two patterns, patients manifesting pain- 
persistence patterns are identified based on the absence or relatively low presence 
of pain-avoidance behavior. It is not yet clear to what extent low pain-avoidance 
behavior is indicative of pain-persistence behavior. Second, the between-group 
differences in these pain-related cognitive behavioral factors may to some extent 
also be attributable to the patients' level of functioning, which was significantly 
worse for the subgroup with the pain-avoidance pattern. However, post-hoc 
analyses showed that the differences between the patients with pain-avoidance 
and those with pain-persistence patterns remained overall significant, also when 
indicators of physical and psychological functioning were added as covariates, 
which suggests that these are distinctive patterns characterized by specific 
pain-related cognitive behavioral factors (Chapter 3). Finally, cut-off points are 
used for the classification of pain-avoidance and pain-persistence patterns, while 
a continuous model may be more suitable. Despite the relatively high agreement 
we obtained between the therapist-based and screening-based patterns, there 
was still a group without such agreement, which may indicate some overlap 
between the two cognitive behavioral patterns. One may even argue that patients 
scoring around the cut-off point may benefit equally well from a pain-avoidance 
or a pain-persistence treatment. Accordingly, future studies should try to establish 
the relative independence or possible overlap between these two cognitive 
behavioral patterns.
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Future research
With our studies we showed that systematic pre-treatment screening and multi­
disciplinary treatment comprising CBT and physical exercise tailored to the 
patient's cognitive behavioral pattern is effective in improving the physical and 
psychological functioning, the impact of fibromyalgia on daily life, physical 
fitness, and cognitive behavioral factors in high-risk patients with fibromyalgia. 
However, several challenging questions merit additional discussion.
Cognitive behavioral factors in fibromyalgia
The contribution of the cognitive behavioral factors of pain-avoidance and pain- 
persistence require both more experimental and more longitudinal research. We 
will propose several directions for such future research. It is paramount to further 
delineate the underlying motivational mechanisms of pain-avoidance and pain- 
persistence patterns. For example, the mood-as-input theory, a recent approach 
to pain-related persistence, suggests a relationship between mood and so-called 
'stop rules'. Therefore, when people persist in an activity as long as possible, they 
will probably have adopted the so-called 'As-Many-As-Can' stop rule, while they 
will apply the 'Feel-Like-Discontinuing' stop rule when they decide to finish what 
they are doing due to a decrease in enjoyment.38 It is plausible to suggest that 
patients with a pain-avoidance and those with a pain-persistence pattern will 
differ in the use of these stop rules. Personality characteristics that may be related 
to persistence behavior in pain patients, such as low self-esteem and perfectionism, 
also warrant further research.3940 The suppression of pain-related thoughts and 
ignoring pain-related signals are also possible mechanisms, but the empirical 
evidence for these factors is scarce as yet.41 The short-term and long-term 
consequences of pain-persistence patterns in chronic pain conditions also merit a 
greater in-depth exploration. It has been argued that because patients remain 
active, persistence behavior may be a more adequate response, in view of the fact 
that avoidance of activities is the main contributing factor for the development of 
long-term complaints in these syndromes. Some studies indeed found that pain- 
persistence patterns in pain patients were negatively associated with functional 
disability.42 We also found that the patients with a pain-persistence pattern 
reported fewer and less severe complaints (including functional disability) than 
the patients with a pain-avoidance pattern, suggesting that the former pattern 
may be less maladaptive, at least in early stages of the condition (Chapters 3 and 
9). In this context it is important to underline that we only enrolled patients in our 
intervention studies who reported heightened levels of distress, with whom the
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patterns probably proved to be maladaptive. The adverse effects of the cognitive 
behavioral patterns were supported by the fact that the pain-avoidance as well as 
the pain-persistence group reported more (serious) complaints than the patients 
we had assessed as not being at risk (Chapters 7 and 9). Preliminary evidence also 
pointed to pain-persistence patterns as a risk factor for the development and 
maintenance of chronic pain.43 Nevertheless, additional research is needed to 
further clarify the short-term and long-term as well as the adaptive and maladaptive 
consequences of these two cognitive behavioral patterns. Moreover, the relative 
independence and long-term stability of these patterns should be further 
explored, because it is plausible that some patients may alternate or switch 
between the two patterns, depending on changes in circumstances or the course 
of their complaints. For example, it has been proposed that in pain syndromes, 
pain-persistence patterns may be particularly relevant in the transitional phase, 
i.e. the early, more acute stages before actual chronicity has set in, but that they 
are likely to eventually lead to exhaustion, exacerbated pain and frustration, and 
hence pain-avoidance behavior in the longer term.40 Finally, measures such as 
self-observation lists, daily pain/activity diaries or objective measures of activity 
levels (actometer, step counter) need to be validated to qualify and quantify 
patterns of pain-avoidance and pain-persistence and their underlying cognitive 
behavioral mechanisms.44 When testing our screening instrument (Chapter 3), for 
instance, we found that the objectively rated physical fitness of patients exhibiting 
pain-persistence patterns was superior to that of patients with pain-avoidance 
patterns, which may suggest that the former group did not merely claim that they 
persisted in (most of) their usual activities, but that they were also actually more 
physically active.
In addition to these pain-related cognitive behavioral factors, cognitive 
behavioral factors, such as the illness cognitions of helplessness and acceptance 
as well as perceived social support, have also been shown to be relevant when 
evaluating health outcomes in chronic pain conditions, including fibromyalgia.45'48 
The results of the studies presented in this thesis also support their relevance. 
In search of prognostic factors in still relatively well-functioning fibromyalgia 
patients (Chapter 4),for instance, we found that less acceptance and less perceived 
social support were predictive of an increased level of psychological distress 
several months later. In addition, high-risk fibromyalgia patients showed higher 
levels of helplessness and lower levels of acceptance than the patients not at risk 
and these factors showed significant post-treatment improvements and 6-month 
improvements after treatment (Chapters 5 and 9). Based on earlier and our current
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findings, the existing theoretical models of chronic pain can be extended by 
including cognitions of helplessness and acceptance and perceived social support. 
It has been suggested that helplessness as an attributional style in which patients 
focus on the adverse aspects of their condition is particularly relevant for the 
assessment and treatment of patients exhibiting pain-avoidance patterns, as 
these patients tend to catastrophize more about pain and pay more attention to 
pain.41'4950 We also found significant higher levels of helplessness in the patients 
with pain-avoidance patterns than in the patients showing pain-persistence 
patterns (Chapter 9). Furthermore, several studies have shown the protective 
effects of high acceptance and perceived social support that may be related to 
more adaptive cognitive behavioral patterns in chronic pain patients.4551 Future 
research should aim at investigating the role of both specific and generic factors 
in the development of pain-avoidance and pain-persistence patterns.
Tailoring treatment in fibromyalgia
The efficacy of our tailored treatment approach needs to be substantiated by 
trials directly comparing the effects for high-risk and low-risk fibromyalgia 
patients and for patients with a recent diagnosis and those with longstanding 
diagnosis, as well as tailored versus non-tailored or mismatched treatments. 
To date, little is also known about the specific cognitive behavioral mechanisms 
that are responsible for therapeutic changes in health outcomes. Most treatment 
interventions comprise a broad range of therapeutic techniques, making it 
difficult to examine the specific working mechanisms and treatment components 
responsible for the treatment effects. In order to further improve treatment 
efficacy, we need to learn more about these mechanisms of change, i.e. the 
mediators by which we can explain the treatment effects and the moderators 
(e.g., treatment and patient characteristics) by which we can predict or moderate 
treatment success.24 Our explorative mediation analyses showed that 
pain-avoidance behavior and activity pacing may be relevant mechanisms of 
change in the pain-avoidance and the pain-persistence treatment, respectively 
(Chapter 9). However, we used cross-sectional data obtained during treatment, 
which leaves the direction of the causality open to question. Adding assessments 
during treatment or using cross-lagged panel analyses will help demonstrate 
whether observed changes occurred before a change in functioning orvice versa. 
Future research should further focus on the specific working mechanisms of 
pain-avoidance and pain-persistence treatments, in addition to the factors of 
pain-avoidance behavior and activity pacing. Specific moderator analyses may
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also be added in trials directly comparing the effects for patients with high- and 
low-risk profiles and more recent and longstanding diagnosis. Knowledge about 
these possible moderators may support the present findings that psychological 
functioning improved more in high-risk patients with a shorter duration of 
complaints, underscoring the idea that tailored treatments are more effective in 
an early stage of the condition. Finally, the possible additional contribution of 
recent treatment developments, such as adding components of acceptance- 
based treatments5253 as well as E-health applications for specific cognitive 
behavioral modules,5455 may be a focus in future studies. As to the cost-effective- 
ness of our tailored treatment approach to fibromyalgia, future studies should 
include economic outcome measures more systematically, such as health care 
consumption and prescription drug use. Explorative post-hoc analyses in our 
study suggested a reduction in the use of health care during the 6-month 
follow-up in terms of fewer visits to the physiotherapist and fewer applications for 
medical devices in the treatment condition compared to the control condition. 
However, future studies may study changes in direct and indirect costs more 
systematically in terms of use of health care and work productivity. When 
incorporating our tailored treatment approaches into standard care, stepwise 
treatment options depending on the patient's risk factors may have the greatest 
chance of being most cost-effective.
Clinical implications and implementation
The screening protocol for fibromyalgia patients helps select those patients who 
are most at risk of long-term dysfunction and therefore most likely to benefit from 
the current multidisciplinary treatment consisting of tailored cognitive behavioral 
therapy and exercise training. Pending further reliability and validity studies, the 
instrument has a potential for use in the clinical practice. The self-report instrument 
is easy to administer and provides an insight into how the patient perceives and 
copes with his or her condition. It also estimates cognitive and behavioral risk 
factors that are not usually assessed as part of the regular clinical care. This hence 
allows high-risk patients to be identified in an early stage of the condition, which 
may help prevent chronicity and long-term dysfunction.The screening instrument 
can also be conveniently used to distinguish between patients with different 
pain-related cognitive behavioral patterns, i.e. pain-avoidance and pain- 
persistence patterns, allowing interventions to be tailored to the patients' main 
dysfunctional cognitive behavioral pattern. Although the results of both screening 
instruments are promising, the reliability and validity has to be further examined.
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Therefore, we recommend extending the self-assessments by a more extensive 
assessment in clinical practice,for instance a semi-structured interview conducted 
by cognitive behavioral therapists experienced in dysfunctional cognitive 
behavioral patterns.
Based on our overall large effects up to six months after treatment, we 
tentatively conclude that tailoring fibromyalgia treatment to patients with the 
distinct patterns of pain-avoidance or pain-persistence shows a great promise for 
optimizing treatment outcome. By specifically targeting the patient's individual 
cognitive behavioral pattern we obtained substantial improvements in the overall 
functioning of relatively recently diagnosed high-risk patients. Apart from adding 
empirical support, our studies also fit in well with the recent interest of healthcare 
professionals in tailored interventions. Tailoring interventions to specific 
subgroups offers interesting possibilities for a stepped care approach: besides 
selecting and offering the high-risk patients intensive multidisciplinary treatment, 
psycho-education about possible risk factors should be considered for those 
patients who are currently assessed as not being high-risk patients.
In a recently undertaken implementation project, the first steps to 
systematically implement our screening procedure and tailored treatments in 
several centers in the Netherlands have been made. Extensive protocols for the 
screening and intake procedure were developed and an elaborate treatment 
manual with supporting patient materials was made available. The cognitive 
behavioral and physiotherapists of the participating centers have been specially 
trained. The first results show that both the screening protocol and treatments 
are feasible for implementation in clinical practice, now that the screening 
procedure and tailored treatments are currently being used in various centers in 
the Netherlands.
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Conclusions
The main conclusions we can draw from the results obtained with the studies 
presented in this thesis can be summarized as follows:
- A screening instrument has been developed that distinguishes between 
pain-avoidance and pain-persistence patterns in fibromyalgia patients at risk of 
long-term dysfunction in order to select patients who can benefit from tailored 
multidisciplinary treatment.
- Cognitive behavioral therapy and exercise training specifically tailored to the 
patient's pain-avoidance or pain-persistence pattern is effective in improving 
self-reported physical and psychological functioning, the impact of fibromyalgia 
in daily life, physical fitness, and cognitive behavioral factors in high-risk 
fibromyalgia patients in a relatively early stage after their diagnosis.
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Fibromyalgie is een veelvoorkomende chronische pijnaandoening waarvan de 
oorzaak grotendeels onbekend is. Patiënten rapporteren naast wijdverspreide 
pijn ook andere klachten zoals functionele bewegingsbeperkingen, vermoeid heid, 
(ochtend)stijfheid, slaapproblemen, angst en depressieve klachten. Biopsychoso- 
ciale modellen beschrijven verschillende factoren die mogelijk bijdragen aan de 
ontwikkeling, instandhouding en verergering van deze klachten. Met betrekking 
tot de behandeling van deze aandoening worden de meest veelbelovende 
resultaten gevonden voor multidisciplinaire behandelingen, bestaande uit 
cognitieve gedragstherapie (CGT) en oefentherapie, die zijn gebaseerd op deze 
biopsychosociale modellen. Echter, de effectiviteit is beperkt en niet alle patiënten 
rapporteren dezelfde verbetering na de behandeling. In onderzoek bij patiënten 
met fibromyalgie en andere chronische pijnaandoeningen werden aanwijzingen 
verkregen dat de effectiviteit van interventies verbeterd kan worden als er 
rekening wordt gehouden met de heterogeniteit van de patiëntenpopulatie. Het 
voornaamste doel van de studies die beschreven worden in dit proefschrift was 
dan ook om mogelijke screeningsmethoden te verkennen voor de identificatie 
van specifieke patiëntgroepen en om vervolgens de effectiviteit te onderzoeken 
van behandelingen op maat toegespitst op specifieke disfunctionele cognitieve 
gedragspatronen bij patiënten met fibromyalgie.
Na een inleiding (Hoofdstuk 1) werd in deel 1 van dit proefschrift (Hoofdstuk 2) 
de theoretische achtergrond, de laatste ontwikkelingen en aanbevelingen van 
non-farmacologische behandelopties, zoals CGT en oefentherapie, voor de 
behandeling van fibromyalgie besproken. In deel 2 (Hoofdstukken 3 en 4) werden 
verschillende screeningsmethoden beschreven om specifieke patiëntgroepen te 
selecteren voor multidisciplinaire behandelingen. Het doel van deze studies was 
om meer inzicht te krijgen in verschillende risicoprofielen bij patiënten met 
fibromyalgie met betrekking tot de mate van psychologische distress en twee 
verschillende cognitieve gedragspatronen, een pijnvermijding versus een pijn- 
persistentie patroon. In deel 3 (Hoofdstukken 5 tot en met 9) werden de resultaten 
beschreven van verschillende studies waarin de effectiviteit werd onderzocht van 
behandelingen op maat bestaande uit CGT en oefentherapie die werden 
aangeboden aan patiënten met een verhoogd risico op langere termijn 
disfunctioneren in een relatief vroeg stadium na de diagnose. Vervolgens werden 
in Hoofdstuk 10 en 11 de resultaten van de verschillende studies samengevat en 
bediscussieerd.
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Deel 1: Theoretische en empirische achtergrond van de behandeling van 
fibromyalgie
In Hoofdstuk 2 werd een overzicht gegeven van de resultaten van verschillende 
studies naar de effectiviteit van niet-farmacologische behandelingen, inclusief 
CGT, oefentherapie en combinaties hiervan. Dertig studies met een 
gerandomiseerd, gecontroleerd design gepubliceerd voor januari 2006 werden 
geïncludeerd in deze review. In overeenstemming met eerdere meta-analyses en 
reviews vonden we dat combinaties van CGT en oefentherapie de meest 
veelbelovende resultaten lieten zien. Echter, ook de effectiviteit van deze multi­
disciplinaire behandelingen bleek beperkt en het positieve effect verdween vaak 
op de langere termijn. Daarnaast lieten de resultaten zien dat er sprake was van 
een grote individuele variatie en dat niet alle patiënten evenveel baat hadden bij 
dezelfde behandeling. Patiënten met fibromyalgie ontvangen doorgaans dezelfde 
behandeling wat mogelijk leidt tot een hoge dropout en kleine effecten door de 
hoge variabiliteit in klachten en patiëntkarakteristieken. In overeenstemming met 
eerdere aanbevelingen en voorlopige behandelresultaten werd verondersteld 
dat de effectiviteit van behandelingen bij fibromyalgie vergroot kan worden door 
behandelingen op maat aan te bieden in een relatief vroeg stadium na de diagnose 
aan patiënten met een verhoogd risico op langere termijn disfunctioneren.
Deel 2: Screeningsmethoden voor behandelingen op maat bij fibromyalgie
Een betrouwbare en valide screeningsmethode om patiëntgroepen met een 
risicoprofiel te identificeren is een eerste vereiste voor een succesvolle behandeling 
op maat. In het algemeen kunnen er twee belangrijke indicatoren van een 
verslechtering op de langere termijn bij patiënten met fibromyalgie worden 
geïdentificeerd, namelijk de mate van psychologische distress en specifieke 
cognitieve gedragsfactoren.
Het doel van de studie beschreven in Hoofdstuk 3 was om de validiteit 
te onderzoeken van een screeningsinstrument dat gebruikt werd om een onder­
scheid te maken tussen patiënten met verschillende cognitieve gedragspatronen, 
namelijk een pijnvermijding en een pijnpersistentie patroon. De validiteit van 
het instrument werd ondersteund door de significante verschillen die werden 
gevonden tussen patiënten met een pijnvermijding en een pijnpersistentie 
patroon op specifieke pijngerelateerde cognitieve gedragsfactoren en de fysieke 
conditie. Daarnaast werd een hoge overeenkomst (75-80%) gevonden tussen het 
screeningsinstrument en het oordeel van een therapeut die blind was voor de 
resultaten van het screeningsinstrument. Ondanks dat verder onderzoek naar dit
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screeningsinstrument wenselijk is, laten de resultaten zien dat een screenings- 
instrument gebaseerd op een korte zelfrapportage vragenlijst voldoende is om 
een betrouwbaar onderscheid te maken tussen specifieke cognitieve gedrags­
patronen en mogelijk geschikt is voor gebruik in de klinische praktijk.
In dit onderzoek werd tevens een screeningsmethode gebruikt om patiënten 
met een verhoogde mate van psychologische distress te selecteren, aangezien 
deze groep een verhoogd risico heeft op een verergering van de klachten op de 
langere termijn. Daarnaast is hetvan belang om mogelijke risicofactoren voor een 
negatief langere termijn beloop te identificeren in de groep patiënten met een 
huidig laag niveau van distress, omdat deze patiënten vaak niet in aanmerking 
komen voor multidisciplinaire behandelingen. Het doel van de studie beschreven 
in Hoofdstuk 4 was dan ook om risicofactoren te identificeren die voorspellend 
zijn voor een toename in distress in deze relatief goed functionerende subgroep. 
We vonden dat specifieke ziektecognities, verschillende pijnvermijdingsfactoren 
en sociale factoren geassocieerd waren met een verandering in distress een aantal 
maanden later. Een hoger niveau van distress kon in het bijzonder worden 
voorspeld door een hoger niveau van hypervigilantie (verhoogde aandacht 
voor pijn) en een lager niveau van acceptatie en waargenomen sociale steun. 
Deze prognostische factoren bieden aanknopingspunten om in de klinische 
praktijk in een vroeg stadium patiënten met een verhoogd risico te identificeren 
en disfunctioneren op de langere termijn te voorkomen door hen vroegtijdig een 
gerichte behandeling aan te bieden.
Deel 3: Een behandeling op maat voor fibromyalgie
Bij de ontwikkeling van een behandeling is het ook van belang om de haalbaarheid 
en mogelijke effectiviteit in kaart te brengen door middel van case studies. 
In Hoofdstuk 5 werden twee case studies met de bijbehorende behandel- 
protocollen van de pijnvermijding en pijnpersistentie behandelingen beschreven. 
Het beloop van de behandeling voor een patiënt met een pijnvermijding patroon 
en een patiënt met een pijnpersistentie patroon werd in detail beschreven om de 
Ínhoud en de voortgang van de twee behandelingen op maat te beschrijven. 
Beide interventies werden in groepsverband met ongeveer 8 deelnemers gegeven 
en bestonden uit 16 bijeenkomsten van CGT en oefentherapie die tweemaal per 
week plaatsvonden en een terugkomdag drie maanden na de behandeling. 
De pijnvermijding behandeling was gericht op een toename van de dagelijkse 
activiteiten en het verminderen van het pijnvermijdingsgedrag. Dit werd gedaan 
door de deelnemers aan te moedigen tot een graduele en systematische toename
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van hun dagelijkse activiteiten met individuele doelen en de blootstelling aan 
angstgerelateerde situaties als leidraad. De pijnpersistentie behandeling 
daarentegen was gericht op het verminderen van het pijnpersistentie gedrag van 
de deelnemers door hen te leren hun activiteiten in balans te houden en activiteit 
en inactiviteit voldoende af te wisselen, gevolgd door een graduele toename in 
dagelijkse activiteiten. De vergelijking van de metingen voor de behandeling, 
direct na de behandeling en 6 maanden na de behandeling op de uitkomstmaten 
pijn, functionele beperkingen, vermoeidheid, angst en depressie liet een klinisch 
significante verbetering zien voor beide case studies. Ook de twee fysieke testen 
die werden afgenomen voor de behandeling, na de behandeling en 3 maanden 
na de behandeling lieten een verbeterd functioneren zien. Op basis van deze 
positieve resultaten werd geconcludeerd dat een behandeling bestaande uit CGT 
en oefentherapie op maat haalbaar is en mogelijk leidt tot klinisch significante 
verbeteringen in fibromyalgie patiënten met een verhoogd risicoprofiel.
In onderzoek en de klinische praktijk wordt steeds meer belang gehecht aan 
het perspectief van de patiënt en dit wordt gezien als een belangrijke indicator 
voor behandeleffecten. De relatie tussen het perspectief van de patiënt op de 
vooruitgang tijdens de behandeling en gestandaardiseerde veranderingen in 
voor- en nametingen is echter onduidelijk. In Hoofdstuk 6 werd om die reden het 
perspectief van de patiënt met betrekking tot de uitkomsten van de behandelingen 
op maat onderzocht door deze te vergelijken met de behandelresultaten op basis 
van de voor- en nametingen van de fysieke en psychische uitkomstmaten die 
werden gemeten met gevalideerde zelfrapportage instrumenten. Correlaties 
tussen de uitkomsten vanuit het perspectief van de patiënt en de verschillen 
tussen de voor- en nameting op de fysieke uitkomstmaten (pijn, vermoeidheid, 
functionele beperkingen) varieerden van gemiddeld tot relatief hoog, terwijl de 
correlaties met betrekking tot de psychische uitkomstmaten (angst en depressie) 
klein of niet-significant waren. Deze resultaten suggereren dat het perspectief 
van de patiënt met betrekking tot de vooruitgang tijdens de behandeling en de 
verschillen tussen de voor- en nametingen verschillende aspecten van het 
behandelbeloop meten.
In Hoofdstuk 7 onderzochten we de effectiviteit van twee behandelingen op 
maat bij patiënten in een relatief vroeg stadium na de diagnose fibromyalgie. 
Patiënten met een verhoogd risicoprofiel werden geselecteerd en vervolgens 
gerandomiseerd naar een wachtlijstcontroleconditie of een behandeling toegespitst 
op hun specifieke pijnvermijding of pijnpersistentie patroon. De primaire uitkomst­
maten van het fysieke functioneren (pijn, vermoeid heid, functionele beperkingen).
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het psychische functioneren (angst, depressie) en de totale impact van 
fibromyalgie op het dagelijks functioneren werden gemeten voorde behandeling, 
direct na de behandeling en 6 maanden na de behandeling. De patiënten in de 
behandelconditie lieten, vergeleken met de controlegroep, een verbetering zien 
in hun fysieke en psychische functioneren. De mate van pijn, vermoeidheid, 
functionele beperkingen, angst, depressie en de impact van fibromyalgie op het 
dagelijkse leven nam significant af tijdens de behandeling en deze resultaten 
werden behouden gedurende defollow-up. Er werden geen verschillen gevonden 
tussen de pijnvermijding en de pijnpersistentie behandeling. De klinische 
relevantie van deze resultaten werd in kaart gebracht door middel van 
effectgroottes en de berekening van het percentage responders voor beide 
condities. De effectgroottes op de nameting en de follow-up meting waren over 
het algemeen groot en het percentage responders was hoger in de behandel­
conditie vergeleken met de controleconditie, wat duidt op een klinische relevante 
verandering.
In Hoofdstuk 8 onderzochten we de effectiviteit van de behandeling met 
betrekking tot de fysieke conditie van de patiënten. De resultaten van twee 
fysieke testen voor de behandeling en 3 maanden na de behandeling toonden 
aan dat, relatief aan de controleconditie, de behandelde patiënten een significant 
verbeterde conditie hadden met grote effectgroottes. De behandelde patiënten 
gaven na de behandeling tevens aan de fysieke activiteit als lichamelijk minder 
belastend te ervaren, vergeleken met de patiënten in de controleconditie.
Om meer inzicht te verkrijgen in de werkzame mechanismen van de 
pijnvermijding en pijnpersistentie behandelingen werd in Hoofdstuk 9 het effect 
onderzocht met betrekking tot verschillende pijngerelateerde cognitieve 
gedragsfactoren. Hierbij werd specifiek de rol van pijnvermijdingsgedrag in de 
pijnvermijding behandeling onderzocht en de rol van activiteiten regulatie in de 
pijnpersistentie behandeling, aangezien dit de belangrijkste veronderstelde 
mechanismen zijn van deze gedragspatronen. De resultaten lieten zien dat de 
pijnvermijding behandeling effectief was in het verminderen van pijnvermijdings­
gedrag en de pijnpersistentie behandeling in het verbeteren van de activiteiten- 
regulatie. De mediatie analyses ondersteunden tevens een medieërend effect 
van pijnvermijdingsgedrag in de pijnvermijding behandeling en van activiteiten- 
regulatie in de pijnpersistentie behandeling. Deze resultaten tonen aan dat een 
pijnvermijding en een pijnpersistentie behandeling toegespitst op het cognitieve 
gedragspatroon van de patiënt effectief is in respectievelijk het verbeteren van 
pijnvermijdingsgedrag en activiteitenregulatie en dat deze factoren de positieve
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uitkomsten op het fysieke en psychische functioneren deels kunnen verklaren.
Geconcludeerd kan worden dat de studies beschreven in dit proefschrift 
aantonen dat een systematische screening van specifieke subgroepen en een 
multidisciplinaire behandeling bestaande uit CGT en oefentherapie toegespitst 
op het cognitieve gedragspatroon van de patiënt effectief is in het verbeteren 
van het fysieke en psychische functioneren van patiënten met fibromyalgie op 
zowel de korte als de langere termijn. Aangezien eerder onderzoek slechts kleine 
tot gem iddelde effecten liet zien, lijkt een dergelijke behandeling op maat 
veelbelovend voor een verbetering van het fysieke en psychische welbevinden 
van patiënten met fibromyalgie om hiermee de last voor de patiënt en de 
maatschappij te verminderen. Toekomstig onderzoek dient zich te richten op het 
onderzoeken van de langere termijn (kosten-)effectiviteit van deze behandeling 
en het verder in kaart brengen van de specifieke cognitieve gedragsmechanismen 
die verantwoordelijk zijn voor de positieve behandelresultaten.
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